
<html lang="en"     class="pb-page"  data-request-id="d53df2c7-2e7d-4e51-9875-8e61f20cad1b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01700"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition" /></meta><meta name="dc.Creator" content="Sanket J.  Mishra" /></meta><meta name="dc.Creator" content="Weiya  Liu" /></meta><meta name="dc.Creator" content="Kristin  Beebe" /></meta><meta name="dc.Creator" content="Monimoy  Banerjee" /></meta><meta name="dc.Creator" content="Caitlin N.  Kent" /></meta><meta name="dc.Creator" content="Vitumbiko  Munthali" /></meta><meta name="dc.Creator" content="John  Koren, III" /></meta><meta name="dc.Creator" content="John A  Taylor, III" /></meta><meta name="dc.Creator" content="Leonard M.  Neckers" /></meta><meta name="dc.Creator" content="Jeffrey  Holzbeierlein" /></meta><meta name="dc.Creator" content="Brian S. J.  Blagg" /></meta><meta name="dc.Description" content="The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding of select proteins, many of which are directly associated with cancer progression. Consequently, ..." /></meta><meta name="Description" content="The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding of select proteins, many of which are directly associated with cancer progression. Consequently, ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 11, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01700" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01700" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01700" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01700" /></link>
        
    
    

<title>The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01700" /></meta><meta property="og:title" content="The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0015.jpeg" /></meta><meta property="og:description" content="The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding of select proteins, many of which are directly associated with cancer progression. Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways. Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials for the treatment of cancer, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms, which may lead to adverse effects. The development of Hsp90 isoform-selective inhibitors represents an alternative approach toward the treatment of cancer and may limit some of these detriments. Described herein, is a structure-based approach to develop isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels. Together, these initial studies support the development of Hsp90β-selective inhibitors as a method for overcoming the detriments associated with pan-inhibition." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01700"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01700">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01700&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01700&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01700&amp;href=/doi/10.1021/acs.jmedchem.0c01700" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1545-1557</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01692" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01707" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with <i>pan</i>-Hsp90 Inhibition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sanket J. Mishra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sanket J. Mishra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sanket+J.++Mishra">Sanket J. Mishra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weiya Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weiya Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Urologic Oncology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weiya++Liu">Weiya Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristin Beebe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristin Beebe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Rockville, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Beebe">Kristin Beebe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Monimoy Banerjee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monimoy Banerjee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monimoy++Banerjee">Monimoy Banerjee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Caitlin N. Kent</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caitlin N. Kent</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caitlin+N.++Kent">Caitlin N. Kent</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vitumbiko Munthali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vitumbiko Munthali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vitumbiko++Munthali">Vitumbiko Munthali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Koren III</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Koren, III</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Koren%2C++III">John Koren, III</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John A Taylor III</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John A Taylor, III</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Urologic Oncology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+A++Taylor%2C++III">John A Taylor, III</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leonard M. Neckers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leonard M. Neckers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Rockville, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leonard+M.++Neckers">Leonard M. Neckers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey Holzbeierlein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey Holzbeierlein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Urologic Oncology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey++Holzbeierlein">Jeffrey Holzbeierlein</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Brian S. J. Blagg</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian S. J. Blagg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7715151b16101037191359121302"><span class="__cf_email__" data-cfemail="2e4c4c424f49496e404a004b4a5b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+S.+J.++Blagg">Brian S. J. Blagg</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6200-3480" title="Orcid link">http://orcid.org/0000-0002-6200-3480</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01700&amp;href=/doi/10.1021%2Facs.jmedchem.0c01700" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1545–1557</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 11, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 September 2020</li><li><span class="item_label"><b>Published</b> online</span>11 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01700" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01700</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1545%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSanket%2BJ.%2BMishra%252C%2BWeiya%2BLiu%252C%2BKristin%2BBeebe%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D3%26contentID%3Dacs.jmedchem.0c01700%26title%3DThe%2BDevelopment%2Bof%2BHsp90%25CE%25B2-Selective%2BInhibitors%2Bto%2BOvercome%2BDetriments%2BAssociated%2Bwith%2Bpan-Hsp90%2BInhibition%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1557%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01700"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1617</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01700" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sanket&quot;,&quot;last_name&quot;:&quot;J. Mishra&quot;},{&quot;first_name&quot;:&quot;Weiya&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Beebe&quot;},{&quot;first_name&quot;:&quot;Monimoy&quot;,&quot;last_name&quot;:&quot;Banerjee&quot;},{&quot;first_name&quot;:&quot;Caitlin&quot;,&quot;last_name&quot;:&quot;N. Kent&quot;},{&quot;first_name&quot;:&quot;Vitumbiko&quot;,&quot;last_name&quot;:&quot;Munthali&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Koren&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A Taylor&quot;},{&quot;first_name&quot;:&quot;Leonard&quot;,&quot;last_name&quot;:&quot;M. Neckers&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;Holzbeierlein&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;S. J. Blagg&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;1545-1557&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01700&quot;},&quot;abstract&quot;:&quot;The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding of select proteins, many of which are directly associated with cancer progression. Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways. Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials for the treatment of cancer, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms, which may lead to adverse effects. The development of Hsp90 isoform-selective inhibitors represents an alternative approach toward the treatment of cancer and may limit some of these detriments. Described herein, is a structure-based approach to develop isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels. Together, these initial studies support the development of Hsp90β-selective inhibitors as a method for ov&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01700&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01700" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01700&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01700" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01700&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01700" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01700&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01700&amp;href=/doi/10.1021/acs.jmedchem.0c01700" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01700" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01700" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01700%26sid%3Dliteratum%253Aachs%26pmid%3D33428418%26genre%3Darticle%26aulast%3DMishra%26date%3D2021%26atitle%3DThe%2BDevelopment%2Bof%2BHsp90%25CE%25B2-Selective%2BInhibitors%2Bto%2BOvercome%2BDetriments%2BAssociated%2Bwith%2Bpan-Hsp90%2BInhibition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D3%26spage%3D1545%26epage%3D1557%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/jmcmar.2021.64.issue-3/20210211/jmcmar.2021.64.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding of select proteins, many of which are directly associated with cancer progression. Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways. Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials for the treatment of cancer, all of which bind the Hsp90 N-terminus and exhibit <i>pan</i>-inhibitory activity against all four Hsp90 isoforms, which may lead to adverse effects. The development of Hsp90 isoform-selective inhibitors represents an alternative approach toward the treatment of cancer and may limit some of these detriments. Described herein, is a structure-based approach to develop isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels. Together, these initial studies support the development of Hsp90β-selective inhibitors as a method for overcoming the detriments associated with <i>pan</i>-inhibition.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The molecular chaperone, heat shock protein 90 kDa (Hsp90), regulates cellular homeostasis by assisting in the maturation of nascent polypeptides, the refolding of denatured proteins, and the disaggregation of protein aggregates.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Hsp90 modulates the conformation of more than 300 client protein substrates into their biologically active conformation. Many of these client proteins, such as signaling proteins, are drivers of cancer progression, initiation, and/or metastasis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In fact, Hsp90’s clients are associated with all 10 hallmarks of cancer, and in principle, Hsp90 inhibition should mimic the effects of combination therapy.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> As a result, Hsp90 has emerged as a promising target for the development of anti-cancer agents.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10">(3−10)</a></div><div class="NLM_p">Hsp90 as a chemotherapeutic target is further supported by its upregulation during malignant transformation, maintenance, and progression.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Despite its abundance in normal tissues, Hsp90 can be targeted selectively in tumor cells due to increased levels of the Hsp90 heteroprotein complex that resides within cancer cells and possesses >200-fold higher affinity for ATP/inhibitors than the Hsp90 homodimer found in normal cells.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Consequently, Hsp90 inhibitors accumulate in tumor cells at significantly higher concentrations than normal tissues and exhibit a large therapeutic window. As a result, Hsp90 has been extensively sought after as a therapeutic target for the treatment of cancer and, ultimately, led to the investigation of 17 clinical candidates.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14−17)</a> Unfortunately, the clinical evaluation of these inhibitors has produced a number of complications.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23">(18−23)</a> Detriments observed with current Hsp90 inhibitors include the lack of translational efficacy, induction of the heat shock response (HSR) that produces increased levels of Hsp90, and on-target toxicities amongst others. Hsp90 inhibitors that have undergone clinical investigation for the treatment of cancer bind the N-terminal nucleotide-binding site and inhibit all four Hsp90 isoforms (<i>pan</i>-inhibition) with similar affinity.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> The Hsp90ß isoform is constitutively expressed in the cytoplasm, whereas Hsp90α is inducible and expressed in the cytosol upon exposure to cellular stress. The organelle-specific isoforms glucose-regulated protein 94 (Grp94) reside in the endoplasmic reticulum, and tumor necrosis factor receptor-associated protein 1 (Trap-1) is localized to the mitochondria.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Recent studies have shown that maturation and trafficking of the hERG channel is solely dependent upon the Hsp90α isoform, suggesting that inhibition of Hsp90α is likely to contribute toward the cardio and ocular toxicities observed in clinical trials.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Consequently, isoform-selective inhibitors may prove useful to identify isoform-dependent substrates and overcome the liabilities associated with <i>pan</i>-inhibition.</div><div class="NLM_p">Hydrolysis of ATP by the N-terminal nucleoside-binding pocket provides the requisite energy needed for the maturation of client protein substrates, and all four Hsp90 isoforms share >85% identity within this region.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31">(27−31)</a> In fact, 21 of the 29 residues within this pocket are totally conserved, and the remaining 8 share a high degree of similarity. Grp94 manifests the lowest identity within the N-terminal-binding site, as Grp94 exhibits a unique structural feature that results from a five-amino acid insertion into the primary sequence, which translates into a Grp94-exclusive binding pocket. Prior studies exploited the Grp94-exclusive binding pocket and led to isoform-selective inhibitors, which have revealed unexpected therapeutic opportunities for Grp94-selective inhibition.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> As a result, multiple scaffolds that manifest selective Grp94 inhibition have now been disclosed. In contrast, Hsp90α and Hsp90ß share ∼95% identity within this region and only two amino acids differ between these isoforms, making the development of Hsp90α- or Hsp90ß-selective inhibitors very challenging.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a><b>KUNB31</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) represents the first Hsp90ß isoform-selective inhibitor discovered, which was achieved by taking advantage of subtle differences between the Hsp90α and Hsp90β co-crystal structures and analysis of the conserved water molecules that reside within these regions.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Remarkably, <b>KUNB31</b> was shown to induce the degradation of Hsp90β-dependent clients without concomitant induction of Hsp90 levels, providing an alternate approach for the treatment of cancer that addresses two of the major detriments associated with <i>pan</i>-Hsp90 inhibitors (Hsp90 induction and hERG maturation).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Water-mediated network of hydrogen bonds. (A) Hydrogen-bonding network at the bottom of the Hsp90β pocket (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>). (B) Hydrogen-bonding network in the bottom of the Hsp90α-binding pocket (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XAB">2XAB</a>). (C) Two-dimensional representation of the Hsp90β-binding pocket with the known <i>pan</i>-inhibitor AT11387. (D) <b>KUNB31</b> bound to Hsp90β with apparent Kd values observed in fluorescence polarization assay (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UCJ">5UCJ</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sequence alignment of the residues that form the Hsp90α and Hsp90β N-terminal ATP-binding pockets revealed Hsp90β to contain Ala52 and Leu91 in lieu of Ser52 and Ile91, which are present in Hsp90α (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B). Substitution of these two amino acids results in a small and extended binding pocket in Hsp90β (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B) due to the increased flexibility of Leu91, unlike Ile91 in Hsp90α (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref31 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref35">(31,35)</a> In addition, all four Hsp90 isoforms contain a water-mediated hydrogen bond network in close proximity to Asp93 that facilitates Hsp90’s interactions with ligands, as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B. In silico overlay of the Hsp90α and Hsp90β co-crystal structures indicate, these water molecules play a different role in each isoform. Ser52 is replaced with Ala52 in Hsp90β and forms a hydrogen bond with bound water molecule <b>A</b>, whereas Ala52 does not participate in the hydrogen-bonding network. Therefore, it was hypothesized that Hsp90β-selective inhibitors could be developed via the introduction of substituents that sterically clash with Ile91 in Hsp90α and, consequently, disrupt the water-mediated hydrogen-bonding network.</div><div class="NLM_p last"><b>KUNB31</b> is a ring-constrained variant of substitutions at the 3- and 4-positions, which were designed to minimize the entropic penalty upon binding Hsp90β, while simultaneously displacing water molecules <b>A</b> and <b>B</b> (visible in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). <b>KUNB31</b> was found to manifest an apparent Kd of 180 nM against Hsp90β and ∼50-fold selectivity versus other Hsp90 isoforms. Through solution of the co-crystal structure, it was confirmed that <b>KUNB31</b> displaced both water molecules and validated this approach toward the development of Hsp90β-selective inhibitors. Based on these observations, a new scaffold was pursued in an effort to improve both affinity and selectivity for Hsp90ß. Reported herein, is the rational development of an isoquinolin-1(2<i>H</i>)-one-containing inhibitor that selectively binds the Hsp90β isoform with nanomolar affinity and exhibits greater than 200-fold selectivity versus other Hsp90 isoforms.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>SNX 2112</b> is a benzamide-containing Hsp90 inhibitor that was previously reported (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) and shown to exhibit equipotent affinity for both Hsp90α and Hsp90β (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Subsequent optimization by Vertex Pharmaceuticals led to <b>31</b>, which manifests selective inhibition of both Hsp90α and Hsp90β without affinity for Grp94 and Trap1. The co-crystal structure of <b>31</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O0B">4O0B</a>) bound to Hsp90α was overlaid with the Hsp90β co-crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>), which revealed <b>31</b> does not interfere with the conserved water molecules found in the Hsp90α/β pockets (depicted as red spheres in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, labeled as <b>A</b> and <b>B</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Compound <b>31</b> also contains a ring-constrained benzamide group, which appears to lock the amide into a rigid conformation to facilitate interactions with Asp93.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Molecular modelling studies with <b>31</b> suggested that modifications to the 2′-position (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B) could displace the conserved water molecules and extend into the Hsp90β subpocket and produce Hsp90ß-selective inhibition.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Structures and IC50’s of the benzamide-based Hsp90 inhibitors SNX 2112 and compound <b>31</b> in the FP assay. (B) Alignment of compound <b>4</b> (yellow) and compound <b>31</b> modeled into the Hsp90α (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O0B">4O0B</a>) and Hsp90ß (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>) ATP-binding pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to modifications at the 2-position, the cyclopentyl group was replaced with a <i>trans</i>-4-cylcohexanolamine to enhance occupation and increase solubility. The tetrahydroindazolone fragment was also incorporated in lieu of the pyrazolone present in compound <b>31</b>, as it does not change affinity significantly. The unsaturated alkene was used to explore the spatial constraints of the Hsp90β-subpocket, as computational studies supported that its introduction would allow the benzamide to maintain key interactions with Asp93 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The 2′-position substitutions in the proposed compound series represented by <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) appeared to project toward the Hsp90β-specific subpocket, allowing investigation of this subpocket as depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B. Given the hydrophobic nature of the Hsp90β subpocket, linear aliphatic chains were attached to the 2′-position for investigation of the initial analogues. In addition, methyl ethers and alcohols were attached to the 2′-position to probe for beneficial interactions with Leu-48 (in both α and β) and/or Ser-52 in Hsp90α.</div><div class="NLM_p">Synthesis of these analogues commenced via installation of the saturated indazolone (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, Ethanol, 60<sup>o</sup> C. (b) 2-Acetyldimedone, Ethanol, Reflux. (c) β-ketoester, K<sub>2</sub>CO<sub>3</sub>, DMF, 70<sup>o</sup> C. (d) H<sub>2</sub>SO<sub>4</sub>/Water/Acetic Acid (2:1:7), 130 °C, 6 h. (e) <i>tran</i>s-Cyclohexanolamine, DIPEA, DMSO, 140<sup>o</sup> C, 12 h</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">2,4,6-Trifluorobenzonitrile (<b>1</b>) was treated with hydrazine hydrate and 2-acetyl dimedone to produce <b>2</b>, which was subsequently exposed to a variety of β-ketoesters that contained the desired R-groups in the presence of potassium carbonate to ultimately give the β-ketoester-substituted benzonitriles. The resulting benzonitriles underwent condensation and cyclization reactions upon treatment with acetic acid and sulfuric acid to yield intermediates <b>3a–3i</b>. The <i>trans</i>-4-aminocyclohexanol moiety was installed via an SNAr reaction in the presence of diisopropylethylamine to furnish the final products, <b>4a–i</b>. Compound <b>3j</b> was prepared upon the exposure of <b>3i</b> with boron tribromide, and installation of the amine on <b>3j</b> yielded <b>4j</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of <b>3j</b> and <b>4j</b>; (a) BBr<sub>3</sub>, DCM, 0 °C. (b) <i>trans</i>-4-aminocyclohexanol, DIPEA, DMSO, 140 °C</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>5a–5g</b> were prepared from <b>3d</b> via the reaction conditions described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of <b>5a–5g</b> (a) Amine, DIPEA, DMSO, 140 °C</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Once prepared, the compounds were evaluated for their binding affinities against the cytosolic isoforms, Hsp90α and Hsp90β, by measuring their ability to competitively displace FITC-labeled geldanamycin (GDA) in a fluorescence polarization assay (IC<sub>50</sub>’s listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC50 Values of Compounds <b>4a–4j</b> against Hsp90α and Hsp90β Determined Using Fluorescence Polarization (FP) Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0013.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">Hsp90α IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">Hsp90β IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">0.294 ± 0.023</td><td class="colsep0 rowsep0" align="left">0.101 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">0.180 ± 0.036</td><td class="colsep0 rowsep0" align="left">0.068 ± 0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">0.173 ± 0.036</td><td class="colsep0 rowsep0" align="left">0.051 ± 0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">propyl</td><td class="colsep0 rowsep0" align="left">0.886 ± 0.040</td><td class="colsep0 rowsep0" align="left">0.040 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-butyl</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">0.156 ± 0.018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left"><i>t</i>-butyl</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">0.264 ± 0.030</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">1.88 ± 0.28</td><td class="colsep0 rowsep0" align="left">0.946 ± 0.038</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.306 ± 0.023</td><td class="colsep0 rowsep0" align="left">0.159 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.824 ± 0.104</td><td class="colsep0 rowsep0" align="left">0.233 ± 0.018</td></tr></tbody></table></div></div><div class="NLM_p">The first compound in the series, <b>4a</b>, contained a methyl at the 2′-position and exhibited 3-fold selectivity for Hsp90ß, suggesting that further modification could enhance selectivity. Elongation of the chain to include an ethyl appendage (<b>4b</b>) enhanced affinity for both Hsp90α and Hsp90ß, which occurs by occupation of the subpocket in both isoforms. An isopropyl group was installed to generate <b>4c</b>, which maintained a similar affinity and selectivity as <b>4b</b> and established that a branched aliphatic chain could be accommodated within the subpocket. Increasing the chain length to the propyl derivative (<b>4d</b>) led to an improvement in both affinity and selectivity, as <b>4d</b> manifested ∼40 nM IC<sub>50</sub> for Hsp90β and ∼21-fold selectivity over Hsp90α. In addition, <b>4d</b> exhibited a decreased binding affinity toward Trap-1 and Grp94 (>50 μM for both isoforms, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_001.pdf" class="ext-link">SI</a>). Encouraged by these results, a butyl chain was incorporated to probe the depth of the Hsp90β subpocket. Expectedly, the <i>n</i>-butyl group (<b>4e</b>) was found to exhibit excellent selectivity for Hsp90β (>300-fold vs Hsp90α) but a reduced affinity (IC<sub>50</sub> = 186 nM). Since the isopropyl group was accommodated in both Hsp90α and Hsp90β, a <i>t</i>-butyl appendage was attached (<b>4f</b>) to determine whether the pocket could accommodate spherical bulk. Compound <b>4e</b> did not bind either isoform. Compound <b>4g</b> was synthesized to contain an isobutyl group, which maintained selectivity, but also led to a decrease in affinity. A cyclopropyl group was also evaluated (<b>4h</b>), and a loss of potency was observed as compared to <b>4c</b>. Surprisingly, compounds <b>4i</b> and <b>4j</b> displayed a loss of selectivity for Hsp90β over Hsp90α but also contained polar appendages.</div><div class="NLM_p">Computational studies suggested that replacement of the <i>trans</i>-4-aminocyclohexanolamine with other surrogates may alter the binding conformation and, thus, affinity and selectivity. Therefore, multiple amines were investigated that incorporated various functional groups, including ionizable tertiary amines to improve solubility. The computationally derived binding mode for <b>5a</b>, a morpholine-containing compound, is presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and suggests a slight rotation of the isoquino-lin-1(2<i>H</i>)-one ring, which appears to result from disfavored interactions between the morpholine ring and protein surface. This conformational change appears to align the 2′-appendage at an angle that is neither optimized for selectivity nor affinity. An additional reason to replace the <i>trans</i>-4-aminocyclohexanol is to disrupt the planarity that is caused by the intramolecular hydrogen bond between the aniline and carbonyl moieties, which is likely to affect solubility.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of proposed binding modes of <b>4d</b> (cyan) and <b>5a</b> (yellow) in Hsp90β (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon their preparation, compounds <b>5a–5g</b> were evaluated for their binding affinities against the cytosolic Hsp90 isoforms (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The binding profile of the morpholine-containing compound, <b>5a</b>, was consistent with the proposed hypothesis and exhibited excellent selectivity for Hsp90β with a IC50 of ∼121 nM. The binding profile for <b>5a</b> mirrored <b>4e</b>, which contains an <i>n</i>-butyl group at the 2′-position.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Compounds <b>5a–5g</b> against Hsp90α and Hsp90β Determined via Fluorescence Polarization (FP) Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0014.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">Hsp90α IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±">Hsp90β IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char="±">0.121 ± 0.017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">38.00 ± 1.10</td><td class="colsep0 rowsep0" align="char" char="±">0.091 ± 0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">8.52 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">0.426 ± 0.053</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char="±">4.47 ± 0.278</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char="±">0.463 ± 0.031</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">17.083 ± 0.66</td><td class="colsep0 rowsep0" align="char" char="±">0.513 ± 0.067</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char="±">4.46 ± 0.188</td></tr></tbody></table></div></div><div class="NLM_p">This data suggests that, with <b>5a</b>, the propyl chain aligns in Hsp90β in a manner similar to the butyl chain of <b>4e</b> and, thus, increases selectivity. Compound <b>5b</b>, which contains an alcohol, was proposed to interact with the amino acids at the gate of the binding pocket, such as Gly-97 and Lys-58. Alcohol <b>5b</b> was found to exhibit ∼91 nM IC<sub>50</sub> for Hsp90β with >400-fold selectivity over Hsp90α, which supports the proposed binding model. Incorporation of <i>N</i>-methyl piperazine (<b>5c</b>) led to a decrease in affinity and selectivity as compared to <b>5a</b> and <b>5b</b>, which is likely to result from unfavorable interactions with Lys-58, which is present in both isoforms. Similarly, compounds <b>5d–5g</b> manifested reduced affinity for Hsp90β. Based on the proposed binding model, it appears that the carbonyl electrons could participate in stronger hydrogen-bonding interactions if the lactam was more flexible. In addition, this flexibility would allow appendages at the 2-position to project more efficiently into the Hsp90β-specific subpocket. Therefore, the saturated lactams <b>6a</b> and <b>6b</b> were pursued and are shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Upon preparation as racemic mixtures (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), <b>6a</b> and <b>6b</b> were evaluated; <b>6a</b> was shown to exhibit increased binding affinity as well as enhanced selectivity in comparison with <b>4d</b>, while <b>6b</b> lost both selectivity and affinity.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed binding mode of <b>6a</b> in the Hsp90β-binding site (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>). (B) Structures and IC50 values of <b>6a</b> and <b>6b</b> determined using the FP assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. (a) Pd/C, H<sub>2</sub> 200 psi, Ethanol</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>4d</b> and <b>6a</b> were evaluated for their inhibitory activity against the NCI-60 cancer cell line panel and shown to manifest potent inhibition of select cancers. Interestingly, <b>4d</b> exhibited GI50’s below 100 nM against several cancers, including, leukemia, colon, breast, and renal carcinoma. In parallel, <b>4d</b> and <b>6a</b> were also evaluated for inhibitory activity against urological cancers, such as bladder and prostate cancers. As noted in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <b>4d</b> was found to manifest GI50 values of ∼508 and ∼196 nM against UM-UC-3 and T24 bladder cancer cells, respectively, whereas the efficacy of <b>4d</b> against prostate cancer cells ranged between 1–2.5 μM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. GI<sub>50</sub> Values of <b>4d</b> against Urological Cancer Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cancer type</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bladder cancer</td><td class="colsep0 rowsep0" align="left">UM-UC3</td><td class="colsep0 rowsep0" align="char" char=".">0.45 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">T24</td><td class="colsep0 rowsep0" align="char" char=".">0.196</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate cancer</td><td class="colsep0 rowsep0" align="left">PC3-MM2</td><td class="colsep0 rowsep0" align="char" char=".">1.56 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">LNCap-LN3</td><td class="colsep0 rowsep0" align="char" char=".">1.07 ± 0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">C4-2B</td><td class="colsep0 rowsep0" align="char" char=".">1.42 ± 0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">LAPC-4</td><td class="colsep0 rowsep0" align="char" char=".">2.85 ± 0.41</td></tr></tbody></table></div></div><div class="NLM_p">Since Hsp90 inhibition induces the degradation of Hsp90-dependent substrates via the ubiquitin-proteosome pathway, the levels of both kinase and nonkinase Hsp90 clients were assessed via Western blot analysis (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Known Hsp90 clients, fibroblast growth factor receptor 3 (FGFR3) (highly mutated and/or overexpressed in nonmuscle-invasive urothelial carcinomas), CXCR4, and B-Raf, along with HSR elements Hsf-1 and Hsp27, were analyzed following the administration of <b>4d</b> to UM-UC-3 cells. After a 24 hour incubation with <b>4d</b>, Hsp90-dependent client proteins were reduced at concentrations that mirrored the cellular IC50 value (0.5 μM), clearly linking cell viability to Hsp90β inhibition (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Western blot analysis of client proteins with <b>4d</b> in UM-UC-3 cells. 17-AAG (10 μM) was included as the positive control and the vehicle (DMSO) as the negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A marked dose-dependent reduction of FGFR3 levels was observed alongside Hsp90β-dependent clients, CXCR4, and B-raf. Heat-shock-related proteins Hsp27 and Hsf-1 also declined upon increasing doses of <b>4d</b>, which mirrored the trend previously observed with the Hsp90β-selective compound, <b>KUNB31</b>. Survivin, which is an Hsp90α-dependent substrate was not affected, and it provides direct evidence for isoform-selective inhibition in the cellular context. The saturated derivative, <b>6a</b>, exhibited similar effects after 24 h exposure to HCT-116 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, GI50 0.427 ± 0.07 μM). In addition, <b>6a</b> induced the degradation of known Hsp90β-dependent clients such as CDK4 and CDK6. Total levels of Erk5 and Raf-1 also decreased at higher concentration of <b>6a</b>, while the Hsp90α-dependent substrate survivin was minimally affected, which provides further evidence for isoform-selective inhibition with the cellular environment.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a> The GI50 values obtained from in vitro evaluation against Hct116 and HEK293 cells suggest that an increase in hsp90β-selectivity results in a decrease in cytotoxicity (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_001.pdf" class="ext-link">Table S2</a>); however, the effect of physicochemical properties on cellular efficacy will require further investigation.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Western blot analysis of client proteins with <b>6a</b> in HCT-116 cells. Geldanamycin (GDA) (0.5 μM) was included as the positive control and the vehicle (DMSO) as the negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since compound <b>5b</b> exhibited high selectivity for Hsp90β with IC50 ∼91 nM, it was evaluated in SkBr3 cells for its effectiveness on the maturation of proteins that drive oncogenesis (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Hsp90α knockdown via Hsp90α siRNA was carried out to distinguish the roles of Hsp90α and Hsp90β on maturation of the known Hsp90 client, ErbB2 (HER2). HER2 belongs to the epidermal growth factor receptor family of proteins (EGFR) and exhibits intrinsic receptor tyrosine kinase activity that is overexpressed in ∼30% of the breast cancers and many other cancers. It is hypothesized in literature that plasma membrane-bound HER2 in SkBr3 cells is dependent upon Grp94; however, the cytosolic HER2 population is still maintained by Hsp90.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(39−41)</a> Compound <b>5b</b> was utilized as a chemical tool to inhibit Hsp90β, which revealed HER2 to be dependent upon both cytosolic isoforms, as the inhibition of Hsp90β with <b>5b</b> was not effective at reducing HER2 maturation (control siRNA, 18 h reading). However, upon knockdown of Hsp90α with siRNA in the presence of <b>5b</b>, the levels of HER2 were significantly reduced. Therefore, HER2 maturation exhibits redundant dependency upon both Hsp90 isoforms, and therefore, a functional loss of Hsp90β can be compensated for by Hsp90α for HER2. Unlike the <i>pan</i>-inhibitor, GDA, <b>5b</b> did not induce the heat-shock response even at 10 μM (control siRNA, 18 h), which is an attribute of Hsp90β-selective inhibitors. In addition, known Hsp90β-dependent clients such as CDK4 and c-IAP1 were degraded in a dose-dependent manner upon increasing concentrations of <b>5b</b>, but they were unaffected by Hsp90α knockdown.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Western blot analysis of <b>5b</b> to study client protein degradation in SkBr3 cells, GA: gambogic acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hsp90 inhibitors that have undergone clinical evaluation bind the Hsp90 N-terminal ATP-binding site and manifest <i>pan</i>-inhibitory activity. Therefore, the development of Hsp90-isoform-selective inhibitors represents a novel opportunity for cancer treatment and provides a mechanism in which isoform-dependent substrates can be identified and ultimately targeted for degradation. While the on-target toxicities associated with <i>pan</i>-inhibition are poorly understood, they may be overcome via inhibition of individual Hsp90 isoforms. Thus, isoform-selective inhibitors such as those disclosed herein provide an opportunity to elucidate the individual roles played by each isoform and identify isoform-dependent substrates while evading the liabilities associated with <i>pan</i>-inhibition.</div><div class="NLM_p">In an effort to develop new paradigms for Hsp90 inhibition, small molecule inhibitors that manifest selective inhibition of individual Hsp90 isoforms were pursued. Using a structure-based approach, a new series of rationally designed Hsp90β-selective inhibitors have now been disclosed. Analogues based on the benzamide inhibitor were developed and found to manifest Hsp90β-selective inhibition by taking advantage of minor structural differences that exist between the Hsp90α and Hsp90β Ν-terminal-binding sites, which until recently, was considered indistinguishable by ligands. Although only two amino acids differ within the binding sites of Hsp90α and Hsp90β, rationally designed analogues that perturb the conserved water molecules that reside in the subpocket led to the discovery of a novel scaffold that selectively inhibits the Hsp90β isoform. The reported isoquinolin-1(2<i>H</i>)-one series of compounds provides an improvement over the previously reported Hsp90β-selective inhibitor, <b>KUNB31</b>, by exhibiting an increase in affinity (∼40–90 nM), selectivity (20 to >400-fold), and cellular efficacy.</div><div class="NLM_p last">Compound <b>4d</b> has been shown to manifest ∼20-fold selectivity for Hsp90β, while compound <b>6a</b> manifests >45-fold selectivity for Hsp90β. Both <b>4d</b> and <b>6a</b> demonstrate selectivity toward specific cancer cell lines. In fact, <b>4d</b> was screened against the NCI-60 cancer cell panel to identify cancer cell lines sensitive to Hsp90β inhibition. Several cancers were inhibited by <b>4d</b> at low nanomolar concentrations and at concentrations comparable to the <i>pan</i>-inhibitors that have undergone clinical evaluation. Furthermore, Hsp90β-selective inhibition via <b>4d</b> and <b>6a</b> induced the degradation of Hsp90β-dependent clients, further supporting isoform inhibition as a distinct and alternative mechanism for the treatment of cancer. In conclusion, a potent Hsp90β-selective series has been described that provides the opportunity to evade the detriments associated with Hsp90 <i>pan</i>-inhibition.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Information</h3><div class="NLM_p">All reactions were performed in oven-dried glassware under an argon atmosphere unless otherwise stated. Commercially available anhydrous solvents and reagents were utilized during synthesis. Flash column chromatography was performed using silica gel (40–63 μm particle size). The 1H spectra were recorded on a Brucker instrument at 600, 500, and 400 MHz frequencies and <sup>13</sup>C NMR were recorded at 151, 126, and 101 MHz frequencies. Data are reported as p = pentet, q = quartet, t = triplet, d = doublet, s = singlet, bs = broad singlet, m = multiplet; coupling constant(s) in Hz. High-resolution mass spectral data were obtained on a time-of-flight mass spectrometer, and analysis was performed using electrospray ionization. The final products were determined to be ≥95% purity using an Agilent technologies Infinity II instrument with a Poroshell 120 EC-C18 2.7 μm (4.6 × 100 mm) column using a solvent gradient of solvent A (H<sub>2</sub>O with 0.1% trifluoroacetic acid) and solvent B (acetonitrile with 0.1% trifluoroacetic acid). Thin-layer chromatography was performed with TLC Sslica gel 60F254 plates purchased from Millipore Sigma and visualized by UV light.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 2,6-Difluoro-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)benzonitrile (<b>2</b>)</h4><div class="NLM_p last"><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(a)</td><td colspan="5" valign="top" class="paragraph"><p class="last">To a solution of 2,4,6-trifluurobenzonitrile (<b>1</b>) (5 g, 31.8 mmol, 1 equiv) in 50 mL of ethanol heated to 60 °C was added hydrazine hydrate (50–60% solution) (3.4 g, 63.6 mmol, ∼2 equiv). Upon consumption of <b>1</b> (monitored using TLC), the solvent was evaporated from the reaction mixture under vacuum. To the remaining white semisolid mass was added 50 mL water, and the organic mass was extracted with ethyl acetate (3 × 50 mL). The combined organic fractions were combined and washed with brine (100 mL). The organic fraction was separated and dried over sodium sulfate. Subsequently, evaporation of the organic layer provided ∼6.5 g of the white mixture that was utilized in the next reaction without further purification.</p></td></tr><tr class="li1"><td valign="top">(b)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Above obtained crude product (6 g, 35.5 mmol, 1 equiv) was suspended in 100 mL ethanol in a 250 mL capacity sealed reaction vessel. 2-Acetyldimedone (16.1 g, 88.75 mmol, 2.5 equiv), an orange colored oil, was subsequently added to the reaction vessel, which was sealed and heated to 100 °C for 6 h. The reaction vessel was allowed to cool to rt, ethanol was removed in vacuo, and the remaining mass was extracted with ethyl acetate (3 × 100 mL) and water (200 mL). Organic layers were combined and washed with 100 mL of water. A separated organic layer was dried using sodium sulfate and adsorbed onto silica and purified using column chromatography (SiO<sub>2</sub>, 3:2 hexanes/ethyl acetate) to afford <b>2</b> (5.8 g, 52%) as light-yellow solid. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.39–7.33 (m, 2H), 2.91 (s, 2H), 2.55 (s, 3H), 2.45 (s, 2H), 1.17 (s, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 192.9, 164.5 (d, <i>J</i> = 6.5 Hz), 162.5 (d, <i>J</i> = 6.4 Hz), 151.8, 149.4, 144.5–144.1 (m), 118.8, 108.5, 106.2 (d, <i>J</i> = 4.1 Hz), 106.0 (d, <i>J</i> = 3.9 Hz), 99.9, 52.0, 38.0, 36.0, 28.4 (2), 13.3. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>17</sub>H<sub>16</sub>F<sub>2</sub>N<sub>3</sub>O, 316.1261, found 316.1237.</p></td></tr></table></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Method for Preparation of <b>3a–3i</b></h4><div class="NLM_p last"><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(a)</td><td colspan="5" valign="top" class="paragraph"><p class="last">To a solution of benzonitrile <b>2</b> (200 mg, 0.64 mmol, 1 equiv) in 2 mL of DMF in a 10 mL round-bottom flask, desired β-ketoethylester (0.76 mmol, 1.2 equiv), potassium carbonate (106 mg, 0.76 mmol, 1.2 equiv) was added and stirred at 70 °C until <b>2</b> was consumed, as determined by TLC. Upon completion, the reaction was acidified to pH 5 with 1 N aq. HCl; subsequently, 10 mL of NH<sub>4</sub>Cl saturated solution was added and extracted using ethyl acetate (3 × 10 mL). The combined organic fractions were washed with brine and dried over sodium sulfate. The organic fraction was then adsorbed on silica, and a quick flash column chromatography was performed using 3:7 ethyl acetate/hexane as the solvent system. The product fractions were collected and dried, and the resulting mass was utilized in the further reaction.</p></td></tr><tr class="li1"><td valign="top">(b)</td><td colspan="5" valign="top" class="paragraph"><p class="last">The crude mass obtained (∼210 mg) was taken in a 15 mL sealed reaction vessel; to which, 1 mL of sulfuric acid (36 N) and 8.5 mL acetic acid and 0.5 mL water were added. The vessel was sealed and heated to 140 °C for 8 h. The reaction was then quenched with the addition of the reaction mixture to 100 mL of water. Precipitated solid was filtered under vacuum to yield a brown-colored solid cake that was dried, dissolved in ethyl acetate, and adsorbed onto silica for further purification. Upon column chromatography with 5:5 hexane/ethyl acetate, the desired product was isolated as white solid (30–40% yield).</p></td></tr></table></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 8-Fluoro-3-methyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3a</b>)</h4><div class="NLM_p last">Yield 35%, 78 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 10.63 (s, 1H), 7.40–7.35 (m, 1H), 7.29–7.25 (m, 1H), 6.34 (s, 1H), 2.91 (s, 2H), 2.57 (s, 3H), 2.44 (s, 2H), 2.41 (d, <i>J</i> = 1.0 Hz, 3H), 1.15 (s, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.3, 163.0 (d, <i>J</i> = 265.2 Hz), 161.3 (d, <i>J</i> = 3.9 Hz), 150.8, 149.2, 142.4 (d, <i>J</i> = 11.7 Hz), 142.1 (d, <i>J</i> = 1.8 Hz), 140.5, 117.8, 114.3 (d, <i>J</i> = 4.2 Hz), 112.0 (d, <i>J</i> = 6.4 Hz), 107.5 (d, <i>J</i> = 25.6 Hz), 103.9 (d, <i>J</i> = 2.7 Hz), 52.2, 37.7, 36.0, 28.4 (2), 19.3, 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>20</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>2</sub>, 354.1617, found 354.1626.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 3-Ethyl-8-fluoro-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3b</b>)</h4><div class="NLM_p last">Yield 36%, 77 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 9.51 (s, 1H), 7.41 (d, <i>J</i> = 2.0 Hz, 1H), 7.27 (d, <i>J</i> = 0.6 Hz, 1H), 6.33 (s, 1H), 2.92 (s, 2H), 2.64 (q, <i>J</i> = 7.5 Hz, 2H), 2.57 (s, 3H), 2.44 (s, 2H), 1.36 (t, <i>J</i> = 7.5 Hz, 3H), 1.15 (s, 6H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 193.3, 162.1, 160.8, 150.8, 149.2, 145.4, 142.5, 142.0, 117.9, 114.6 (d, <i>J</i> = 4.1 Hz), 112.3, 107.6 (d, <i>J</i> = 25.5 Hz), 102.8, 52.3, 37.7, 36.0, 28.4 (2), 26.4, 13.4, 12.0. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>21</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>2</sub>Na, 390.1594 found 390.1609.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 8-Fluoro-3-isopropyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3c</b>)</h4><div class="NLM_p last">Yield 40%, 96 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 9.31 (s, 1H), 7.41 (d, <i>J</i> = 2.0 Hz, 1H), 7.27 (dd, <i>J</i> = 11.7, 2.0 Hz, 1H), 6.32 (s, 1H), 2.91 (s, 2H), 2.86–2.79 (m, 1H), 2.57 (s, 3H), 2.44 (s, 2H), 1.36 (d, <i>J</i> = 6.9 Hz, 6H), 1.15 (s, 6H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 193.31, 162.99 (d, <i>J</i> = 265.3 Hz), 160.6, 150.8, 149.4, 149.2, 142.4 (d, <i>J</i> = 11.7 Hz), 142.0, 117.9, 114.8 (d, <i>J</i> = 4.3 Hz), 112.4, 107.6 (d, <i>J</i> = 25.6 Hz), 100.9 (d, <i>J</i> = 2.6 Hz), 52.3, 37.7, 36.0, 32.2, 28.4 (2), 21.2 (2), 13.4. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>Na, 404.1750, found 404.1743.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 8-Fluoro-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3d</b>)</h4><div class="NLM_p last">Yield 45%, 113 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 10.32 (s, 1H), 7.40 (d, <i>J</i> = 2.0 Hz, 1H), 7.26 (d, <i>J</i> = 14.0 Hz, 1H), 6.37–6.29 (s, 1H), 2.91 (s, 2H), 2.61 (t, <i>J</i> = 7.6 Hz, 2H), 2.57 (s, 3H), 2.44 (s, 2H), 1.80 (h, <i>J</i> = 7.4 Hz, 2H), 1.15 (s, 6H), 1.04 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.3, 162.9 (d, <i>J</i> = 265.2 Hz), 161.1 (d, <i>J</i> = 4.5 Hz), 150.8, 149.3, 144.5, 142.8 (d, <i>J</i> = 11.9 Hz), 142.0 (d, <i>J</i> = 2.4 Hz), 117.8, 114.6 (d, <i>J</i> = 4.6 Hz), 112.2 (d, <i>J</i> = 7.2 Hz), 107.5 (d, <i>J</i> = 25.7 Hz), 103.3 (d, <i>J</i> = 3.5 Hz), 52.3, 37.8, 36.0, 35.2, 28.4 (2), 21.4, 13.5, 13.4. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>Na, 404.1750, found 404.1765.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-Butyl-8-fluoro-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3e</b>)</h4><div class="NLM_p last">Yield 40%, 100 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 9.99 (d, <i>J</i> = 20.1 Hz, 1H), 7.40 (d, <i>J</i> = 1.9 Hz, 1H), 7.25 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 6.32 (s, 1H), 2.91 (s, 2H), 2.61 (t, <i>J</i> = 7.7 Hz, 2H), 2.58–2.55 (m, 3H), 2.44 (s, 2H), 1.73 (p, <i>J</i> = 7.7 Hz, 2H), 1.45 (h, <i>J</i> = 7.4 Hz, 2H), 1.15 (s, 6H), 1.01–0.95 (m, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 193.3, 163.0 (d, <i>J</i> = 265.5 Hz), 161.1 (d, <i>J</i> = 3.6 Hz), 150.8, 149.2, 144.6, 142.4 (d, <i>J</i> = 11.5 Hz), 142.1, 117.9, 114.6 (d, <i>J</i> = 4.1 Hz), 112.3 (d, <i>J</i> = 6.3 Hz), 107.5 (d, <i>J</i> = 25.5 Hz), 103.2 (d, <i>J</i> = 2.6 Hz), 52.3, 37.8, 36.0, 33.1, 30.1, 28.4 (2), 22.1, 13.7, 13.4. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>23</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>2</sub>Na, 418.1907, found 418.1902.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-(<i>tert</i>-Butyl)-8-fluoro-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3f</b>)</h4><div class="NLM_p last">Yield 38%, 95 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 8.78 (s, 1H), 7.44 (d, <i>J</i> = 1.9 Hz, 1H), 7.27 (d, <i>J</i> = 0.7 Hz, 1H), 6.37 (s, 1H), 2.91 (s, 2H), 2.56 (s, 3H), 2.44 (s, 2H), 1.38 (s, 9H), 1.15 (s, 6H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 193.3, 161.2 (d, <i>J</i> = 254.3 Hz), 155.6, 151.3, 150.8, 149.2, 142.4 (d, <i>J</i> = 11.5 Hz) 141.9, 140.8, 117.9, 115.1, 107.7 (d, <i>J</i> = 25.8 Hz), 100.3, 52.3, 37.8, 36.0, 34.5, 28.8 (3), 28.4 (2), 13.4. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>23</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>2</sub>Na, 418.1907, found 418.1897.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 8-Fluoro-3-isobutyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3g</b>)</h4><div class="NLM_p last">Yield 35%, 88 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 8.74 (s, 1H), 7.43 (d, <i>J</i> = 2.0 Hz, 1H), 7.24 (dd, <i>J</i> = 11.7, 2.0 Hz, 1H), 6.28 (s, 1H), 2.91 (s, 2H), 2.56 (s, 3H), 2.44 (s, 2H), 2.41 (d, <i>J</i> = 7.4 Hz, 2H), 1.15 (s, 6H), 1.02 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 197.0, 171.0, 161.3 (d, <i>J</i> = 3.9 Hz), 150.8, 149.2, 148.7, 142.5 (d, <i>J</i> = 11.7 Hz), 142.1 (d, <i>J</i> = 1.8 Hz), 139.2, 122.4, 114.3 (d, <i>J</i> = 4.2 Hz), 112.0 (d, <i>J</i> = 6.4 Hz), 107.5 (d, <i>J</i> = 25.6 Hz), 103.9 (d, <i>J</i> = 2.7 Hz), 53.4, 42.8, 37.7, 36.0, 28.4, 22.2 (2), 14.2 (2). HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>23</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>2</sub>Na, 418.1907, found 418.1913.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-Cyclopropyl-8-fluoro-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3h</b>)</h4><div class="NLM_p last">Yield 33%, 80 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 9.43 (s, 1H), 7.38–7.35 (m, 1H), 7.23 (dd, <i>J</i> = 11.8, 2.0 Hz, 1H), 6.24–6.20 (m, 1H), 2.90 (s, 2H), 2.56 (s, 3H), 2.43 (s, 2H), 1.90–1.83 (m, 1H), 1.14 (s, 6H), 1.10–1.08 (m, 2H), 0.93–0.90 (m, 2H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 193.3, 163.0 (d, <i>J</i> = 265.1 Hz), 160.6, 150.8, 149.2, 145.7, 142.5, 142.0, 117.9, 114.4 (d, <i>J</i> = 4.2 Hz), 112.2 (d, <i>J</i> = 6.3 Hz), 107.4 (d, <i>J</i> = 25.5 Hz), 101.1 (d, <i>J</i> = 2.7 Hz), 52.3, 37.8, 35.9, 28.4 (2), 13.5, 13.4, 7.4 (2). HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>22</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>2</sub>Na, 402.1594, found 402.1603.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 8-Fluoro-3-(methoxymethyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3i</b>)</h4><div class="NLM_p last">Yield 33%, 80 mg; <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 8.74 (s, 1H), 7.38 (d, <i>J</i> = 2.0 Hz, 1H), 7.22 (dd, <i>J</i> = 11.7, 2.0 Hz, 1H), 6.30 (s, 1H), 4.30 (s, 2H), 3.39 (s, 3H), 2.83 (s, 2H), 2.49 (s, 3H), 2.36 (s, 2H), 1.07 (s, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.2, 162.9 (d, <i>J</i> = 265.1 Hz), 159.7, 150.9, 149.2, 142.6, 141.2 (d, <i>J</i> = 2.2 Hz), 139.5, 117.9, 114.9 (d, <i>J</i> = 4.6 Hz), 113.3 (d, <i>J</i> = 6.2 Hz), 108.2 (d, <i>J</i> = 25.7 Hz), 102.6 (d, <i>J</i> = 3.3 Hz), 70.0, 58.7, 52.2 37.8, 35.9, 28.4 (2), 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>21</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>3</sub>, 384.1723, found 384.1716.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 8-Fluoro-3-(hydroxymethyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>3j</b>)</h4><div class="NLM_p last">To a solution of <b>3i</b> (100 mg, 0.26 mmol, 1 equiv) in 3 mL of DCM cooled to 0 °C was added 0.8 mL of 1 M BBr<sub>3</sub> solution in DCM (0.78 mmol, 3 equiv) dropwise, the reaction completion was monitored using TLC. After 2 h, the reaction was quenched dropwise using 2 mL of saturated sodium bicarbonate solution, and resulting biphasic mixture was extracted using ethyl acetate (10 mL × 2). The organic fractions were collected, washed with water, and dried over sodium sulfate. The organic fraction was adsorbed onto silica for column chromatography purification using (4:6 ethyl acetate/hexane) to furnish 55 mg (0.155 mmol, yield 60%) as white solid. <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 10.28 (s, 1H), 7.35 (d, <i>J</i> = 1.9 Hz, 1H), 7.24 (dd, <i>J</i> = 11.8, 2.0 Hz, 1H), 6.36 (s, 1H), 4.59 (s, 2H), 2.83 (s, 2H), 2.49 (s, 3H), 2.36 (s, 2H), 1.07 (s, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.25, 166.29 (d, <i>J</i> = 265.1 Hz) 151.0, 149.3, 142.3, 141.4, 118.0, 114.9 (d, <i>J</i> = 4.6 Hz), 112.7, 108.2 (d, <i>J</i> = 25.4 Hz), 102.7 (d, <i>J</i> = 2.9 Hz), 100.8, 99.9, 61.1, 52.2, 37.7, 35.9, 28.4 (2), 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub>, 370.1567, found 370.1581.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure for Preparation of <b>4a–5j</b> and <b>5a–5g</b></h4><div class="NLM_p last">A solution of the desired intermediate <b>3a–3j</b> (0.07 mmol, 1 equiv) in 1 mL of DMSO was taken in a 5 mL sealed reaction vessel; the corresponding amine (<i>trans</i>-4-aminocyclohexanol for <b>4a–4j</b>) (0.212 mmol, 3 equiv) and then diisopropyl ethyl amine (DIPEA)(0.212 mmol, 3 equiv) were introduced. The reaction vessel was then sealed and heated to 140 °C for 12 h and cooled, and water (25 mL) was added. The aqueous layer was extracted with ethyl acetate (25 mL × 3); the organic fractions were combined and washed with brine (25 mL) and dried over sodium sulfate. Purification with column chromatography (SiO<sub>2</sub>, 4:96 methanol/DCM for <b>4a–4k</b>, <b>5a</b>, <b>5b</b>, <b>5e</b> and 5:1:94 methanol:7 M NH<sub>3</sub> in methanol/DCM for <b>5c</b>, <b>5d</b>, <b>5f</b>, and <b>5 g</b>) resulted in the desired products, which were further purified by preparative TLC to give the desired compounds <b>4a–4j</b> and <b>5a–5g</b> as light yellow solids.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-methyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4a</b>)</h4><div class="NLM_p last">Yield 70%, 22 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.16 (d, <i>J</i> = 7.5 Hz, 1H), 9.05 (s, 1H), 6.51–6.40 (m, 2H), 6.09 (s, 1H), 3.74–3.59 (m, 2H), 3.31 (d, <i>J</i> = 24.2 Hz, 1H), 2.78 (s, 2H), 2.49 (s, 3H), 2.34 (s, 2H), 2.19 (s, 3H), 2.17–2.08 (m, 2H), 2.04–1.95 (m, 2H), 1.38 (q, <i>J</i> = 11.1, 9.9 Hz, 4H), 1.04 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.4, 185.3, 169.7, 165.5, 151.4, 150.0, 149.1, 143.5, 143.2, 142.1, 137.4, 107.3, 105.7, 104.8, 100.3, 69.7, 52.4, 50.2, 37.8, 35.8, 33.5, 29.9, 28.4 (2), 19.0, 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>26</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>, 449.2553, found 449.2566.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-Ethyl-8-(((1r,4r)-4-hydroxycyclohexyl)amino)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4b</b>)</h4><div class="NLM_p last">Yield 58%, 19 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.77 (s, 1H), 9.45 (s, 1H), 6.63 (d, <i>J</i> = 2.0 Hz, 1H), 6.56 (d, <i>J</i> = 1.9 Hz, 1H), 6.26–6.16 (m, 1H), 3.77 (dd, <i>J</i> = 8.7, 4.4 Hz, 1H), 3.44 (s, 1H), 2.89 (s, 2H), 2.62–2.55 (m, 5H), 2.43 (s, 2H), 2.30–2.17 (m, 2H), 2.10 (d, <i>J</i> = 10.4 Hz, 3H), 1.54–1.42 (m, 4H), 1.32 (q, <i>J</i> = 7.6 Hz, 3H), 1.14 (s, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 193.4, 165.6, 150.9, 150.1, 149.5, 149.1, 143.4, 143.1, 142.1, 119.4, 117.3, 104.3, 99.9, 88.4, 69.6, 52.4, 37.8, 35.8 (2), 33.5 (2), 29.7, 29.7, 28.4 (2), 26.1, 13.5, 12.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>28</sub>H<sub>38</sub>N<sub>5</sub>O<sub>2</sub>, 476.3026, found 476.3049.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-isopropyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4c</b>)</h4><div class="NLM_p last">Yield 65%, 21 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 11.01–10.60 (m, 1H), 9.29 (d, <i>J</i> = 7.4 Hz, 1H), 6.59 (d, <i>J</i> = 2.0 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.21 (d, <i>J</i> = 1.8 Hz, 1H), 3.79–3.70 (m, 1H), 3.47–3.38 (m, 1H), 2.88–2.77 (m, 3H), 2.56 (s, 3H), 2.41 (s, 2H), 2.25–2.18 (m, 2H), 2.10–2.04 (m, 2H), 1.52–1.38 (m, 4H), 1.34 (d, <i>J</i> = 6.9 Hz, 6H), 1.11 (s, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.6, 166.8–165.9 (m), 151.3 (d, <i>J</i> = 15.4 Hz), 149.9, 149.2, 147.6 (d, <i>J</i> = 17.2 Hz), 143.1, 142.2, 117.1, 107.6 (d, <i>J</i> = 2.7 Hz), 105.1 (d, <i>J</i> = 2.7 Hz), 102.9 (t, <i>J</i> = 2.6 Hz), 100.1, 69.7, 52.4, 50.1 (d, <i>J</i> = 11.0 Hz), 37.7, 35.9, 33.6 (2), 31.9 (d, <i>J</i> = 6.7 Hz), 30.2 (2), 28.4 (2), 21.4 (2), 13.48. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>28</sub>H<sub>37</sub>N<sub>4</sub>O<sub>3</sub>Na, 499.2685, found 499.2672.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4d</b>)</h4><div class="NLM_p last">Yield 65%, 22 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 10.44 (s, 1H), 9.29 (d, <i>J</i> = 7.4 Hz, 1H), 6.60 (d, <i>J</i> = 1.9 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.21 (d, <i>J</i> = 1.9 Hz, 1H), 3.80–3.73 (m, 1H), 3.47–3.38 (m, 1H), 2.87 (s, 2H), 2.58 (s, 3H), 2.54 (t, <i>J</i> = 7.5 Hz, 2H), 2.43 (s, 2H), 2.28–2.20 (m, 2H), 2.12–2.03 (m, 2H), 1.76 (h, <i>J</i> = 7.4 Hz, 2H), 1.55–1.36 (m, 4H), 1.13 (s, 6H), 1.01 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.5, 166.3, 151.4, 149.9, 149.1, 143.1, 142.2, 141.9, 117.2, 107.5, 105.4, 104.9, 100.0, 69.8, 52.4, 50.2, 37.7, 35.9, 34.8, 33.6 (2), 30.1 (2), 28.4 (2), 21.3, 13.5, 13.5. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>28</sub>H<sub>36</sub>N<sub>4</sub>O<sub>3</sub>Na, 499.2685, found 499.2688.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-Butyl-8-(((1r,4r)-4-hydroxycyclohexyl)amino)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4e</b>)</h4><div class="NLM_p last">Yield 58%, 20 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 10.21 (s, 1H), 9.27 (d, <i>J</i> = 7.5 Hz, 1H), 6.59 (d, <i>J</i> = 1.9 Hz, 1H), 6.51 (d, <i>J</i> = 2.0 Hz, 1H), 6.20 (d, <i>J</i> = 2.0 Hz, 1H), 3.79–3.72 (m, 1H), 3.47–3.37 (m, 1H), 2.87 (s, 2H), 2.60–2.52 (m, 5H), 2.42 (s, 2H), 2.26–2.19 (m, 2H), 2.11–2.05 (m, 2H), 1.74–1.64 (m, 2H), 1.54–1.32 (m, 6H), 1.12 (s, 6H), 0.96 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.5, 166.1, 151.4, 149.9, 149.1, 143.1, 142.2, 142.1, 117.2, 107.5, 105.2, 104.9, 100.1, 69.8, 52.4, 50.2, 37.7, 35.8, 33.7 (2), 32.6, 30.1 (2), 30.0, 28.4 (2), 22.1, 13.9, 13.5. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>29</sub>H<sub>39</sub>N<sub>4</sub>O<sub>3</sub>, 491.3022, found 491.3011.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-(<i>tert</i>-Butyl)-8-(((1r,4r)-4-hydroxycyclohexyl)amino)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4f</b>)</h4><div class="NLM_p last">Yield 65%, 22 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.53 (s, 1H), 9.28 (d, <i>J</i> = 6.9 Hz, 1H), 6.68–6.51 (m, 2H), 6.27 (d, <i>J</i> = 2.1 Hz, 1H), 3.80–3.73 (m, 1H), 3.47–3.43 (m, 1H), 2.88 (s, 2H), 2.58 (s, 3H), 2.43 (s, 2H), 2.25–2.18 (m, 2H), 2.13–2.06 (m, 2H), 1.53–1.40 (m, 4H), 1.38 (s, 9H), 1.13 (s, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.5, 165.7, 150.9, 150.0, 149.3, 149.1, 143.2, 141.9, 117.2, 107.6, 105.8, 102.3, 100.7, 69.8, 52.4, 50.6, 37.8, 35.9, 34.3, 33.7 (2), 30.1 (2), 28.9 (3), 28.4 (2), 13.5. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>29</sub>H<sub>38</sub>N<sub>4</sub>O<sub>3</sub>Na, 513.2842, found 513.2821.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-isobutyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4g</b>)</h4><div class="NLM_p last">Yield 55%, 19 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.57 (s, 1H), 9.24 (d, <i>J</i> = 7.5 Hz, 1H), 6.60 (d, <i>J</i> = 1.9 Hz, 1H), 6.50 (d, <i>J</i> = 1.9 Hz, 1H), 6.17 (d, <i>J</i> = 2.0 Hz, 1H), 3.80–3.72 (m, 1H), 3.46–3.37 (m, 1H), 2.87 (s, 2H), 2.63 (s, 4H), 2.42 (s, 2H), 2.39 (d, <i>J</i> = 7.4 Hz, 2H), 2.23 (dd, <i>J</i> = 9.4, 5.0 Hz, 2H), 2.11–1.97 (m, 3H), 1.53–1.39 (m, 4H), 1.12 (s, 6H), 0.99 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.5, 165.9, 151.4, 150.0, 149.1, 143.1, 142.0, 141.0, 117.2, 107.5, 106.1, 105.0, 100.1, 69.8, 52.4, 50.3, 42.4, 37.7, 35.8, 33.7 (2), 30.1 (2), 28.4, 27.9 (2), 22.3 (2), 13.5. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>29</sub>H<sub>39</sub>N<sub>4</sub>O<sub>3</sub>, 491.3022, found 491.3019.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-Cyclopropyl-8-(((1r,4r)-4-hydroxycyclohexyl)amino)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4h</b>)</h4><div class="NLM_p last">Yield 66%, 22 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.67 (s, 1H), 9.26 (d, <i>J</i> = 7.2 Hz, 1H), 6.58 (d, <i>J</i> = 1.9 Hz, 1H), 6.53 (d, <i>J</i> = 2.0 Hz, 1H), 6.15 (d, <i>J</i> = 1.9 Hz, 1H), 3.80–3.73 (m, 1H), 3.48–3.39 (m, 1H), 2.88 (s, 2H), 2.59 (s, 3H), 2.44 (s, 2H), 2.26–2.18 (m, 2H), 2.12–2.04 (m, 2H), 1.87–1.78 (m, 1H), 1.55–1.38 (m, 4H), 1.14 (s, 6H), 1.04–0.99 (m, 2H), 0.95–0.90 (m, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 193.5, 165.7, 150.0, 149.1, 143.2, 143.2, 142.0, 117.2, 107.5, 105.0, 103.4, 100.2, 69.8, 52.4, 50.3, 37.7, 35.8, 33.7 (2), 30.0 (2), 28.4 (2), 13.5, 13.4, 7.1 (2). HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>28</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub>, 475.2709, found 475.2698.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-(methoxymethyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4i</b>)</h4><div class="NLM_p last">Yield 60%, 20 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.27 (d, <i>J</i> = 7.5 Hz, 1H), 8.63 (s, 1H), 6.62 (d, <i>J</i> = 1.8 Hz, 1H), 6.56 (s, 1H), 6.25 (s, 1H), 4.32 (s, 2H), 3.42 (s, 3H), 2.86 (s, 2H), 2.57 (s, 3H), 2.42 (s, 2H), 2.21 (s, 2H), 2.07 (s, 2H), 1.49 (q, <i>J</i> = 11.9, 10.3 Hz, 4H), 1.12 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.3, 164.9, 151.5, 150.0, 149.0, 143.2, 141.2, 137.1, 117.3, 108.4, 105.3, 105.1, 101.0, 70.2, 69.7, 58.4, 52.4, 50.3, 37.8, 35.8, 33.5 (2), 29.9 (2), 28.4 (2), 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>27</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub>, 479.2658, found 479.2665.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-(hydroxymethyl)-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>4j</b>)</h4><div class="NLM_p last">Yield 63%, 20 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.31 (s, 1H), 9.19 (d, <i>J</i> = 7.4 Hz, 1H), 6.55 (d, <i>J</i> = 1.7 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.22 (s, 1H), 4.49 (s, 2H), 3.79–3.64 (m, 1H), 3.40 (d, <i>J</i> = 16.0 Hz, 1H), 2.83 (s, 2H), 2.55 (s, 3H), 2.40 (s, 2H), 2.19 (d, <i>J</i> = 11.2 Hz, 2H), 2.09–2.00 (m, 2H), 1.44 (dd, <i>J</i> = 18.9, 9.5 Hz, 4H), 1.10 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.6, 172.2, 151.4, 150.1, 149.3, 143.1, 141.5, 139.9, 117.2, 108.2, 105.4, 103.9, 100.8, 69.5, 60.7, 52.3, 50.2, 37.7, 35.8, 33.4 (2), 29.9 (2), 28.3 (2), 13.3. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>26</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub>, 465.2502, found 465.2501.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 8-Morpholino-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>5a</b>)</h4><div class="NLM_p last">Yield 65%, 20 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.53 (s, 1H), 7.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.05 (d, <i>J</i> = 2.1 Hz, 1H), 6.25 (s, 1H), 4.00 (t, <i>J</i> = 4.5 Hz, 4H), 3.22 (s, 4H), 2.86 (s, 2H), 2.57 (s, 5H), 2.43 (s, 2H), 1.76 (h, <i>J</i> = 7.4 Hz, 2H), 1.12 (s, 6H), 1.03 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 193.4, 162.1, 155.4, 150.4, 149.1, 143.1, 142.8, 141.9, 117.5, 115.4, 112.9, 109.7, 104.3, 67.2 (2), 53.4 (2), 52.4, 37.6, 35.9, 34.8, 28.4 (2), 21.2, 13.5, 13.5. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>26</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>, 449.2553, found 449.2557.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 8-(4-Hydroxypiperidin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>5b</b>)</h4><div class="NLM_p last">Yield 55%, 18 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.03 (s, 1H), 6.98 (d, <i>J</i> = 3.3 Hz, 2H), 6.15 (s, 1H), 3.86 (s, 1H), 3.41 (s, 2H), 2.87 (s, 2H), 2.78 (s, 2H), 2.52–2.44 (m, 5H), 2.35 (s, 2H), 2.12–2.03 (m, 2H), 1.92–1.81 (m, 2H), 1.67 (h, <i>J</i> = 7.4 Hz, 2H), 1.05 (s, 6H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 193.5, 162.0, 155.8, 150.3, 149.1, 142.9, 142.4, 141.8, 117.4, 115.5, 112.4, 110.1, 104.2, 53.4, 52.4 (2), 37.6, 35.9, 34.9 (2), 30.9, 29.7, 28.4 (2), 21.1, 13.5, 13.5. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>27</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub>, 463.2709, found 463.2710.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 8-(4-Methylpiperazin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>5c</b>)</h4><div class="NLM_p last">Yield 55%, 18 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.56 (s, 1H), 9.35 (d, <i>J</i> = 7.3 Hz, 1H), 7.17 (d, <i>J</i> = 2.0 Hz, 1H), 7.02 (d, <i>J</i> = 2.1 Hz, 1H), 6.19 (d, <i>J</i> = 1.9 Hz, 1H), 2.87 (s, 2H), 2.80 (s, 1H), 2.57 (s, 3H), 2.52 (t, <i>J</i> = 7.4 Hz, 2H), 2.43 (s, 2H), 2.33 (s, 3H), 2.26 (t, <i>J</i> = 10.5 Hz, 2H), 2.16–2.08 (m, 2H), 1.79–1.58 (m, 7H), 1.13 (s, 6H), 1.01 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.5, 165.8, 151.2, 149.9, 149.0, 143.1, 142.1, 141.6, 140.8, 107.7, 105.3, 105.0, 100.2, 52.4, 46.3, 37.7, 35.8, 34.9 (2), 32.1, 31.6, 31.4, 28.4 (2), 21.2 (2), 13.5, 13.4. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>28</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>Na, 498.2845, found 498.2823.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 8-(Piperazin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>5d</b>)</h4><div class="NLM_p last">Yield 45%, 14 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.59 (s, 1H), 7.09 (d, <i>J</i> = 2.0 Hz, 1H), 7.04 (d, <i>J</i> = 2.0 Hz, 1H), 6.17 (s, 1H), 3.13 (s, 6H), 2.79 (s, 2H), 2.50 (s, 5H), 2.35 (s, 2H), 2.27–2.01 (m, 2H), 1.68 (h, <i>J</i> = 7.4 Hz, 2H), 1.05 (s, 6H), 0.95 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 193.4, 161.7, 155.8, 150.3, 149.1, 143.0, 142.2, 141.9, 117.4, 115.5, 112.7, 109.8, 104.3, 54.3, 52.4 (2), 46.1 (2), 37.6, 35.9, 34.9, 28.5 (2), 21.2, 13.5, 13.5. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>26</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub>, 448.2713, found 448.2706.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>tert</i>-Butyl-4-(1-oxo-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)-1,2-dihydroisoquinolin-8-yl)piperazine-1-carboxylate (<b>5e</b>)</h4><div class="NLM_p last">Yield 53%, 20 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.93 (s, 1H), 7.01 (d, <i>J</i> = 2.0 Hz, 1H), 6.96 (d, <i>J</i> = 2.1 Hz, 1H), 6.16 (d, <i>J</i> = 2.0 Hz, 1H), 3.75 (s, 4H), 3.08 (s, 4H), 2.79 (s, 2H), 2.51–2.43 (m, 5H), 2.35 (s, 2H), 1.66 (h, <i>J</i> = 7.4 Hz, 2H), 1.42 (s, 9H), 1.05 (s, 6H), 0.94 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 193.4, 161.8, 155.4, 154.9, 150.4, 149.1, 143.0, 142.5, 141.9, 117.5, 115.6, 112.9, 110.0, 104.2, 79.8, 53.0 (2), 52.4 (2), 37.6, 35.9, 34.9, 31.6, 28.5 (4), 21.1, 13.5, 13.5. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>31</sub>H<sub>42</sub>N<sub>5</sub>O<sub>4</sub>, 548.3237, found 548.3226.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 8-((1-Methylpiperidin-4-yl)amino)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>5f</b>)</h4><div class="NLM_p last">Yield 40%, 13 mg; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.56 (s, 1H), 9.35 (d, <i>J</i> = 7.3 Hz, 1H), 6.60 (d, <i>J</i> = 2.0 Hz, 1H), 6.53 (d, <i>J</i> = 2.1 Hz, 1H), 6.19 (d, <i>J</i> = 1.9 Hz, 1H), 2.87 (s, 2H), 2.80 (s, 1H), 2.57 (s, 3H), 2.52 (t, <i>J</i> = 7.4 Hz, 2H), 2.43 (s, 2H), 2.33 (s, 3H), 2.26 (t, <i>J</i> = 10.5 Hz, 2H), 2.16–2.08 (m, 2H), 1.79–1.58 (m, 7H), 1.13 (s, 6H), 1.01 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.5, 165.8, 151.3, 149.9, 149.1, 143.1, 142.1, 141.6, 140.8, 107.6, 105.3, 105.0, 100.2, 52.4, 46.3, 37.7, 35.8, 34.9 (2), 32.1, 31.6, 31.4, 28.4 (2), 21.2 (2), 13.5, 13.4. HRMS (ESI) <i>m/z</i> [M + Na] calcd for C<sub>28</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>Na, 498.2845, found 498.2823.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 8-((2-(Diethylamino)ethyl)(methyl)amino)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)isoquinolin-1(2<i>H</i>)-one (<b>5g</b>)</h4><div class="NLM_p last">Yield 45%, 14 mg; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.22 (s, 1H), 7.03 (d, <i>J</i> = 2.0 Hz, 1H), 7.00 (d, <i>J</i> = 2.0 Hz, 1H), 6.21 (s, 1H), 3.44–3.37 (m, 2H), 3.02 (s, 3H), 2.86 (s, 2H), 2.77 (t, <i>J</i> = 7.4 Hz, 2H), 2.57 (s, 3H), 2.56–2.48 (m, 6H), 2.42 (s, 2H), 1.81–1.71 (m, 2H), 1.12 (s, 6H), 1.03 (t, <i>J</i> = 7.3 Hz, 3H), 0.97 (t, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 193.5, 162.0, 155.2, 150.1, 149.1, 142.9, 141.5, 117.3, 114.5, 111.4, 110.0, 104.3, 55.5, 52.4, 50.4, 47.3 (2), 41.7, 37.5, 35.9, 35.0, 29.9, 28.4 (2), 21.2, 13.6, 13.5 (2), 11.7. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>29</sub>H<sub>42</sub>N<sub>5</sub>O<sub>2</sub>, 492.3338, found 492.3352.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure for the Syntheses of <b>6a</b> and <b>6b</b></h3><div class="NLM_p">To a solution of <b>4d/5b</b> (0.1 mmol, 1 equiv) in 10 mL of ethanol was introduced palladium (10% on activated carbon) (10 mol %) in a pressure reactor vessel. After multiple cycles of degassing under vacuum, hydrogen gas was introduced at 200 psi and the reactor vessel was heated to 90 °C for 24 h. Upon completion, the reaction mixture was passed through a plug of Celite and solvent was removed under vacuum. Subsequently, preparative TLC was performed (SiO<sub>2</sub>, 5% MeOH in dichloromethane) to obtain the desired compounds.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 8-(((1r,4r)-4-Hydroxycyclohexyl)amino)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>6a</b>)</h4><div class="NLM_p last">White amorphous solid, 20 mg, yield 42%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.78 (d, <i>J</i> = 7.5 Hz, 1H), 6.56 (d, <i>J</i> = 2.0 Hz, 1H), 6.49 (d, <i>J</i> = 1.9 Hz, 1H), 5.72 (s, 1H), 3.75 (dt, <i>J</i> = 9.6, 4.9 Hz, 1H), 3.60 (m, <i>J</i> = 8.4, 6.8, 5.0, 2.7 Hz, 1H), 3.40–3.27 (m, 1H), 2.91 (dd, <i>J</i> = 15.4, 4.2 Hz, 1H), 2.83 (s, 2H), 2.74 (dd, <i>J</i> = 15.3, 10.5 Hz, 1H), 2.55 (s, 3H), 2.41 (s, 2H), 2.23–1.98 (m, 4H), 1.64–1.52 (m, 2H), 1.50–1.36 (m, 6H), 1.12 (s, 6H), 0.97 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.4, 168.7, 150.7, 150.0, 148.9, 142.3, 142.0, 117.2, 108.5, 107.9, 104.1, 69.6, 53.4, 52.3, 50.5, 50.2, 37.7, 37.2, 35.8, 35.6, 33.6, 30.2, 30.1 (2), 28.4, 18.6, 13.9, 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>28</sub>H<sub>39</sub>N<sub>4</sub>O<sub>3</sub>, 479.3017, found 479.3041.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 8-(4-Hydroxypiperidin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazol-1-yl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>6b</b>)</h4><div class="NLM_p last">White amorphous solid, 24 mg, yield 47%; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 6.94 (d, <i>J</i> = 2.1 Hz, 1H), 6.85 (d, <i>J</i> = 2.1 Hz, 1H), 6.01–5.90 (m, 1H), 3.88 (dd, <i>J</i> = 8.5, 4.6 Hz, 1H), 3.66–3.54 (m, <i>J</i> = 10.5, 6.6, 3.2 Hz, 1H), 3.50–3.32 (m, 3H), 3.05–2.88 (m, 3H), 2.82–2.71 (m, 3H), 2.54 (s, 3H), 2.42–2.36 (m, 2H), 2.16–1.98 (m, 1H), 1.99–1.74 (m, 2H), 1.65–1.52 (m, 2H), 1.51–1.37 (m, <i>J</i> = 14.3, 7.2, 5.1 Hz, 2H), 1.10 (d, <i>J</i> = 6.6 Hz, 6H), 0.97 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 193.4, 165.2, 153.8, 150.1, 149.0, 143.0, 141.1, 118.1, 117.2, 114.0, 111.8, 67.4, 52.3, 50.2, 50.1, 49.5, 37.4, 36.9, 36.8, 35.9, 34.3, 34.2, 28.5, 28.3, 18.8, 13.9, 13.4. HRMS (ESI) <i>m/z</i> [M + H] calcd for C<sub>27</sub>H<sub>37</sub>N<sub>4</sub>O<sub>3</sub>, 465.2860, found 465.2864.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Fluorescence Polarization Assay</h3><div class="NLM_p last">The assay was performed in a 96-well format in black, flat-bottom plates (Santa Cruz Biotechnology) with a final volume of 100 μL. Twenty-five microliters of assay buffer (20 mM HEPES, pH 7.3, 50 mM KCl, 5 mM MgCl2, 20 mM Na2MoO4, 2 mM DTT, 0.1 mg/mL BGG, and 0.01% NP-40), 25 μL of assay buffer containing 6 nM FITC-GDA (fluorescent tracer, stock in DMSO and diluted in assay buffer), and 50 μL of assay buffer containing 10 nM of Hsp90β(Enzo, ADI-SPP-777), Hsp90α(Enzo, ADI-SPP-776), Grp94(Enzo, ADI-SPP-766), or 50 nM Trap1 (Enzo, ADI-SPP-848) was added to each well. Compounds were tested in triplicate wells (1% DMSO final concentration). For each plate, wells containing buffer only (background), tracer in buffer only (low polarization control), and protein and tracer in buffer with 1% DMSO (high polarization control) were included. Plates were incubated at 4 °C with rocking for 2 h. Polarization values (in mP units) were measured at 37 °C with an excitation filter at 485 nm and an emission filter at 528 nm. Polarization values were correlated to % tracer bound and compound concentrations. The concentration at which the tracer was 50% displaced by the inhibitor was determined using MS Excel and reported with a standard deviation value from average of triplicates.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Cell Proliferation Assay</h3><div class="NLM_p last">Cell proliferation was measured by the Cell Titer-Glo luminescent cell viability assay (Promega, Madison, WI) according to the manufacturer’s instructions. Bladder cancer cells/well (2 × 103) were cultured in 96-well white plates in media for 24 h and then treated by compounds for 72 h. Luminescent signals were read on the BioTek Synergy 4 plate reader (BioTek Instruments, Winooski, VT). Data were analyzed from three independent experiments performed in triplicate, and nonlinear regression and sigmoidal dose–response curves (GraphPad Prism, La Jolla, CA) were used to calculate IC<sub>50</sub> and <i>R</i><sup>2</sup> values.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Western Blot Analysis HCT-116 Cells</h3><div class="NLM_p">HCT-116 cells were grown in DMEM (Corning, 10-027-CV) containing 1% Pen-Strep (VWR, K952-100ML) and 10% FBS+ (Atlas Biologicals, F-0500-D),and plated in a 6-well plate (VWR, 10861–696). At ∼80%, cells were treated with GDA at 500 nM and compound <b>6a</b> at 100, 250, 1.25, and 2.5 μM for 24 h.</div><div class="NLM_p last">Cell culture samples were lysed using RIPA buffer-containing protease and phosphatase inhibitors. Lysate protein concentrations were determined by the BCA assay (Thermo). Samples were separated by SDS-PAGE using 4–20% SDS gradient gels (BioRad). Gel contents were transferred to PVDF membranes. Membranes were blocked with 7% nonfat dry milk solution. Blots were probed with antibodies raised against Erk5 (Cell Signaling, 3552S), CDK4, (Cell Signaling, 12790S), CDK6 (Cell Signaling, 3136S), beta-Actin (Cell Signaling, 3700S), Survivin (Cell Signaling, 2808S), and c-Raf (Cell Signaling, 7065S). Antibody dilutions were 1:1000 unless otherwise stated, and all secondary antibodies were used at 1:1000 (Southern Biotech). Blots were developed using ECL (Amersham, 45-000-999) on a ChemiDoc Imaging System (BioRad). Densitometry was performed using Image Lab software (BioRad).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Western Blot Analysis of Client Proteins in UMUC-3 Bladder Cancer Cells</h3><div class="NLM_p last">After 24 h treatment of compounds, UMUC-3 cells were harvested. SDS-PAGE lysates were prepared in RIPA buffer with protease and phosphatase inhibitor cocktail (Sigma-Aldrich, Inc., St. Louis, MO) and lysed by three freeze–thaw cycles using liquid nitrogen and a 37 °C water bath. Protein concentration was determined using a DC protein assay (Bio-Rad Laboratories, Hercules, CA). Equal amounts of protein (20 μg) were loaded on a Novex E-PAGETM 8% protein gel (Life Technologies), transferred to a nitrocellulose membrane by Novex iBlotR Gel Transfer system (Invitrogen, Carlsbad, CA), blocked in protein-free (PBS) blocking buffer (Pierce, Thermo Scientific), and probed with primary antibodies (1:1000 dilution). Membranes were incubated with HRP conjugated secondary antibody (1:10:000 dilution) and visualized with the Odyssey Infrared Imager system (LI-COR, Lincoln, NE). All Western blots were probed for the loading control β-actin. The data were representative of at least three independent experiments.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> siRNA Silencing of Hsp90α</h3><div class="NLM_p last">siRNA-targeting HSP90α was obtained from Dharmacon (ON-TARGETplus SMARTpool, catalog no. L-005186–00-0005; ON-TARGETplus siRNA, catalog no. J-005186-08-0050). Negative control siRNA was obtained from Dharmacon (ON-TARGETplus control pool, catalog no. D-001810-10-05). SkBr3 cells were seeded in six-well plates at a density of 100,000 cells per well, 16 h before transfection. For each sample, siRNA was mixed with 100 mL of Opti-MEM (ThermoFisher Scientific) to a final concentration of 10 nM (mix A). In a separate tube, 5 mL of Lipofectamine RNAiMAX (Invitrogen) was mixed with 100 mL Opti-MEM (mix B). Mixes A and B were then combined and further incubated for 20 min at room temperature. The siRNA/Lipofectamine complexes were added dropwise to 3 mL of culture medium containing the cells. After 2.5 days, the culture medium containing siRNA/Lipofectamine complexes was removed, and fresh media containing indicated concentrations of KUNB106 or geldanamycin were added to the cells for 6 or 18 h. Cells were then lysed with TNES lysis buffer (50 mM Tris–HCl pH 7.5, 1% NP-40, 2 mM EDTA, and 100 mM NaCl) containing protease and phosphatase inhibitors (Sigma, catalog nos. 4693124001 and 4906845001, respectively). Total protein for each sample was determined by the BCA protein assay (ThermoFisher Scientific), and equal amounts of total protein were analyzed via Western blotting. Antibodies used included: anti-Hsp90a(D1A7, Cell Signaling, #8165); anti-ErbB2 (HER-2/c-erbB-2/neu Ab-17, ThermoFisher Scientific, #MS-730-P1-A); anti-phospho-Akt (Ser473, Cell Signaling, #9271); anti-Akt (Cell Signaling, #9272); anti-Cdk4 (H-22, Santa Cruz Biotechnology, #sc-601); anti-c-IAP1 (Cell Signaling, #4952); and anti-α-tubulin as a loading control (DM1A, EMD Millipore, #CP06).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Molecular Modeling</h3><div class="NLM_p last">The Surflex–Docking module in SybylX was used for molecular modeling and docking studies. The co-crystal structures of SNX 2112 bound to Hsp90 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH7">4NH7</a>), compound 31 bound to Hsp90a (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O0B">4O0B</a>) and PU-3 bound to Hsp90b (PDB code:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>) were utilized for modeling experiments. Pymol was used for further visualization and figure preparation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01700" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01700?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01700</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Effect of Hsp90β inhibition on proliferation of Hsp90α KO cells, HPLC analysis of select compound, and NCI-60 cell line screening results of <b>4d</b> and <b>6a</b>; Grp94 and Trap1 inhibition data, GI50 values of <b>4a</b>, <b>5b</b>, and <b>6a</b> against Hek293 cells, molecular formula strings file with IC50 value against cancer cell lines and computational models (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline"><b>4d</b> (beta) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><b>4d</b> (alpha) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><b>6a</b> (beta) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_005.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_001.pdf">jm0c01700_si_001.pdf (1.37 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_002.csv">jm0c01700_si_002.csv (0.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_003.pdb">jm0c01700_si_003.pdb (149.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_004.pdb">jm0c01700_si_004.pdb (151.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_005.pdb">jm0c01700_si_005.pdb (149.22 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01700" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian S. J. Blagg</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6200-3480" title="Orcid link">http://orcid.org/0000-0002-6200-3480</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1f7d7d737e78785f717b317a7b6a"><span class="__cf_email__" data-cfemail="7d1f1f111c1a1a3d131953181908">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanket J. Mishra</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiya Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Urologic Oncology, University of Kansas
Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Beebe</span> - <span class="hlFld-Affiliation affiliation">Center
for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Rockville, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monimoy Banerjee</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caitlin N. Kent</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vitumbiko Munthali</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Koren</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A Taylor</span> - <span class="hlFld-Affiliation affiliation">Department
of Urologic Oncology, University of Kansas
Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonard M. Neckers</span> - <span class="hlFld-Affiliation affiliation">Center
for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Rockville, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey Holzbeierlein</span> - <span class="hlFld-Affiliation affiliation">Department
of Urologic Oncology, University of Kansas
Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Mishra and Blagg have recently started Grannus Therapeutics in an effort to move this research towards clinical evaluation.<br /></br><p class="inlineNote">The authors have recently started Grannus Therapeutics to develop a similar scaffold.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from The National Institutes of Health to CA213566 (B.S.J.B.), and the National Institutes of Health Graduate Training Grant T32GM075762 (C.N.K.). Support for the NMR instrumentation was provided by NIH Shared Instrumentation Grants (S10OD016360, S10RR024664) and NSF Major Research Instrumentation Grant (0320648).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Databank</p></td></tr><tr><td class="NLM_term">CDK4</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 4</p></td></tr><tr><td class="NLM_term">CDK6</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 6</p></td></tr><tr><td class="NLM_term">cIAP1</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein-1</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">C-X-C motif chemokine receptor 4</p></td></tr><tr><td class="NLM_term">Akt-1</td><td class="NLM_def"><p class="first last">AKT serine/threonine kinase 1</p></td></tr><tr><td class="NLM_term">Raf-1</td><td class="NLM_def"><p class="first last">Raf-1 proto-oncogene</p></td></tr><tr><td class="NLM_term">Hsf-1</td><td class="NLM_def"><p class="first last">heat shock transcription factor 1</p></td></tr><tr><td class="NLM_term">Hsp70</td><td class="NLM_def"><p class="first last">heat shock protein 70</p></td></tr><tr><td class="NLM_term">SNAr</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreedhar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmár, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csermely, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.-F.</span></span> <span> </span><span class="NLM_article-title">Hsp90 isoforms: functions, expression and clinical importance</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00229-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2FS0014-5793%2804%2900229-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=15069952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2004&pages=11-15&author=A.+S.+Sreedharauthor=%C3%89.+Kalm%C3%A1rauthor=P.+Csermelyauthor=Y.-F.+Shen&title=Hsp90+isoforms%3A+functions%2C+expression+and+clinical+importance&doi=10.1016%2FS0014-5793%2804%2900229-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 isoforms: functions, expression and clinical importance</span></div><div class="casAuthors">Sreedhar Amere Subbarao; Kalmar Eva; Csermely Peter; Shen Yu-Fei</div><div class="citationInfo"><span class="NLM_cas:title">FEBS letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">11-5</span>
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein, Hsp90, is a main functional component of an important cytoplasmic chaperone complex, and it is involved in various cellular processes, such as cell proliferation, differentiation and apoptosis.  Identification of Hsp90 as a molecular target of various anticancer drugs highlighted its importance from the clinical point of view.  Here we summarize the current knowledge of various Hsp90 isoforms regarding their genomic location, molecular evolution, functional differences, differential induction after various environmental stresses and in pathological conditions as well as the growing importance of discriminating between Hsp90 isoforms in clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPSA2r_aCgUoNpW7w2tapOfW6udTcc2eYVVmlWED2k87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D&md5=d5340d922f408298ba90a5cc906b60f2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900229-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900229-7%26sid%3Dliteratum%253Aachs%26aulast%3DSreedhar%26aufirst%3DA.%2BS.%26aulast%3DKalm%25C3%25A1r%26aufirst%3D%25C3%2589.%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DY.-F.%26atitle%3DHsp90%2520isoforms%253A%2520functions%252C%2520expression%2520and%2520clinical%2520importance%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D562%26spage%3D11%26epage%3D15%26doi%3D10.1016%2FS0014-5793%2804%2900229-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piel, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruford, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, A.</span></span> <span> </span><span class="NLM_article-title">The HSP90 family of genes in the human genome: insights into their divergence and evolution</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1016/j.ygeno.2005.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.ygeno.2005.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=16269234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2005&pages=627-637&author=B.+Chenauthor=W.+H.+Pielauthor=L.+Guiauthor=E.+Brufordauthor=A.+Monteiro&title=The+HSP90+family+of+genes+in+the+human+genome%3A+insights+into+their+divergence+and+evolution&doi=10.1016%2Fj.ygeno.2005.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 family of genes in the human genome: Insights into their divergence and evolution</span></div><div class="casAuthors">Chen, Bin; Piel, William H.; Gui, Liming; Bruford, Elspeth; Monteiro, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-637</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">HSP90 proteins are important mol. chaperones.  Transcriptome and genome analyses revealed that the human HSP90 family includes 17 genes that fall into four classes.  A standardized nomenclature for each of these genes is presented here.  Classes HSP90AA, HSP90AB, HSP90B, and TRAP contain 7, 6, 3, and 1 genes, resp.  HSP90AA genes mapped onto chromosomes 1, 3, 4, and 11; HSP90AB genes mapped onto 3, 4, 6, 13 and 15; HSP90B genes mapped onto 1, 12, and 15; and the TRAP1 gene mapped onto 16.  Six genes, HSP90AA1, HSP90AA2, HSP90N, HSP90AB1, HSP90B1 and TRAP1, were recognized as functional, and the remaining 11 genes were considered putative pseudogenes.  Amino acid polymorphic variants were detected for genes HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1.  The structures of these genes and the functional motifs and polymorphic variants of their proteins were documented and the features and functions of their proteins were discussed.  Phylogenetic analyses based on both nucleotide and protein data demonstrated that HSP90(AA + AB + B) formed a monophyletic clade, whereas TRAP is a relatively distant paralogue of this clade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWj0BC1lItPLVg90H21EOLACvtfcHk0ljjb_GPxRyyyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN&md5=ce235856d3bc4abf368fecdb5de9ba46</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ygeno.2005.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygeno.2005.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPiel%26aufirst%3DW.%2BH.%26aulast%3DGui%26aufirst%3DL.%26aulast%3DBruford%26aufirst%3DE.%26aulast%3DMonteiro%26aufirst%3DA.%26atitle%3DThe%2520HSP90%2520family%2520of%2520genes%2520in%2520the%2520human%2520genome%253A%2520insights%2520into%2520their%2520divergence%2520and%2520evolution%26jtitle%3DGenomics%26date%3D2005%26volume%3D86%26spage%3D627%26epage%3D637%26doi%3D10.1016%2Fj.ygeno.2005.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Anticancer inhibitors of Hsp90 function: beyond the usual suspects</span>. <i>Adv. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fbs.acr.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26916001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=51-88&author=G.+Gargauthor=A.+Khandelwalauthor=B.+S.+J.+Blagg&title=Anticancer+inhibitors+of+Hsp90+function%3A+beyond+the+usual+suspects&doi=10.1016%2Fbs.acr.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer inhibitors of Hsp90 function: beyond the usual suspects</span></div><div class="casAuthors">Garg, Gaurav; Khandelwal, Anuj; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">51-88</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The 90-kDa heat-shock protein (Hsp90) is a mol. chaperone responsible for the stability and function of a wide variety of client proteins that are crit. for cell growth and survival.  Many of these client proteins are frequently mutated and/or overexpressed in cancer cells and are therefore being actively pursued as individual therapeutic targets.  Consequently, Hsp90 inhibition offers a promising strategy for simultaneous degrdn. of several anticancer targets.  Currently, most Hsp90 inhibitors under clin. evaluation act by blocking the binding of ATP to the Hsp90 N-terminal domain and thereby, induce the degrdn. of many Hsp90-dependent oncoproteins.  Although, they have shown some promising initial results, clin. challenges such as induction of the heat-shock response, retinopathy, and gastrointestinal tract toxicity are emerging from human trials, which constantly raise concerns about the future development of these inhibitors.  Novobiocin derivs., which do not bind the chaperone's N-terminal ATPase pocket, have emerged over the past decade as an alternative strategy to inhibit Hsp90, but to date, no deriv. has been investigated in the clin. setting.  In recent years, a no. of natural or synthetic compds. have been identified that modulate Hsp90 function via various mechanisms.  These compds. not only offer new chemotypes for the development of future Hsp90 inhibitors but can also serve as chem. probes to unravel the biol. of Hsp90.  This chapter presents a synopsis of inhibitors that directly, allosterically, or even indirectly alters Hsp90 function, and highlights their proposed mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxUbLOX6QhIbVg90H21EOLACvtfcHk0ljjb_GPxRyyyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWru7Y%253D&md5=32f8b44222a82f678ebadf5ae24cf7ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGarg%26aufirst%3DG.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DAnticancer%2520inhibitors%2520of%2520Hsp90%2520function%253A%2520beyond%2520the%2520usual%2520suspects%26jtitle%3DAdv.%2520Cancer.%2520Res.%26date%3D2016%26volume%3D129%26spage%3D51%26epage%3D88%26doi%3D10.1016%2Fbs.acr.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitesell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S. L.</span></span> <span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1038/nrc1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer&doi=10.1038%2Fnrc1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0ljjb_GPxRyyyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772%26doi%3D10.1038%2Fnrc1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elif
Karagöz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüdiger, S. G. D.</span></span> <span> </span><span class="NLM_article-title">Hsp90 interaction with clients</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.tibs.2014.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=25579468" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=117-125&author=G.+Elif%0AKarag%C3%B6zauthor=S.+G.+D.+R%C3%BCdiger&title=Hsp90+interaction+with+clients&doi=10.1016%2Fj.tibs.2014.12.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DElif%2BKarag%25C3%25B6z%26aufirst%3DG.%26aulast%3DR%25C3%25BCdiger%26aufirst%3DS.%2BG.%2BD.%26atitle%3DHsp90%2520interaction%2520with%2520clients%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2015%26volume%3D40%26spage%3D117%26epage%3D125%26doi%3D10.1016%2Fj.tibs.2014.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Röhl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">The chaperone Hsp90: changing partners for demanding clients</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.tibs.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23507089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=253-262&author=A.+R%C3%B6hlauthor=J.+Rohrbergauthor=J.+Buchner&title=The+chaperone+Hsp90%3A+changing+partners+for+demanding+clients&doi=10.1016%2Fj.tibs.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone Hsp90: changing partners for demanding clients</span></div><div class="casAuthors">Rohl Alina; Rohrberg Julia; Buchner Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Trends in biochemical sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">253-62</span>
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">The heat shock protein (Hsp)90 chaperone machinery regulates the activity of hundreds of client proteins in the eukaryotic cytosol.  It undergoes large conformational changes between states that are similar in energy.  These transitions are rate-limiting for the ATPase cycle.  It has become evident that several of the many Hsp90 co-chaperones affect the conformational equilibrium by stabilizing specific intermediate states.  Consequently, there is an ordered progression of different co-chaperones during the conformational cycle.  Asymmetric complexes containing two different co-chaperones may be important for the processing of the client protein, although our understanding of this aspect, as well as the details of the interaction of Hsp90 with client proteins, is still in its infancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS2inA-utJHL5XHngOXiV_fW6udTcc2eZm23tJhwJ9Prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D&md5=3f0c5df5ba9088c3b41b3257b21b9d7a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hl%26aufirst%3DA.%26aulast%3DRohrberg%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520chaperone%2520Hsp90%253A%2520changing%2520partners%2520for%2520demanding%2520clients%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D253%26epage%3D262%26doi%3D10.1016%2Fj.tibs.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuehlke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and co-chaperones twist the functions of diverse client proteins</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1002/bip.21292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1002%2Fbip.21292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=19697319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Sj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2010&pages=211-217&author=A.+Zuehlkeauthor=J.+L.+Johnson&title=Hsp90+and+co-chaperones+twist+the+functions+of+diverse+client+proteins&doi=10.1002%2Fbip.21292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 and co-chaperones twist the functions of diverse client proteins</span></div><div class="casAuthors">Zuehlke, Abbey; Johnson, Jill L.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-217</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Hsp90 mol. chaperones are required for the stability and activity of a diverse range of client proteins that have crit. roles in signal transduction, cellular trafficking, chromatin remodeling, cell growth, differentiation, and reprodn.  Mammalian cells contain three types of Hsp90s: cytosolic Hsp90, mitochondrial Trap-1, and Grp94 of the endoplasmic reticulum.  Each of the Hsp90s, as well as the bacterial homolog, HtpG, hydrolyze ATP and undergo similar conformational changes.  Unlike the other forms of Hsp90, cytosolic Hsp90 function is dependent on a battery of co-chaperone proteins that regulate the ATPase activity of Hsp90 or direct Hsp90 to interact with specific client proteins.  This review will summarize what is known about Hsp90's ability to mediate the folding and activation of diverse client proteins that contribute to human diseases, such as cancer and fungal and viral infections.  © 2009 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIsUPshTEeIbVg90H21EOLACvtfcHk0lhdQ_GvJYhBQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Sj&md5=0be40189e8b7c408acf69391ef2a1359</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fbip.21292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.21292%26sid%3Dliteratum%253Aachs%26aulast%3DZuehlke%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26atitle%3DHsp90%2520and%2520co-chaperones%2520twist%2520the%2520functions%2520of%2520diverse%2520client%2520proteins%26jtitle%3DBiopolymers%26date%3D2010%26volume%3D93%26spage%3D211%26epage%3D217%26doi%3D10.1002%2Fbip.21292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span> <span> </span><span class="NLM_article-title">Understanding of the Hsp90 molecular chaperone reaches new heights</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1038/nsmb1210-1400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnsmb1210-1400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=21127511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1400-1404&author=C.+K.+Vaughanauthor=L.+Neckersauthor=P.+W.+Piper&title=Understanding+of+the+Hsp90+molecular+chaperone+reaches+new+heights&doi=10.1038%2Fnsmb1210-1400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding of the Hsp90 molecular chaperone reaches new heights</span></div><div class="casAuthors">Vaughan, Cara K.; Neckers, Len; Piper, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1400-1404</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) was the focus of a recent meeting in the Swiss Alps, where the Hsp90 community met to discuss the operation and functions of this ubiquitous and essential mol. chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_Bb0rccr4LVg90H21EOLACvtfcHk0lhdQ_GvJYhBQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSku7jP&md5=b77f393fa083a04b4695cabc5e8c6a0a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1210-1400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1210-1400%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26atitle%3DUnderstanding%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520reaches%2520new%2520heights%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1400%26epage%3D1404%26doi%3D10.1038%2Fnsmb1210-1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span> <span> </span><span class="NLM_article-title">A global view of Hsp90 functions</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnsmb.2481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23288357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsleisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1-4&author=G.+Chiosisauthor=C.+A.+Dickeyauthor=J.+L.+Johnson&title=A+global+view+of+Hsp90+functions&doi=10.1038%2Fnsmb.2481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A global view of Hsp90 functions</span></div><div class="casAuthors">Chiosis, Gabriela; Dickey, Chad A.; Johnson, Jill L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Sixth International Conference on Hsp90 in 2012 revealed new functions of this key mol. chaperone.  Attendees of the meeting at Les Diablerets, Switzerland, addressed new discoveries about Hsp90 and its cochaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrJZHeOegBLVg90H21EOLACvtfcHk0lhdQ_GvJYhBQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsleisw%253D%253D&md5=fe27eda8ca2eb9adae4ecb012c171156</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2481%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26atitle%3DA%2520global%2520view%2520of%2520Hsp90%2520functions%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1%26epage%3D4%26doi%3D10.1038%2Fnsmb.2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">The therapeutic target Hsp90 and cancer hallmarks</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.2174/138161213804143725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.2174%2F138161213804143725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22920906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=347-365&author=Y.+Miyataauthor=H.+Nakamotoauthor=L.+Neckers&title=The+therapeutic+target+Hsp90+and+cancer+hallmarks&doi=10.2174%2F138161213804143725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic target Hsp90 and cancer hallmarks</span></div><div class="casAuthors">Miyata, Yoshihiko; Nakamoto, Hitoshi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a major mol. chaperone that is expressed abundantly and plays a pivotal role in assisting correct folding and functionality of its client proteins in cells.  The Hsp90 client proteins include a wide variety of signal transducing mols. such as protein kinases and steroid hormone receptors.  Cancer is a complex disease, but most types of human cancer share common hallmarks, including self-sufficiency in growth signals, insensitivity to growth-inhibitory mechanism, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  A surprisingly large no. of Hsp90-client proteins play crucial roles in establishing cancer cell hallmarks.  We start the review by describing the structure and function of Hsp90 since conformational changes during the ATPase cycle of Hsp90 are closely related to its function.  Many co-chaperones, including Hop, p23, Cdc37, Aha1, and PP5, work together with Hsp90 by modulating the chaperone machinery.  Post-translational modifications of Hsp90 and its co-chaperones are vital for their function.  Many tumor-related Hsp90-client proteins, including signaling kinases, steroid hormone receptors, p53, and telomerase, are described.  Hsp90 and its co-chaperones are required for the function of these tumor-promoting client proteins; therefore, inhibition of Hsp90 by specific inhibitors such as geldanamycin and its derivs. attenuates the tumor progression.  Hsp90 inhibitors can be potential and effective cancer chemotherapeutic drugs with a unique profile and have been examd. in clin. trials.  We describe possible mechanisms why Hsp90 inhibitors show selectivity to cancer cells even though Hsp90 is essential also for normal cells.  Finally, we discuss the "Hsp90-addiction" of cancer cells, and suggest a role for Hsp90 in tumor evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCHug6Q3PILVg90H21EOLACvtfcHk0lh-ShWcD9KQzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D&md5=07f817fc5afc5ef0669aae0cd0dab15d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161213804143725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143725%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DNakamoto%26aufirst%3DH.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DThe%2520therapeutic%2520target%2520Hsp90%2520and%2520cancer%2520hallmarks%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D347%26epage%3D365%26doi%3D10.2174%2F138161213804143725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lh-ShWcD9KQzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span> <span> </span><span class="NLM_article-title">Stressing the development of small molecules targeting HSP90</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1158%2F1078-0432.CCR-13-2571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=24166908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=275-277&author=L.+Neckersauthor=J.+B.+Trepel&title=Stressing+the+development+of+small+molecules+targeting+HSP90&doi=10.1158%2F1078-0432.CCR-13-2571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Stressing the Development of Small Molecules Targeting HSP90</span></div><div class="casAuthors">Neckers, Len; Trepel, Jane B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-277</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the mol. chaperone HSP90 have been in clin. development as anticancer agents since 1999.  Recent clin. studies, including the work of Saif and colleagues in this issue of Clin. Cancer Research, demonstrate that significant progress has been made in overcoming the obstacles preventing regulatory approval.  Clin Cancer Res; 20(2); 275-7. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokmt4J2prgYrVg90H21EOLACvtfcHk0lh-ShWcD9KQzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D&md5=a81694c35395f63f394263843ba5fe3d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2571%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26atitle%3DStressing%2520the%2520development%2520of%2520small%2520molecules%2520targeting%2520HSP90%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2014%26volume%3D20%26spage%3D275%26epage%3D277%26doi%3D10.1158%2F1078-0432.CCR-13-2571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Travers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">HSP90 inhibition: two-pronged exploitation of cancer dependencies</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.drudis.2011.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22245656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=242-252&author=J.+Traversauthor=S.+Sharpauthor=P.+Workman&title=HSP90+inhibition%3A+two-pronged+exploitation+of+cancer+dependencies&doi=10.1016%2Fj.drudis.2011.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 inhibition: two-pronged exploitation of cancer dependencies</span></div><div class="casAuthors">Travers, Jon; Sharp, Swee; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">242-252</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The early clin. hypothesis for inhibiting HSP90 in cancers was based on the dependence of certain key client proteins in malignant cells - including a host of well-characterized oncoproteins - on the activity of HSP90 for their function and stability.  The addnl. concept has been established that cancer cells have heightened dependence on the efficient maintenance of intracellular proteomic homeostasis, central components of which are HSP90 and other heat shock proteins.  We evaluate the evidence that inhibiting HSP90 in cancer exploits both of these biol. vulnerabilities very effectively, we review the current status of the discovery and development of HSP90 inhibitors and we identify routes to improve their clin. efficacy, based on emerging knowledge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopukpOX3xzQrVg90H21EOLACvtfcHk0lgvk9RQmQIgQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggsr8%253D&md5=333666e312c67442e94d9dace72d5817</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DTravers%26aufirst%3DJ.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520inhibition%253A%2520two-pronged%2520exploitation%2520of%2520cancer%2520dependencies%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D242%26epage%3D252%26doi%3D10.1016%2Fj.drudis.2011.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummalapalli, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotella, D. P.</span></span> <span> </span><span class="NLM_article-title">Progress in the discovery and development of heat shock protein 90 (hsp90) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8718</span>– <span class="NLM_lpage">8728</span>, <span class="refDoi"> DOI: 10.1021/jm500823a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500823a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8718-8728&author=R.+Bhatauthor=S.+R.+Tummalapalliauthor=D.+P.+Rotella&title=Progress+in+the+discovery+and+development+of+heat+shock+protein+90+%28hsp90%29+inhibitors&doi=10.1021%2Fjm500823a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Tummalapalli, Sreedhar R.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8718-8728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The discovery and clin. development of heat shock protein 90 (Hsp90) inhibitors continue to progress.  A no. of Hsp90 inhibitors are in clin. trials, and preclin. discoveries of new chemotypes that bind to distinct regions in the protein as well as isoform selective compds. are active areas of research.  This review will highlight progress in the field since 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-SwLv_-B9xLVg90H21EOLACvtfcHk0lgvk9RQmQIgQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK&md5=132784687bbbcf62cfa8fe04a22577ce</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500823a%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DTummalapalli%26aufirst%3DS.%2BR.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DProgress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8718%26epage%3D8728%26doi%3D10.1021%2Fjm500823a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haystead, T. A. J.</span></span> <span> </span><span class="NLM_article-title">Hsp90, an unlikely ally in the war on cancer</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1111/febs.12147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1111%2Ffebs.12147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23356585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFWlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=1381-1396&author=J.+J.+Barrottauthor=T.+A.+J.+Haystead&title=Hsp90%2C+an+unlikely+ally+in+the+war+on+cancer&doi=10.1111%2Ffebs.12147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90, an unlikely ally in the war on cancer</span></div><div class="casAuthors">Barrott, Jared J.; Haystead, Timothy A. J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1381-1396</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  On the surface heat shock protein 90 (Hsp90) is an unlikely drug target for the treatment of any disease, let alone cancer.  Hsp90 is highly conserved and ubiquitously expressed in all cells.  There are two major isoforms α and β encoded by distinct genes and together they may constitute 1%-3% of the cellular protein.  Deletion of the protein is embryonic lethal and there are no recognized polymorphisms suggesting an assocn. or causal relationship with any human disease.  With respect to cancer, the proteins absence from two recent high profile articles, Hallmarks of cancer: the next generation' [Hanahan & Weinberg (2011) Cell144, 646-674] and Comprehensive mol. portraits of human breast tumors' [Koboldt et al. (2012) Nature] underlines the perception that it is an unlikely bona fide target to treat this disease.  Yet, to date, there are 17 distinct Hsp90 inhibitors in clin. trials for multiple indications in cancer.  The protein has been championed for over 20 years by the National Cancer Institute (Bethesda, MD,USA) as a cancer target since the discovery of the antitumor activity of the natural product geldanamycin.  This review aims to look at the conundrum of why Hsp90 can even be considered a druggable target for the treatment of cancer.  We propose that in contrast to the majority of chemotherapeutics our growing armamentarium of investigational Hsp90 drugs represents an elegant choice that offers real hope in the long-term treatment of certain cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jK5jqqavALVg90H21EOLACvtfcHk0lgvk9RQmQIgQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFWlt7g%253D&md5=d25c4efeecd07fa342bb6221f728aafa</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12147%26sid%3Dliteratum%253Aachs%26aulast%3DBarrott%26aufirst%3DJ.%2BJ.%26aulast%3DHaystead%26aufirst%3DT.%2BA.%2BJ.%26atitle%3DHsp90%252C%2520an%2520unlikely%2520ally%2520in%2520the%2520war%2520on%2520cancer%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D1381%26epage%3D1396%26doi%3D10.1111%2Ffebs.12147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jhaveri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.bbamcr.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22062686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers&doi=10.1016%2Fj.bbamcr.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span></div><div class="casAuthors">Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an ATP dependent mol. chaperone protein which integrates multiple oncogenic pathways.  As such, Hsp90 inhibition is a promising anti-cancer strategy.  Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clin. evaluation.  Robust pre-clin. data suggested anti-tumor activity in multiple cancer types.  Clin., encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma.  In breast cancer, proof-of-concept was demonstrated by first generation Hsp90 inhibitors in combination with trastuzumab mainly in human epidermal growth factor receptor 2 (HER2) + metastatic breast cancer.  There are a multitude of second generation Hsp90 inhibitors currently under investigation.  To date, however, there is no FDA approved Hsp90 inhibitor nor standardized assay to ascertain Hsp90 inhibition.  This review summarizes the current status of both first and second generation Hsp90 inhibitors based on their chem. classification and stage of clin. development.  It also discusses the pharmacodynamic assays currently implemented in clinic as well as other novel strategies aimed at enhancing the effectiveness of Hsp90 inhibitors.  Ultimately, these efforts will aid in maximizing the full potential of this class of agents.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDrDTpRQxfYrVg90H21EOLACvtfcHk0lg4Cz6wMeJ_6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D&md5=03cef7dc96667a4698324f635aacee7a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755%26doi%3D10.1016%2Fj.bbamcr.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Natural product inspired N-terminal Hsp90 inhibitors: from bench to bedside?</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1002/med.21351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1002%2Fmed.21351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26010985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=92-118&author=A.+Khandelwalauthor=V.+M.+Crowleyauthor=B.+S.+J.+Blagg&title=Natural+product+inspired+N-terminal+Hsp90+inhibitors%3A+from+bench+to+bedside%3F&doi=10.1002%2Fmed.21351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?</span></div><div class="casAuthors">Khandelwal, Anuj; Crowley, Vincent M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-118</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation of nascent polypeptides and the rematuration of denatured proteins.  Proteins dependent upon Hsp90 are assocd. with all six hallmarks of cancer.  Upon Hsp90 inhibition, protein substrates are degraded via the ubiquitin-proteasome pathway.  Consequentially, inhibition of Hsp90 offers a therapeutic opportunity for the treatment of cancer.  Natural product inhibitors of Hsp90 have been identified in vitro, which have served as leads for the development of more efficacious inhibitors and analogs that have entered clin. trials.  This review highlights the development of natural product analogs, as well as the development of clin. important inhibitors that arose from natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqloFmLYY5brbVg90H21EOLACvtfcHk0lg4Cz6wMeJ_6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK&md5=7625868e7c1e904cdd20036003ffb0d4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmed.21351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21351%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DNatural%2520product%2520inspired%2520N-terminal%2520Hsp90%2520inhibitors%253A%2520from%2520bench%2520to%2520bedside%253F%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D92%26epage%3D118%26doi%3D10.1002%2Fmed.21351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lg4Cz6wMeJ_6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz-Ares, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hsp90 molecular chaperones: moving into the clinic</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e358</span>– <span class="NLM_lpage">e369</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2FS1470-2045%2813%2970169-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23896275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=e358-e369&author=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Inhibition+of+Hsp90+molecular+chaperones%3A+moving+into+the+clinic&doi=10.1016%2FS1470-2045%2813%2970169-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HSP90 molecular chaperones: moving into the clinic</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Carnero, Amancio; Paz-Ares, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e358-e369</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (HSP90) is a mol. chaperone that is crucial for the stability and function of many proteins essential for cell survival.  Many oncogenes, including tyrosine kinases, transcription factors, and cell-cycle regulatory proteins, are client proteins of HSP90.  Inhibition of HSP90 causes client protein degrdn. via the ubiquitin-proteasome pathway, and is a mechanism that might simultaneously downregulate several redundant pathways crucial for cell viability and tumor development.  HSP90 inhibitors are currently being developed as anticancer agents, and have shown early promising results in molecularly defined subgroups of solid tumors (eg, ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer) and some haematol. malignancies (eg, multiple myeloma).  Here, we review the current status of HSP90 inhibitors in clin. development, including geldanamycin derivs., resorcinol derivs., purine analogs, and other synthetic inhibitors.  We also discuss novel strategies and future perspectives on how to optimize the therapeutic potential of this exciting new class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpulM7j4PFcx7Vg90H21EOLACvtfcHk0lg4Cz6wMeJ_6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI&md5=4821e86073624fb17d7343105d6e82cd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970169-4%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520Hsp90%2520molecular%2520chaperones%253A%2520moving%2520into%2520the%2520clinic%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3De358%26epage%3De369%26doi%3D10.1016%2FS1470-2045%2813%2970169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/jm9004708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.+C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials&doi=10.1021%2Fjm9004708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0lhoeaQqnqKOaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17%26doi%3D10.1021%2Fjm9004708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.ctrv.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23199899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGjsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=375-387&author=D.+S.+Hongauthor=U.+Banerjiauthor=B.+Tavanaauthor=G.+C.+Georgeauthor=J.+Aaronauthor=R.+Kurzrock&title=Targeting+the+molecular+chaperone+heat+shock+protein+90+%28HSP90%29%3A+lessons+learned+and+future+directions&doi=10.1016%2Fj.ctrv.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions</span></div><div class="casAuthors">Hong, David S.; Banerji, Udai; Tavana, Bahareh; George, Goldy C.; Aaron, Joann; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Due to the crit. role of heat shock protein 90 (HSP90) in regulating the stability, activity and intracellular sorting of its client proteins involved in multiple oncogenic processes, HSP90 inhibitors are promising therapeutic agents for cancer treatment.  In cancer cells, HSP90 client proteins play a major role in oncogenic signal transduction (i.e., mutant epidermal growth factor receptor), angiogenesis (i.e., vascular endothelial growth factor), anti-apoptosis (i.e., AKT), and metastasis (i.e., matrix metalloproteinase 2 and CD91), processes central to maintaining the cancer phenotype.  Thus, HSP90 has emerged as a viable target for antitumor drug development, and several HSP90 inhibitors have transitioned to clin. trials.  HSP90 inhibitors include geldanamycin and its derivs. (i.e., tanespimycin, alvespimycin, IPI-504), synthetic and small mol. inhibitors (i.e., AUY922, AT13387, STA9090, MPC3100), other inhibitors of HSP90 and its isoforms (i.e., shepherdin and 5'-N-ethylcarboxamideadenosine).  With more than 200 "client" proteins, many of them meta-stable and oncogenic, HSP90 inhibition can affect an array of tumors.  Here we review the mol. structure of HSP90, structural features of HSP90 inhibition, pharmacodynamic effects and tumor responses in clin. trials of HSP90 inhibitors.  We also discuss lessons learned from completed clin. trials of HSP90 inhibitors, and future directions for these promising therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbTT7zy5jIsrVg90H21EOLACvtfcHk0lhoeaQqnqKOaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGjsLvM&md5=485735cfb38cb7113648b54e2ec99426</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DTavana%26aufirst%3DB.%26aulast%3DGeorge%26aufirst%3DG.%2BC.%26aulast%3DAaron%26aufirst%3DJ.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520molecular%2520chaperone%2520heat%2520shock%2520protein%252090%2520%2528HSP90%2529%253A%2520lessons%2520learned%2520and%2520future%2520directions%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2013%26volume%3D39%26spage%3D375%26epage%3D387%26doi%3D10.1016%2Fj.ctrv.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powers, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the heat shock response: biology and pharmacology</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>581</i></span>,  <span class="NLM_fpage">3758</span>– <span class="NLM_lpage">3769</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2007.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.febslet.2007.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=17559840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlaisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=3758-3769&author=M.+V.+Powersauthor=P.+Workman&title=Inhibitors+of+the+heat+shock+response%3A+biology+and+pharmacology&doi=10.1016%2Fj.febslet.2007.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the heat shock response: Biology and pharmacology</span></div><div class="casAuthors">Powers, Marissa V.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3758-3769</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A no. of human diseases can be linked to aberrations in protein folding which cause an imbalance in protein homeostasis.  Mol. chaperones, including heat shock proteins, act to assist protein folding, stability and activity in the cell.  Attention has begun to focus on modulating the expression and/or activity of this group of proteins for the treatment of a wide variety of human diseases.  This review will describe the progress made to date in developing pharmacol. modulators of the heat shock response, including both agents which affect the entire heat shock response and those that specifically target the HSP70 and HSP90 chaperone families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd1XAAhY6tPLVg90H21EOLACvtfcHk0lhoeaQqnqKOaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlaisbo%253D&md5=3be785569e7caee11e84a8cb4ca20574</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2007.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2007.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520the%2520heat%2520shock%2520response%253A%2520biology%2520and%2520pharmacology%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D3758%26epage%3D3769%26doi%3D10.1016%2Fj.febslet.2007.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskew, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vielhauer, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/mp300138n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300138n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1841-1846&author=L.+B.+Petersonauthor=J.+D.+Eskewauthor=G.+A.+Vielhauerauthor=B.+S.+J.+Blagg&title=The+hERG+channel+is+dependent+upon+the+Hsp90%CE%B1+isoform+for+maturation+and+trafficking&doi=10.1021%2Fmp300138n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking</span></div><div class="casAuthors">Peterson, Laura B.; Eskew, Jeffrey D.; Vielhauer, George A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1841-1846</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) has emerged as a promising therapeutic target for the treatment of cancer.  Several Hsp90 inhibitors have entered clin. trials.  However, some toxicol. detriments have arisen, such as cardiotoxicity resulting from hERG inhibition following the administration of Hsp90 inhibitors.  We sought to investigate this toxicity as hERG has been previously reported as a client protein that depends upon Hsp90 for its maturation and functional trafficking.  In this study we show that hERG depends upon a single Hsp90 isoform. hERG preferentially co-immunopptd. with Hsp90α, and genetic knockdown of Hsp90α, but not Hsp90β, resulted in a trafficking-defective hERG channel.  This study demonstrates the importance of delineating the isoform dependence of Hsp90 client proteins and provides rationale for the design of isoform-selective Hsp90 inhibitors that avoid detrimental effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5BFhqGrKjIbVg90H21EOLACvtfcHk0lhQuHUgWV7jng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D&md5=910dfb5e4a9150f408d5756ab881e492</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fmp300138n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300138n%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DEskew%26aufirst%3DJ.%2BD.%26aulast%3DVielhauer%26aufirst%3DG.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DThe%2520hERG%2520channel%2520is%2520dependent%2520upon%2520the%2520Hsp90%25CE%25B1%2520isoform%2520for%2520maturation%2520and%2520trafficking%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D1841%26epage%3D1846%26doi%3D10.1021%2Fmp300138n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span> <span> </span><span class="NLM_article-title">The molecular chaperone Hsp90a; deficiency causes retinal degeneration by disrupting Golgi organization and vesicle transportation in photoreceptors</span>. <i>J. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1093/jmcb/mjz048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1093%2Fjmcb%2Fmjz048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=31408169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitV2jsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=216-229&author=Y.+Wuauthor=X.+Zhengauthor=Y.+Dingauthor=M.+Zhouauthor=Z.+Weiauthor=T.+Liuauthor=K.+Liao&title=The+molecular+chaperone+Hsp90a%3B+deficiency+causes+retinal+degeneration+by+disrupting+Golgi+organization+and+vesicle+transportation+in+photoreceptors&doi=10.1093%2Fjmcb%2Fmjz048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular chaperone Hsp90U+03B1 deficiency causes retinal degeneration by disrupting Golgi organization and vesicle transportation in photoreceptors</span></div><div class="casAuthors">Wu, Yuan; Zheng, Xiudan; Ding, Yubo; Zhou, Min; Wei, Zhuang; Liu, Tao; Liao, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Cell Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-229</span>CODEN:
                <span class="NLM_cas:coden">JMCBCU</span>;
        ISSN:<span class="NLM_cas:issn">1759-4685</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an abundant mol. chaperone with two isoforms, Hsp90U+03B1 and Hsp90U+03B2.  Hsp90U+03B2 deficiency causes embryonic lethality, whereas Hsp90U+03B1 deficiency causes few abnormities except male sterility.  In this paper, we reported that Hsp90U+03B1 was exclusively expressed in the retina, testis, and brain.  Its deficiency caused retinitis pigmentosa (RP), a disease leading to blindness.  In Hsp90U+03B1-deficient mice, the retina was deteriorated and the outer segment of photoreceptor was deformed.  Immunofluorescence staining and electron microscopic anal. revealed disintegrated Golgi and aberrant intersegmental vesicle transportation in Hsp90U+03B1-deficient photoreceptors.  Proteomic anal. identified microtubule-assocd. protein 1B (MAP1B) as an Hsp90U+03B1-assocd. protein in photoreceptors.  HspU+03B1 deficiency increased degrdn. of MAP1B by inducing its ubiquitination, causing U+03B1-tubulin deacetylation and microtubule destabilization.  Furthermore, the treatment of wild-type mice with 17-DMAG, an Hsp90 inhibitor of geldanamycin deriv., induced the same retinal degeneration as Hsp90U+03B1 deficiency.  Taken together, the microtubule destabilization could be the underlying reason for Hsp90U+03B1 deficiency-induced RP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGQAxBOQ6rybVg90H21EOLACvtfcHk0lhQuHUgWV7jng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitV2jsrbM&md5=f62a02f8218b4af8484f505750dacbd3</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1093%2Fjmcb%2Fmjz048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjmcb%252Fmjz048%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DK.%26atitle%3DThe%2520molecular%2520chaperone%2520Hsp90a%253B%2520deficiency%2520causes%2520retinal%2520degeneration%2520by%2520disrupting%2520Golgi%2520organization%2520and%2520vesicle%2520transportation%2520in%2520photoreceptors%26jtitle%3DJ.%2520Mol.%2520Cell%2520Biol.%26date%3D2020%26volume%3D12%26spage%3D216%26epage%3D229%26doi%3D10.1093%2Fjmcb%2Fmjz048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagatell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paine-Murrieta, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulcini, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesell, L.</span></span> <span> </span><span class="NLM_article-title">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3312</span>– <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10955818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=3312-3318&author=R.+Bagatellauthor=G.+D.+Paine-Murrietaauthor=C.+W.+Taylorauthor=E.+J.+Pulciniauthor=S.+Akinagaauthor=I.+J.+Benjaminauthor=L.+Whitesell&title=Induction+of+a+heat+shock+factor+1-dependent+stress+response+alters+the+cytotoxic+activity+of+hsp90-binding+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of Hsp90-binding agents</span></div><div class="casAuthors">Bagatell, Rochelle; Paine-Murrieta, Gillian D.; Taylor, Charles W.; Pulcini, Elizabeth J.; Akinaga, Shiro; Benjamin, Ivor J.; Whitesell, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3312-3318</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In addn. to its classic role in the cellular stress response, heat shock protein 90 (Hsp90) plays a crit. but less well appreciated role in regulating signal transduction pathways that control cell growth and survival under basal, nonstress conditions.  Over the past 5 yr, the antitumor antibiotics geldanamycin and radicicol have become recognized as selective Hsp90-binding agents (HBA) with a novel ability to alter the activity of many of the receptors, kinases, and transcription factors involved in these cancer-assocd. pathways.  As a consequence of their interaction with Hsp90, however, these agents also induce a marked cellular heat shock response.  To study the mechanism of this response and assess its relevance to the anticancer action of the HBA, we verified that the compds. could activate a reporter construct contg. consensus binding sites for heat shock factor 1 (HSF1), the major transcriptional regulator of the vertebrate heat shock response.  The authors then used transformed fibroblasts derived from HSF1 knock-out mice to show that unlike conventional chemotherapeutics, HBA increased the synthesis and cellular levels of heat shock proteins in an HSF1-dependent manner.  Compared with transformed fibroblasts derived from wild-type mice, HSF1 knock-out cells were significantly more sensitive to the cytotoxic effects of HBA but not to doxorubicin or cisplatin.  Consistent with these in vitro data, the authors found that systemic administration of an HBA led to marked increases in the level of Hsp72 in both normal mouse tissues and human tumor xenografts.  The authors conclude that HBA are useful probes for studying mol. mechanisms regulating the heat shock response both in cells and in whole animals.  Moreover, induction of the heat shock response by HBA will be an important consideration in the clin. application of these drugs, both in terms of modulating their cytotoxic activity as well as monitoring their biol. activity in individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCXM1LsRGAfLVg90H21EOLACvtfcHk0lhQuHUgWV7jng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D&md5=3c6f4e392424161b38ddc010ea97afb1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DPaine-Murrieta%26aufirst%3DG.%2BD.%26aulast%3DTaylor%26aufirst%3DC.%2BW.%26aulast%3DPulcini%26aufirst%3DE.%2BJ.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DBenjamin%26aufirst%3DI.%2BJ.%26aulast%3DWhitesell%26aufirst%3DL.%26atitle%3DInduction%2520of%2520a%2520heat%2520shock%2520factor%25201-dependent%2520stress%2520response%2520alters%2520the%2520cytotoxic%2520activity%2520of%2520hsp90-binding%2520agents%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2000%26volume%3D6%26spage%3D3312%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, R. I.</span></span> <span> </span><span class="NLM_article-title">Role of the heat shock response and molecular chaperones in oncogenesis and cell death</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">1564</span>– <span class="NLM_lpage">1572</span>, <span class="refDoi"> DOI: 10.1093/jnci/92.19.1564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1093%2Fjnci%2F92.19.1564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=11018092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVKitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1564-1572&author=C.+Jollyauthor=R.+I.+Morimoto&title=Role+of+the+heat+shock+response+and+molecular+chaperones+in+oncogenesis+and+cell+death&doi=10.1093%2Fjnci%2F92.19.1564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the heat shock response and molecular chaperones in oncogenesis and cell death</span></div><div class="casAuthors">Jolly, Caroline; Morimoto, Richard I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1564-1572</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 127 refs.  Exposure of cells to conditions of environmental stress - including heat shock, oxidative stress, heavy metals, or pathol. conditions, such as ischemia and reperfusion, inflammation, tissue damage, infection, and mutant proteins assocd. with genetic diseases - results in the inducible expression of heat shock proteins that function as mol. chaperones or proteases.  Mol. chaperones are a class of proteins that interact with diverse protein substrates to assist in their folding, with a crit. role during cell stress to prevent the appearance of folding intermediates that lead to misfolded or otherwise damaged mols.  Consequently, heat shock proteins assist in the recovery from stress either by repairing damaged proteins (protein refolding) or by degrading them, thus restoring protein homeostasis and promoting cell survival.  The events of cell stress and cell death are linked, such that mol. chaperones induced in response to stress appear to function at key regulatory points in the control of apoptosis.  On the basis of these observations - and on the role of mol. chaperones in the regulation of steroid aporeceptors, kinases, caspases, and other protein remodeling events involved in chromosome replication and changes in cell structure - it is not surprising that the heat shock response and mol. chaperones were implicated in the control of cell growth.  In this review, the authors address some of the mol. and cellular events initiated by cell stress - the interrelationships between stress signaling, cell death, and oncogenesis - and chaperones as potential targets for cancer diagnosis and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrht7F_WJ5_Q7Vg90H21EOLACvtfcHk0lgDdgrX_1xYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVKitr4%253D&md5=353f48d5f8135334dd45e541445a0744</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.19.1564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.19.1564%26sid%3Dliteratum%253Aachs%26aulast%3DJolly%26aufirst%3DC.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DRole%2520of%2520the%2520heat%2520shock%2520response%2520and%2520molecular%2520chaperones%2520in%2520oncogenesis%2520and%2520cell%2520death%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D1564%26epage%3D1572%26doi%3D10.1093%2Fjnci%2F92.19.1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraldeschi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centenera, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Maximizing the therapeutic potential of HSP90 inhibitors</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1445</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-15-0234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1158%2F1541-7786.MCR-15-0234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26219697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=1445-1451&author=L.+M.+Butlerauthor=R.+Ferraldeschiauthor=H.+K.+Armstrongauthor=M.+M.+Centeneraauthor=P.+Workman&title=Maximizing+the+therapeutic+potential+of+HSP90+inhibitors&doi=10.1158%2F1541-7786.MCR-15-0234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Maximizing the Therapeutic Potential of HSP90 Inhibitors</span></div><div class="casAuthors">Butler, Lisa M.; Ferraldeschi, Roberta; Armstrong, Heather K.; Centenera, Margaret M.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1445-1451</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HSP90 is required for maintaining the stability and activity of a diverse group of client proteins, including protein kinases, transcription factors, and steroid hormone receptors involved in cell signaling, proliferation, survival, oncogenesis, and cancer progression.  Inhibition of HSP90 alters the HSP90-client protein complex, leading to reduced activity, misfolding, ubiquitination, and, ultimately, proteasomal degrdn. of client proteins.  HSP90 inhibitors have demonstrated significant antitumor activity in a wide variety of preclin. models, with evidence of selectivity for cancer vs. normal cells.  In the clinic, however, the efficacy of this class of therapeutic agents has been relatively limited to date, with promising responses mainly obsd. in breast and lung cancer, but no major activity seen in other tumor types.  In addn., adverse events and some significant toxicities have been documented.  Key to improving these clin. outcomes is a better understanding of the cellular consequences of inhibiting HSP90 that may underlie treatment response or resistance.  This review considers the recent progress that has been made in the study of HSP90 and its inhibitors and highlights new opportunities to maximize their therapeutic potential.  Mol Cancer Res; 13(11); 1445-51. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWZoeQQ9MOV7Vg90H21EOLACvtfcHk0lgDdgrX_1xYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbbP&md5=da00f7d2b830fed75f4e4141ff04d128</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-15-0234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-15-0234%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DL.%2BM.%26aulast%3DFerraldeschi%26aufirst%3DR.%26aulast%3DArmstrong%26aufirst%3DH.%2BK.%26aulast%3DCentenera%26aufirst%3DM.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DMaximizing%2520the%2520therapeutic%2520potential%2520of%2520HSP90%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2015%26volume%3D13%26spage%3D1445%26epage%3D1451%26doi%3D10.1158%2F1541-7786.MCR-15-0234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panaretou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4829</span>– <span class="NLM_lpage">4836</span>, <span class="refDoi"> DOI: 10.1093/emboj/17.16.4829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1093%2Femboj%2F17.16.4829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=9707442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADyaK1cXlslyjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4829-4836&author=B.+Panaretouauthor=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=ATP+binding+and+hydrolysis+are+essential+to+the+function+of+the+Hsp90+molecular+chaperone+in+vivo&doi=10.1093%2Femboj%2F17.16.4829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span></div><div class="casAuthors">Panaretou, Barry; Prodromou, Chrisostomos; Roe, S. Mark; O'Brien, Ronan; Ladbury, John E.; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4829-4836</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hsp90 is an abundant mol. chaperone essential to the establishment of many cellular regulation and signal transduction systems, but remains one of the least well described chaperones.  The biochem. mechanism of protein folding by Hsp90 is poorly understood, and the direct involvement of ATP has been particularly contentious.  Here we demonstrate in vitro an inherent ATPase activity in both yeast Hsp90 and the Escherichia coli homolog HtpG, which is sensitive to inhibition by the Hsp90-specific antibiotic geldanamycin.  Mutations of residues implicated in ATP binding and hydrolysis by structural studies abolish this ATPase activity in vitro and disrupt Hsp90 function in vivo.  These results show that Hsp90 is directly ATP dependent in vivo, and suggest an ATP-coupled chaperone cycle for Hsp90-mediated protein folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA12RZ3cNnYbVg90H21EOLACvtfcHk0lgDdgrX_1xYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslyjsLo%253D&md5=c61fa708d60f9ef44a94aab7e4e1d1ce</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.16.4829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.16.4829%26sid%3Dliteratum%253Aachs%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP%2520binding%2520and%2520hydrolysis%2520are%2520essential%2520to%2520the%2520function%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4829%26epage%3D4836%26doi%3D10.1093%2Femboj%2F17.16.4829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kijima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatokoro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamit-Kush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0141786</span>– <span class="NLM_lpage">e0141786</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0141786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1371%2Fjournal.pone.0141786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26517842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0141786-e0141786&author=T.+L.+Princeauthor=T.+Kijimaauthor=M.+Tatokoroauthor=S.+Leeauthor=S.+Tsutsumiauthor=K.+Yimauthor=C.+Rivasauthor=S.+Alarconauthor=H.+Schwartzauthor=K.+Khamit-Kushauthor=B.+T.+Scrogginsauthor=K.+Beebeauthor=J.+B.+Trepelauthor=L.+Neckers&title=Client+proteins+and+small+molecule+inhibitors+display+distinct+binding+preferences+for+constitutive+and+stress-induced+HSP90+isoforms+and+their+conformationally+restricted+mutants&doi=10.1371%2Fjournal.pone.0141786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants</span></div><div class="casAuthors">Prince, Thomas L.; Kijima, Toshiki; Tatokoro, Manabu; Lee, Sunmin; Tsutsumi, Shinji; Yim, Kendrick; Rivas, Candy; Alarcon, Sylvia; Schwartz, Harvey; Khamit-Kush, Kofi; Scroggins, Bradley T.; Beebe, Kristin; Trepel, Jane B.; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0141786/1-e0141786/15</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The two cytosolic/nuclear isoforms of the mol. chaperone HSP90, stress-inducible HSP90α and constitutively expressed HSP90β, fold, assemble and maintain the threedimensional structure of numerous client proteins.  Because many HSP90 clients are important in cancer, several HSP90 inhibitors have been evaluated in the clinic.  However, little is known concerning possible unique isoform or conformational preferences of either individual HSP90 clients or inhibitors.  In this report, we compare the relative interaction strength of both HSP90α and HSP90β with the transcription factors HSF1 and HIF1α, the kinases ERBB2 and MET, the E3-ubiquitin ligases KEAP1 and RHOBTB2, and the HSP90 inhibitors geldanamycin and ganetespib.  We obsd. unexpected differences in relative client and drug preferences for the two HSP90 isoforms, with HSP90α binding each client protein with greater apparent affinity compared to HSP90β, while HSP90β bound each inhibitor with greater relative interaction strength compared to HSP90α.  Stable HSP90 interaction was assocd. with reduced client activity.  Using a defined set of HSP90 conformational mutants, we found that some clients interact strongly with a single, ATP-stabilized HSP90 conformation, only transiently populated during the dynamic HSP90 chaperone cycle, while other clients interact equally with multiple HSP90 conformations.  These data suggest different functional requirements among HSP90 clientele that, for some clients, are likely to be ATP-independent.  Lastly, the two inhibitors examd., although sharing the same binding site, were differentially able to access distinct HSP90 conformational states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqmyydx9DNLVg90H21EOLACvtfcHk0ljQRHuKyUup4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjsr7N&md5=993b552322f7e9ebe20f26f9aa6d198a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0141786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0141786%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DT.%2BL.%26aulast%3DKijima%26aufirst%3DT.%26aulast%3DTatokoro%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DYim%26aufirst%3DK.%26aulast%3DRivas%26aufirst%3DC.%26aulast%3DAlarcon%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DH.%26aulast%3DKhamit-Kush%26aufirst%3DK.%26aulast%3DScroggins%26aufirst%3DB.%2BT.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DClient%2520proteins%2520and%2520small%2520molecule%2520inhibitors%2520display%2520distinct%2520binding%2520preferences%2520for%2520constitutive%2520and%2520stress-induced%2520HSP90%2520isoforms%2520and%2520their%2520conformationally%2520restricted%2520mutants%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0141786%26epage%3De0141786%26doi%3D10.1371%2Fjournal.pone.0141786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zubrienė, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutkowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulienė, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaleckis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailovienė, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voroncova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venclovas, Č.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zylicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zylicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, D.</span></span> <span> </span><span class="NLM_article-title">Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms</span>. <i>Biophys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.bpc.2010.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.bpc.2010.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=20943306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2isrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2010&pages=153-163&author=A.+Zubrien%C4%97author=M.+Gutkowskaauthor=J.+Matulien%C4%97author=R.+Chaleckisauthor=V.+Michailovien%C4%97author=A.+Voroncovaauthor=%C4%8C.+Venclovasauthor=A.+Zyliczauthor=M.+Zyliczauthor=D.+Matulis&title=Thermodynamics+of+radicicol+binding+to+human+Hsp90+alpha+and+beta+isoforms&doi=10.1016%2Fj.bpc.2010.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms</span></div><div class="casAuthors">Zubriene, Asta; Gutkowska, Malgorzata; Matuliene, Jurgita; Chaleckis, Romanas; Michailoviene, Vilma; Voroncova, Aliona; Venclovas, Ceslovas; Zylicz, Alicja; Zylicz, Maciej; Matulis, Daumantas</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">BICIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0301-4622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Radicicol (RD) is a natural antibiotic that specifically inhibits chaperone Hsp90 activity and binds to its active site with nanomolar affinity.  Radicicol has been widely used as a lead compd. to generate synthetic analogs with reduced toxicity and increased stability that could be employed clin.  Here we present a detailed thermodn. description of radicicol binding to human Hsp90 and yeast Hsc82 studied by isothermal titrn. calorimetry (ITC) and thermal shift assay (TSA).  Titrns. as a function of pH showed a linked protonation event upon radicicol binding.  The intrinsic binding const. and the thermodn. parameters (including the enthalpy, entropy, and heat capacity) were detd. for yeast Hsc82, and human alpha and beta Hsp90.  Recent exptl. evidence in literature shows that yeast Hsc82 has significant differences from human Hsp90 isoenzymes.  Here we support this by demonstrating differences in radicicol binding thermodn. to these proteins.  The intrinsic enthalpy of radicicol binding to Hsc82 was -46.7 kJ/mol, to Hsp90alpha -70.7 kJ/mol, and to Hsp90beta was -66.8 kJ/mol.  The enthalpies of binding were significantly different, while the intrinsic dissocn. consts. were quite similar, equal to 0.25, 0.04, and 0.15 nM, resp.  The structural features responsible for such large difference in binding enthalpy but small difference in the intrinsic binding Gibbs free energy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquG-QjiRgoArVg90H21EOLACvtfcHk0ljQRHuKyUup4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2isrrO&md5=5d709500f52952cca335323cb497475d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bpc.2010.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpc.2010.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DZubrien%25C4%2597%26aufirst%3DA.%26aulast%3DGutkowska%26aufirst%3DM.%26aulast%3DMatulien%25C4%2597%26aufirst%3DJ.%26aulast%3DChaleckis%26aufirst%3DR.%26aulast%3DMichailovien%25C4%2597%26aufirst%3DV.%26aulast%3DVoroncova%26aufirst%3DA.%26aulast%3DVenclovas%26aufirst%3D%25C4%258C.%26aulast%3DZylicz%26aufirst%3DA.%26aulast%3DZylicz%26aufirst%3DM.%26aulast%3DMatulis%26aufirst%3DD.%26atitle%3DThermodynamics%2520of%2520radicicol%2520binding%2520to%2520human%2520Hsp90%2520alpha%2520and%2520beta%2520isoforms%26jtitle%3DBiophys.%2520Chem.%26date%3D2010%26volume%3D152%26spage%3D153%26epage%3D163%26doi%3D10.1016%2Fj.bpc.2010.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Paralog specific Hsp90 inhibitors - a brief history and a bright future</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.2174%2F1568026616666160413141154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=27072700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2779-2791&author=D.+T.+Gewirth&title=Paralog+specific+Hsp90+inhibitors+-+a+brief+history+and+a+bright+future&doi=10.2174%2F1568026616666160413141154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future</span></div><div class="casAuthors">Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2779-2791</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background. The high sequence and structural homol. among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition.  Objective. This review surveys the state of developments in structural anal., compd. screening, and structure-based design that have been brought to bear on this problem.  Results. First generation compds. that selectively bind to Hsp90, Grp94, or Trap-1 have been identified.  Conclusion. With the proof of principle firmly established, the prospects for further progress are bright.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdyZyrXOyou7Vg90H21EOLACvtfcHk0lhkJo94lU286Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN&md5=208025ff36aa6e2d92d3ee107b20ab5f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141154%26sid%3Dliteratum%253Aachs%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DParalog%2520specific%2520Hsp90%2520inhibitors%2520-%2520a%2520brief%2520history%2520and%2520a%2520bright%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2779%26epage%3D2791%26doi%3D10.2174%2F1568026616666160413141154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheon, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span> <span> </span><span class="NLM_article-title">Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">4358</span>– <span class="NLM_lpage">4367</span>, <span class="refDoi"> DOI: 10.1021/ja511893n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja511893n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=4358-4367&author=C.+Leeauthor=H.+K.+Parkauthor=H.+Jeongauthor=J.+Limauthor=A.+J.+Leeauthor=K.+Y.+Cheonauthor=C.+S.+Kimauthor=A.+P.+Thomasauthor=B.+Baeauthor=N.+D.+Kimauthor=S.+H.+Kimauthor=P.+G.+Suhauthor=J.+H.+Ryuauthor=B.+H.+Kang&title=Development+of+a+mitochondria-targeted+Hsp90+inhibitor+based+on+the+crystal+structures+of+human+TRAP1&doi=10.1021%2Fja511893n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1</span></div><div class="casAuthors">Lee, Changwook; Park, Hye-Kyung; Jeong, Hanbin; Lim, Jaehwa; Lee, An-Jung; Cheon, Keun Young; Kim, Chul-Su; Thomas, Ajesh P.; Bae, Boram; Kim, Nam Doo; Kim, Seong Heon; Suh, Pann-Ghill; Ryu, Ja-Hyoung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4358-4367</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mitochondrial pool of Hsp90 and its mitochondrial paralog, TRAP1, suppresses cell death and reprograms energy metab. in cancer cells; therefore, Hsp90 and TRAP1 have been suggested as target proteins for anticancer drug development.  Here, the authors report that the actual target protein in cancer cell mitochondria is TRAP1, and current Hsp90 inhibitors cannot effectively inactivate TRAP1 because of their insufficient accumulation in the mitochondria.  To develop mitochondrial TRAP1 inhibitors, the authors detd. the crystal structures of human TRAP1 complexed with Hsp90 inhibitors.  The iso-Pr amine of the Hsp90 inhibitor PU-H71 was replaced with the mitochondria-targeting moiety triphenylphosphonium to produce SMTIN-P01.  SMTIN-P01 showed a different mode of action from the nontargeted PU-H71, as well as much improved cytotoxicity to cancer cells.  In addn., the authors detd. the structure of a TRAP1-adenylyl-imidodiphosphate (AMP-PNP) complex.  On the basis of comparative anal. of TRAP1 structures, the authors propose a mol. mechanism of ATP hydrolysis that is crucial for chaperone function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-VB5CkPi2LVg90H21EOLACvtfcHk0lhkJo94lU286Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D&md5=c1142149eaa5f4157377ce64662fcfc1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja511893n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja511893n%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DCheon%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DC.%2BS.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DBae%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSuh%26aufirst%3DP.%2BG.%26aulast%3DRyu%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DB.%2BH.%26atitle%3DDevelopment%2520of%2520a%2520mitochondria-targeted%2520Hsp90%2520inhibitor%2520based%2520on%2520the%2520crystal%2520structures%2520of%2520human%2520TRAP1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D4358%26epage%3D4367%26doi%3D10.1021%2Fja511893n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lhkJo94lU286Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+J.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhNth5A3hubrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizziah, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of glucose regulated protein 94-selective inhibitors based on the BnIm and Radamide scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3488</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3471-3488&author=V.+M.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=A.+R.+Stothertauthor=D.+J.+E.+Huardauthor=J.+Zhaoauthor=A.+Muthauthor=A.+S.+Duerfeldtauthor=J.+L.+Kizziahauthor=R.+L.+Liebermanauthor=C.+A.+Dickeyauthor=B.+S.+J.+Blagg&title=Development+of+glucose+regulated+protein+94-selective+inhibitors+based+on+the+BnIm+and+Radamide+scaffold&doi=10.1021%2Facs.jmedchem.6b00085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold</span></div><div class="casAuthors">Crowley, Vincent M.; Khandelwal, Anuj; Mishra, Sanket; Stothert, Andrew R.; Huard, Dustin J. E.; Zhao, Jinbo; Muth, Aaron; Duerfeldt, Adam S.; Kizziah, James L.; Lieberman, Raquel L.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3471-3488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Arylmethyl)imidazolylethyl chlorodihydroxybenzoates I (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) were prepd. as selective inhibitors of glucose regulated protein 94 (Grp94), the endoplasmic reticulum-resident isoform of the heat shock protein 90 (Hsp90), for potential use in the treatment of glaucoma and cancer; the effect of the aryl substituents on Grp94 binding and selectivity was detd.  I were prepd. by the cyclocondensation of a bissilylated chloro(oxopropyl)dihydroxybenzoate with glyoxal and arylmethylamines RCH2NH2 (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) followed by desilylation.  I (R = 2-MeO-4-MeC6H3CH2, 5-chloro-2-furanylmethyl) were tested as inhibitors of cell migration in a cancer metastasis model and for their enhancement of the degrdn. of mutants of the protein myocilin in a glaucoma model.  The structures of the lead compd. radamide bound to Hsp82 and Grp94 and of I (R = 5-chloro-2-furanyl) bound to the N-terminal domain of Hsp94 lacking its acidic linker were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3v_0NEYj1Z7Vg90H21EOLACvtfcHk0lhNth5A3hubrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D&md5=c73bbf30c243e281aae197689162c9e1</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00085%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%2BE.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DKizziah%26aufirst%3DJ.%2BL.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520glucose%2520regulated%2520protein%252094-selective%2520inhibitors%2520based%2520on%2520the%2520BnIm%2520and%2520Radamide%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3471%26epage%3D3488%26doi%3D10.1021%2Facs.jmedchem.6b00085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Transformation of the non-selective aminocyclohexanol-based Hsp90 inhibitor into a Grp94-seletive scaffold</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=244-253&author=S.+J.+Mishraauthor=S.+Ghoshauthor=A.+R.+Stothertauthor=C.+A.+Dickeyauthor=B.+S.+J.+Blagg&title=Transformation+of+the+non-selective+aminocyclohexanol-based+Hsp90+inhibitor+into+a+Grp94-seletive+scaffold&doi=10.1021%2Facschembio.6b00747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DTransformation%2520of%2520the%2520non-selective%2520aminocyclohexanol-based%2520Hsp90%2520inhibitor%2520into%2520a%2520Grp94-seletive%2520scaffold%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D244%26epage%3D253%26doi%3D10.1021%2Facschembio.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzbeierlein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">425</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fs41467-017-02013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=29382832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=425&author=A.+Khandelwalauthor=C.+N.+Kentauthor=M.+Balchauthor=S.+Pengauthor=S.+J.+Mishraauthor=J.+Dengauthor=V.+W.+Dayauthor=W.+Liuauthor=C.+Subramanianauthor=M.+Cohenauthor=J.+M.+Holzbeierleinauthor=R.+Mattsauthor=B.+S.+J.+Blagg&title=Structure-guided+design+of+an+Hsp90%CE%B2+N-terminal+isoform-selective+inhibitor&doi=10.1038%2Fs41467-017-02013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span></div><div class="casAuthors">Khandelwal Anuj; Mishra Sanket J; Kent Caitlin N; Blagg Brian S J; Balch Maurie; Peng Shuxia; Deng Junpeng; Matts Robert; Day Victor W; Liu Weiya; Holzbeierlein Jeffery M; Subramanian Chitra; Cohen Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">425</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression.  Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways.  Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response.  The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments.  Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels.  Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmyRre9-yoQBpyrDyM_m9cfW6udTcc2eb84Y5Mah4B1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D&md5=cfa47e314c9bdbc1c38802108330cba7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBalch%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DV.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DHolzbeierlein%26aufirst%3DJ.%2BM.%26aulast%3DMatts%26aufirst%3DR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520an%2520Hsp90%25CE%25B2%2520N-terminal%2520isoform-selective%2520inhibitor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D425%26doi%3D10.1038%2Fs41467-017-02013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vought, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.bmcl.2013.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=24332488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=204-208&author=J.+T.+Ernstauthor=M.+Liuauthor=H.+Zuccolaauthor=T.+Neubertauthor=K.+Beaumontauthor=A.+Turnbullauthor=A.+Kallelauthor=B.+Voughtauthor=D.+Stamos&title=Correlation+between+chemotype-dependent+binding+conformations+of+HSP90%CE%B1%2F%CE%B2+and+isoform+selectivity-Implications+for+the+structure-based+design+of+HSP90%CE%B1%2F%CE%B2+selective+inhibitors+for+treating+neurodegenerative+diseases&doi=10.1016%2Fj.bmcl.2013.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span></div><div class="casAuthors">Ernst, Justin T.; Liu, Michael; Zuccola, Harmon; Neubert, Timothy; Beaumont, Kevin; Turnbull, Amy; Kallel, Adam; Vought, Bryan; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-208</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HSP90 continues to be a target of interest for neurodegeneration indications.  Selective knockdown of the HSP90 cytosolic isoforms α and β is sufficient to reduce mutant huntingtin protein levels in vitro.  Chemotype-dependent binding conformations of HSP90α/β appear to strongly influence isoform selectivity.  The rational design of HSP90α/β inhibitors selective vs. the mitochondrial (TRAP1) and endoplasmic reticulum (GRP94) isoforms offers a potential mitigating strategy for mechanism-based toxicities.  Better tolerated HSP90 inhibitors would be attractive for targeting chronic neurodegenerative diseases such as Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64ZOr5JsRerVg90H21EOLACvtfcHk0lg0esMFHWnm_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO&md5=6799a46090ee297d70700f7c42b79f80</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DKallel%26aufirst%3DA.%26aulast%3DVought%26aufirst%3DB.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DCorrelation%2520between%2520chemotype-dependent%2520binding%2520conformations%2520of%2520HSP90%25CE%25B1%252F%25CE%25B2%2520and%2520isoform%2520selectivity-Implications%2520for%2520the%2520structure-based%2520design%2520of%2520HSP90%25CE%25B1%252F%25CE%25B2%2520selective%2520inhibitors%2520for%2520treating%2520neurodegenerative%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D204%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2013.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llauger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huezo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span>. <i>J. Biomol. Screen.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1177/1087057104265995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=L.+Llaugerauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+Hsp90&doi=10.1177%2F1087057104265995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0lg0esMFHWnm_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381%26doi%3D10.1177%2F1087057104265995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woody, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcacio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3400</span>, <span class="refDoi"> DOI: 10.1021/jm500042s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500042s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=3382-3400&author=J.+T.+Ernstauthor=T.+Neubertauthor=M.+Liuauthor=S.+Sperryauthor=H.+Zuccolaauthor=A.+Turnbullauthor=B.+Fleckauthor=W.+Kargoauthor=L.+Woodyauthor=P.+Chiangauthor=D.+Tranauthor=W.+Chenauthor=P.+Snyderauthor=T.+Alcacioauthor=A.+Nezamiauthor=J.+Reynoldsauthor=K.+Alviauthor=L.+Gouletauthor=D.+Stamos&title=Identification+of+novel+HSP90%CE%B1%2F%CE%B2+isoform+selective+inhibitors+using+structure-based+drug+design.+demonstration+of+potential+utility+in+treating+CNS+disorders+such+as+Huntington%E2%80%99s+disease&doi=10.1021%2Fjm500042s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease</span></div><div class="casAuthors">Ernst, Justin T.; Neubert, Timothy; Liu, Michael; Sperry, Samuel; Zuccola, Harmon; Turnbull, Amy; Fleck, Beth; Kargo, William; Woody, Lisa; Chiang, Peggy; Tran, Dao; Chen, Weichao; Snyder, Phillip; Alcacio, Timothy; Nezami, Azin; Reynolds, James; Alvi, Khisal; Goulet, Lance; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-based drug design strategy was used to optimize a novel benzolactam series of HSP90α/β inhibitors to achieve >1000-fold selectivity vs. the HSP90 endoplasmic reticulum and mitochondrial isoforms (GRP94 and TRAP1, resp.).  Selective HSP90α/β inhibitors were found to be equipotent to pan-HSP90 inhibitors in promoting the clearance of mutant huntington protein (mHtt) in vitro, however with less cellular toxicity.  Improved tolerability profiles may enable the use of HSP90α/β selective inhibitors in treating chronic neurodegenerative indications such as Huntington's disease (HD).  A potent, selective, orally available HSP90α/β inhibitor, 8-Cyclopentyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one, was identified that crosses the blood-brain barrier and demonstrated proof of concept by successfully reducing brain Htt levels following oral dosing in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKpHcuphxPXbVg90H21EOLACvtfcHk0lg0esMFHWnm_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D&md5=0d55fb738fc0f0615b5336b8dc17056a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500042s%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DFleck%26aufirst%3DB.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DWoody%26aufirst%3DL.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSnyder%26aufirst%3DP.%26aulast%3DAlcacio%26aufirst%3DT.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DAlvi%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520novel%2520HSP90%25CE%25B1%252F%25CE%25B2%2520isoform%2520selective%2520inhibitors%2520using%2520structure-based%2520drug%2520design.%2520demonstration%2520of%2520potential%2520utility%2520in%2520treating%2520CNS%2520disorders%2520such%2520as%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26spage%3D3382%26epage%3D3400%26doi%3D10.1021%2Fjm500042s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slamon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, W. L.</span></span> <span> </span><span class="NLM_article-title">Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1126/science.3798106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1126%2Fscience.3798106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=3798106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADyaL2sXhtVSht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=177-182&author=D.+J.+Slamonauthor=G.+M.+Clarkauthor=S.+G.+Wongauthor=W.+J.+Levinauthor=A.+Ullrichauthor=W.+L.+McGuire&title=Human+breast+cancer%3A+correlation+of+relapse+and+survival+with+amplification+of+the+HER-2%2Fneu+oncogene&doi=10.1126%2Fscience.3798106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Human breast cancer:  correlation of relapse and survival with amplification of the HER-2/neu oncogene</span></div><div class="casAuthors">Slamon, Dennis J.; Clark, Gary M.; Wong, Steven G.; Levin, Wendy J.; Ullrich, Axel; McGuire, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">4785</span>),
    <span class="NLM_cas:pages">177-82</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The HER-2/neu oncogene is a member of the erbB-like oncogene family, and is related to, but distinct from, the epidermal growth factor receptor.  This gene has been shown to be amplified in human breast cancer cell lines.  In the current study, alterations of the gene in 189 primary human breast cancers were investigated.  HER-2/neu was found to be amplified from 2- to >20-fold in 30% of the tumors.  Correlation of gene amplification with several disease parameters was evaluated.  Amplification of the HER-2neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer.  It retained its significance even when adjustments were made for other known prognostic factors.  Moreover, HER-2/neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal-receptor status, in lymph node-pos. disease.  These data indicate that this gene may play a role in the biol. behavior and(or) pathogenesis of human breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWPpNbN8S_QrVg90H21EOLACvtfcHk0lgEZp4PQdDxWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtVSht7s%253D&md5=0889410d6e47651de4d8085e9bbd70d9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscience.3798106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3798106%26sid%3Dliteratum%253Aachs%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DClark%26aufirst%3DG.%2BM.%26aulast%3DWong%26aufirst%3DS.%2BG.%26aulast%3DLevin%26aufirst%3DW.%2BJ.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DMcGuire%26aufirst%3DW.%2BL.%26atitle%3DHuman%2520breast%2520cancer%253A%2520correlation%2520of%2520relapse%2520and%2520survival%2520with%2520amplification%2520of%2520the%2520HER-2%252Fneu%2520oncogene%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D177%26epage%3D182%26doi%3D10.1126%2Fscience.3798106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffernan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1729</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1128/MCB.6.5.1729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1128%2FMCB.6.5.1729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=2878363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADyaL28XktlKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1986&pages=1729-1740&author=D.+F.+Sternauthor=P.+A.+Heffernanauthor=R.+A.+Weinberg&title=p185%2C+a+product+of+the+neu+proto-oncogene%2C+is+a+receptorlike+protein+associated+with+tyrosine+kinase+activity&doi=10.1128%2FMCB.6.5.1729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">p185, A product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity</span></div><div class="casAuthors">Stern, David F.; Heffernan, Patricia A.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1729-40</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The neu oncogene was originally identified in cell lines derived from rat neuroectodermal tumors; neu is related to but distinct from the c-erbB gene, which encodes the epidermal growth factor (EGF) receptor.  Instead, neu encodes a protein, designated p185, that is serol. related to the EGF receptor.  Identification of the normal homolog of p185 encoded by the neu proto-oncogene permitted comparison of the product of the neu proto-oncogene with the mutated version specified by the neu oncogene and with the EGF receptor.  The normal form of p185 was structurally similar to its transforming counterpart, indicating that activation of the neu oncogene did not cause major structural alterations in the gene product.  Both normal and transforming forms of p185 were assocd. with tyrosine kinase  [80449-02-1] activity, supporting the idea that normal p185 functions as a growth factor receptor.  The p185 differed both structurally and functionally from the EGF receptor; the 2 proteins had distinct electrophoretic mobilities when synthesized under normal culture conditions or in the presence of tunicamycin.  EGF did not stimulate increased turnover of p185 and did not bind quant. to p185.  A no. of other growth factors failed to stimulate either degrdn. of p185 or tyrosine phosphorylation of p185 and are therefore unlikely to be ligands for p185.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJA1YsOnmi0LVg90H21EOLACvtfcHk0lgEZp4PQdDxWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktlKlsr0%253D&md5=3d97172b5179592e7651d5e8dc1c1177</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FMCB.6.5.1729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.6.5.1729%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DD.%2BF.%26aulast%3DHeffernan%26aufirst%3DP.%2BA.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3Dp185%252C%2520a%2520product%2520of%2520the%2520neu%2520proto-oncogene%252C%2520is%2520a%2520receptorlike%2520protein%2520associated%2520with%2520tyrosine%2520kinase%2520activity%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1986%26volume%3D6%26spage%3D1729%26epage%3D1740%26doi%3D10.1128%2FMCB.6.5.1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moasser, M. M.</span></span> <span> </span><span class="NLM_article-title">The oncogene HER2; Its signaling and transforming functions and its role in human cancer pathogenesis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">6469</span>– <span class="NLM_lpage">6487</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fsj.onc.1210477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=17471238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=6469-6487&author=M.+M.+Moasser&title=The+oncogene+HER2%3B+Its+signaling+and+transforming+functions+and+its+role+in+human+cancer+pathogenesis&doi=10.1038%2Fsj.onc.1210477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis</span></div><div class="casAuthors">Moasser, M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">6469-6487</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The year 2007 marks exactly two decades since Human Epidermal Growth Factor Receptor-2 (HER2) was functionally implicated in the pathogenesis of human breast cancer.  This finding established the HER2 oncogene hypothesis for the development of some human cancers.  The subsequent two decades have brought about an explosion of information about the biol. of HER2 and the HER family.  An abundance of exptl. evidence now solidly supports the HER2 oncogene hypothesis and etiol. links amplification of the HER2 gene locus with human cancer pathogenesis.  The mol. mechanisms underlying HER2 tumorigenesis appear to be complex and a unified mechanistic model of HER2-induced transformation has not emerged.  Numerous hypotheses implicating diverse transforming pathways have been proposed and are individually supported by exptl. models and HER2 may indeed induce cell transformation through multiple mechanisms.  Here I review the evidence supporting the oncogenic function of HER2, the mechanisms that are felt to mediate its oncogenic functions, and the evidence that links the exptl. evidence with human cancer pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3J_STszvOrVg90H21EOLACvtfcHk0lgEZp4PQdDxWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagsbnN&md5=1ca26e99dc27692105e2751c90ccdb45</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210477%26sid%3Dliteratum%253Aachs%26aulast%3DMoasser%26aufirst%3DM.%2BM.%26atitle%3DThe%2520oncogene%2520HER2%253B%2520Its%2520signaling%2520and%2520transforming%2520functions%2520and%2520its%2520role%2520in%2520human%2520cancer%2520pathogenesis%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D6469%26epage%3D6487%26doi%3D10.1038%2Fsj.onc.1210477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Anping  Guo</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Huan-aoyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wenqin  Xie</span>, <span class="hlFld-ContribAuthor ">Mengjie  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113604. <a href="https://doi.org/10.1016/j.ejmech.2021.113604" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113604%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252BGrp94%252Bselective%252Binhibitors%252Bbased%252Bon%252BPhe199%252Binduced%252Bfit%252Bmechanism%252Band%252Btheir%252Banti-inflammatory%252Beffects%26aulast%3DXu%26aufirst%3DShicheng%26date%3D2021%26volume%3D223%26spage%3D113604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Nannan  Chen</span>, <span class="hlFld-ContribAuthor ">Dandan  Xia</span>, <span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Tong</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>104 </em><a href="https://doi.org/10.1016/j.chembiol.2021.03.016" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252Bcovalent%252Binhibitor%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252Bwith%252Bantitumor%252Bactivity%252Bthat%252Bblocks%252Bthe%252Bco-chaperone%252Bbinding%252Bvia%252BC-terminal%252Bmodification%26aulast%3DLi%26aufirst%3DLi%26date%3D2021%26volume%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Water-mediated network of hydrogen bonds. (A) Hydrogen-bonding network at the bottom of the Hsp90β pocket (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>). (B) Hydrogen-bonding network in the bottom of the Hsp90α-binding pocket (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XAB">2XAB</a>). (C) Two-dimensional representation of the Hsp90β-binding pocket with the known <i>pan</i>-inhibitor AT11387. (D) <b>KUNB31</b> bound to Hsp90β with apparent Kd values observed in fluorescence polarization assay (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UCJ">5UCJ</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Structures and IC50’s of the benzamide-based Hsp90 inhibitors SNX 2112 and compound <b>31</b> in the FP assay. (B) Alignment of compound <b>4</b> (yellow) and compound <b>31</b> modeled into the Hsp90α (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O0B">4O0B</a>) and Hsp90ß (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>) ATP-binding pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, Ethanol, 60<sup>o</sup> C. (b) 2-Acetyldimedone, Ethanol, Reflux. (c) β-ketoester, K<sub>2</sub>CO<sub>3</sub>, DMF, 70<sup>o</sup> C. (d) H<sub>2</sub>SO<sub>4</sub>/Water/Acetic Acid (2:1:7), 130 °C, 6 h. (e) <i>tran</i>s-Cyclohexanolamine, DIPEA, DMSO, 140<sup>o</sup> C, 12 h</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of <b>3j</b> and <b>4j</b>; (a) BBr<sub>3</sub>, DCM, 0 °C. (b) <i>trans</i>-4-aminocyclohexanol, DIPEA, DMSO, 140 °C</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of <b>5a–5g</b> (a) Amine, DIPEA, DMSO, 140 °C</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of proposed binding modes of <b>4d</b> (cyan) and <b>5a</b> (yellow) in Hsp90β (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed binding mode of <b>6a</b> in the Hsp90β-binding site (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM">1UYM</a>). (B) Structures and IC50 values of <b>6a</b> and <b>6b</b> determined using the FP assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. (a) Pd/C, H<sub>2</sub> 200 psi, Ethanol</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Western blot analysis of client proteins with <b>4d</b> in UM-UC-3 cells. 17-AAG (10 μM) was included as the positive control and the vehicle (DMSO) as the negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Western blot analysis of client proteins with <b>6a</b> in HCT-116 cells. Geldanamycin (GDA) (0.5 μM) was included as the positive control and the vehicle (DMSO) as the negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/medium/jm0c01700_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Western blot analysis of <b>5b</b> to study client protein degradation in SkBr3 cells, GA: gambogic acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01700/20210204/images/large/jm0c01700_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01700&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreedhar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmár, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csermely, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.-F.</span></span> <span> </span><span class="NLM_article-title">Hsp90 isoforms: functions, expression and clinical importance</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00229-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2FS0014-5793%2804%2900229-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=15069952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2004&pages=11-15&author=A.+S.+Sreedharauthor=%C3%89.+Kalm%C3%A1rauthor=P.+Csermelyauthor=Y.-F.+Shen&title=Hsp90+isoforms%3A+functions%2C+expression+and+clinical+importance&doi=10.1016%2FS0014-5793%2804%2900229-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 isoforms: functions, expression and clinical importance</span></div><div class="casAuthors">Sreedhar Amere Subbarao; Kalmar Eva; Csermely Peter; Shen Yu-Fei</div><div class="citationInfo"><span class="NLM_cas:title">FEBS letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">11-5</span>
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein, Hsp90, is a main functional component of an important cytoplasmic chaperone complex, and it is involved in various cellular processes, such as cell proliferation, differentiation and apoptosis.  Identification of Hsp90 as a molecular target of various anticancer drugs highlighted its importance from the clinical point of view.  Here we summarize the current knowledge of various Hsp90 isoforms regarding their genomic location, molecular evolution, functional differences, differential induction after various environmental stresses and in pathological conditions as well as the growing importance of discriminating between Hsp90 isoforms in clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPSA2r_aCgUoNpW7w2tapOfW6udTcc2eY2n3oe0NHMxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D&md5=d5340d922f408298ba90a5cc906b60f2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900229-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900229-7%26sid%3Dliteratum%253Aachs%26aulast%3DSreedhar%26aufirst%3DA.%2BS.%26aulast%3DKalm%25C3%25A1r%26aufirst%3D%25C3%2589.%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DY.-F.%26atitle%3DHsp90%2520isoforms%253A%2520functions%252C%2520expression%2520and%2520clinical%2520importance%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D562%26spage%3D11%26epage%3D15%26doi%3D10.1016%2FS0014-5793%2804%2900229-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piel, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruford, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, A.</span></span> <span> </span><span class="NLM_article-title">The HSP90 family of genes in the human genome: insights into their divergence and evolution</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1016/j.ygeno.2005.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.ygeno.2005.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=16269234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2005&pages=627-637&author=B.+Chenauthor=W.+H.+Pielauthor=L.+Guiauthor=E.+Brufordauthor=A.+Monteiro&title=The+HSP90+family+of+genes+in+the+human+genome%3A+insights+into+their+divergence+and+evolution&doi=10.1016%2Fj.ygeno.2005.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 family of genes in the human genome: Insights into their divergence and evolution</span></div><div class="casAuthors">Chen, Bin; Piel, William H.; Gui, Liming; Bruford, Elspeth; Monteiro, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-637</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">HSP90 proteins are important mol. chaperones.  Transcriptome and genome analyses revealed that the human HSP90 family includes 17 genes that fall into four classes.  A standardized nomenclature for each of these genes is presented here.  Classes HSP90AA, HSP90AB, HSP90B, and TRAP contain 7, 6, 3, and 1 genes, resp.  HSP90AA genes mapped onto chromosomes 1, 3, 4, and 11; HSP90AB genes mapped onto 3, 4, 6, 13 and 15; HSP90B genes mapped onto 1, 12, and 15; and the TRAP1 gene mapped onto 16.  Six genes, HSP90AA1, HSP90AA2, HSP90N, HSP90AB1, HSP90B1 and TRAP1, were recognized as functional, and the remaining 11 genes were considered putative pseudogenes.  Amino acid polymorphic variants were detected for genes HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1.  The structures of these genes and the functional motifs and polymorphic variants of their proteins were documented and the features and functions of their proteins were discussed.  Phylogenetic analyses based on both nucleotide and protein data demonstrated that HSP90(AA + AB + B) formed a monophyletic clade, whereas TRAP is a relatively distant paralogue of this clade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWj0BC1lItPLVg90H21EOLACvtfcHk0lj4cfUPrXszyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN&md5=ce235856d3bc4abf368fecdb5de9ba46</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ygeno.2005.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygeno.2005.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPiel%26aufirst%3DW.%2BH.%26aulast%3DGui%26aufirst%3DL.%26aulast%3DBruford%26aufirst%3DE.%26aulast%3DMonteiro%26aufirst%3DA.%26atitle%3DThe%2520HSP90%2520family%2520of%2520genes%2520in%2520the%2520human%2520genome%253A%2520insights%2520into%2520their%2520divergence%2520and%2520evolution%26jtitle%3DGenomics%26date%3D2005%26volume%3D86%26spage%3D627%26epage%3D637%26doi%3D10.1016%2Fj.ygeno.2005.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Anticancer inhibitors of Hsp90 function: beyond the usual suspects</span>. <i>Adv. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fbs.acr.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26916001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=51-88&author=G.+Gargauthor=A.+Khandelwalauthor=B.+S.+J.+Blagg&title=Anticancer+inhibitors+of+Hsp90+function%3A+beyond+the+usual+suspects&doi=10.1016%2Fbs.acr.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer inhibitors of Hsp90 function: beyond the usual suspects</span></div><div class="casAuthors">Garg, Gaurav; Khandelwal, Anuj; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">51-88</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The 90-kDa heat-shock protein (Hsp90) is a mol. chaperone responsible for the stability and function of a wide variety of client proteins that are crit. for cell growth and survival.  Many of these client proteins are frequently mutated and/or overexpressed in cancer cells and are therefore being actively pursued as individual therapeutic targets.  Consequently, Hsp90 inhibition offers a promising strategy for simultaneous degrdn. of several anticancer targets.  Currently, most Hsp90 inhibitors under clin. evaluation act by blocking the binding of ATP to the Hsp90 N-terminal domain and thereby, induce the degrdn. of many Hsp90-dependent oncoproteins.  Although, they have shown some promising initial results, clin. challenges such as induction of the heat-shock response, retinopathy, and gastrointestinal tract toxicity are emerging from human trials, which constantly raise concerns about the future development of these inhibitors.  Novobiocin derivs., which do not bind the chaperone's N-terminal ATPase pocket, have emerged over the past decade as an alternative strategy to inhibit Hsp90, but to date, no deriv. has been investigated in the clin. setting.  In recent years, a no. of natural or synthetic compds. have been identified that modulate Hsp90 function via various mechanisms.  These compds. not only offer new chemotypes for the development of future Hsp90 inhibitors but can also serve as chem. probes to unravel the biol. of Hsp90.  This chapter presents a synopsis of inhibitors that directly, allosterically, or even indirectly alters Hsp90 function, and highlights their proposed mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxUbLOX6QhIbVg90H21EOLACvtfcHk0lh-vVI8-El_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWru7Y%253D&md5=32f8b44222a82f678ebadf5ae24cf7ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGarg%26aufirst%3DG.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DAnticancer%2520inhibitors%2520of%2520Hsp90%2520function%253A%2520beyond%2520the%2520usual%2520suspects%26jtitle%3DAdv.%2520Cancer.%2520Res.%26date%3D2016%26volume%3D129%26spage%3D51%26epage%3D88%26doi%3D10.1016%2Fbs.acr.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitesell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S. L.</span></span> <span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1038/nrc1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer&doi=10.1038%2Fnrc1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0lh-vVI8-El_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772%26doi%3D10.1038%2Fnrc1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elif
Karagöz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüdiger, S. G. D.</span></span> <span> </span><span class="NLM_article-title">Hsp90 interaction with clients</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.tibs.2014.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=25579468" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=117-125&author=G.+Elif%0AKarag%C3%B6zauthor=S.+G.+D.+R%C3%BCdiger&title=Hsp90+interaction+with+clients&doi=10.1016%2Fj.tibs.2014.12.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DElif%2BKarag%25C3%25B6z%26aufirst%3DG.%26aulast%3DR%25C3%25BCdiger%26aufirst%3DS.%2BG.%2BD.%26atitle%3DHsp90%2520interaction%2520with%2520clients%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2015%26volume%3D40%26spage%3D117%26epage%3D125%26doi%3D10.1016%2Fj.tibs.2014.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Röhl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">The chaperone Hsp90: changing partners for demanding clients</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.tibs.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23507089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=253-262&author=A.+R%C3%B6hlauthor=J.+Rohrbergauthor=J.+Buchner&title=The+chaperone+Hsp90%3A+changing+partners+for+demanding+clients&doi=10.1016%2Fj.tibs.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone Hsp90: changing partners for demanding clients</span></div><div class="casAuthors">Rohl Alina; Rohrberg Julia; Buchner Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Trends in biochemical sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">253-62</span>
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">The heat shock protein (Hsp)90 chaperone machinery regulates the activity of hundreds of client proteins in the eukaryotic cytosol.  It undergoes large conformational changes between states that are similar in energy.  These transitions are rate-limiting for the ATPase cycle.  It has become evident that several of the many Hsp90 co-chaperones affect the conformational equilibrium by stabilizing specific intermediate states.  Consequently, there is an ordered progression of different co-chaperones during the conformational cycle.  Asymmetric complexes containing two different co-chaperones may be important for the processing of the client protein, although our understanding of this aspect, as well as the details of the interaction of Hsp90 with client proteins, is still in its infancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS2inA-utJHL5XHngOXiV_fW6udTcc2ea3A1i9L4JKALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D&md5=3f0c5df5ba9088c3b41b3257b21b9d7a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hl%26aufirst%3DA.%26aulast%3DRohrberg%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520chaperone%2520Hsp90%253A%2520changing%2520partners%2520for%2520demanding%2520clients%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D253%26epage%3D262%26doi%3D10.1016%2Fj.tibs.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuehlke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and co-chaperones twist the functions of diverse client proteins</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1002/bip.21292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1002%2Fbip.21292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=19697319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Sj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2010&pages=211-217&author=A.+Zuehlkeauthor=J.+L.+Johnson&title=Hsp90+and+co-chaperones+twist+the+functions+of+diverse+client+proteins&doi=10.1002%2Fbip.21292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 and co-chaperones twist the functions of diverse client proteins</span></div><div class="casAuthors">Zuehlke, Abbey; Johnson, Jill L.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-217</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Hsp90 mol. chaperones are required for the stability and activity of a diverse range of client proteins that have crit. roles in signal transduction, cellular trafficking, chromatin remodeling, cell growth, differentiation, and reprodn.  Mammalian cells contain three types of Hsp90s: cytosolic Hsp90, mitochondrial Trap-1, and Grp94 of the endoplasmic reticulum.  Each of the Hsp90s, as well as the bacterial homolog, HtpG, hydrolyze ATP and undergo similar conformational changes.  Unlike the other forms of Hsp90, cytosolic Hsp90 function is dependent on a battery of co-chaperone proteins that regulate the ATPase activity of Hsp90 or direct Hsp90 to interact with specific client proteins.  This review will summarize what is known about Hsp90's ability to mediate the folding and activation of diverse client proteins that contribute to human diseases, such as cancer and fungal and viral infections.  © 2009 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIsUPshTEeIbVg90H21EOLACvtfcHk0lg0dzxTOacnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Sj&md5=0be40189e8b7c408acf69391ef2a1359</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fbip.21292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.21292%26sid%3Dliteratum%253Aachs%26aulast%3DZuehlke%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26atitle%3DHsp90%2520and%2520co-chaperones%2520twist%2520the%2520functions%2520of%2520diverse%2520client%2520proteins%26jtitle%3DBiopolymers%26date%3D2010%26volume%3D93%26spage%3D211%26epage%3D217%26doi%3D10.1002%2Fbip.21292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span> <span> </span><span class="NLM_article-title">Understanding of the Hsp90 molecular chaperone reaches new heights</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1038/nsmb1210-1400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnsmb1210-1400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=21127511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1400-1404&author=C.+K.+Vaughanauthor=L.+Neckersauthor=P.+W.+Piper&title=Understanding+of+the+Hsp90+molecular+chaperone+reaches+new+heights&doi=10.1038%2Fnsmb1210-1400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding of the Hsp90 molecular chaperone reaches new heights</span></div><div class="casAuthors">Vaughan, Cara K.; Neckers, Len; Piper, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1400-1404</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) was the focus of a recent meeting in the Swiss Alps, where the Hsp90 community met to discuss the operation and functions of this ubiquitous and essential mol. chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_Bb0rccr4LVg90H21EOLACvtfcHk0lg0dzxTOacnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSku7jP&md5=b77f393fa083a04b4695cabc5e8c6a0a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1210-1400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1210-1400%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26atitle%3DUnderstanding%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520reaches%2520new%2520heights%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1400%26epage%3D1404%26doi%3D10.1038%2Fnsmb1210-1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span> <span> </span><span class="NLM_article-title">A global view of Hsp90 functions</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnsmb.2481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23288357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsleisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1-4&author=G.+Chiosisauthor=C.+A.+Dickeyauthor=J.+L.+Johnson&title=A+global+view+of+Hsp90+functions&doi=10.1038%2Fnsmb.2481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A global view of Hsp90 functions</span></div><div class="casAuthors">Chiosis, Gabriela; Dickey, Chad A.; Johnson, Jill L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Sixth International Conference on Hsp90 in 2012 revealed new functions of this key mol. chaperone.  Attendees of the meeting at Les Diablerets, Switzerland, addressed new discoveries about Hsp90 and its cochaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrJZHeOegBLVg90H21EOLACvtfcHk0lg0dzxTOacnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsleisw%253D%253D&md5=fe27eda8ca2eb9adae4ecb012c171156</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2481%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26atitle%3DA%2520global%2520view%2520of%2520Hsp90%2520functions%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1%26epage%3D4%26doi%3D10.1038%2Fnsmb.2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">The therapeutic target Hsp90 and cancer hallmarks</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.2174/138161213804143725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.2174%2F138161213804143725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22920906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=347-365&author=Y.+Miyataauthor=H.+Nakamotoauthor=L.+Neckers&title=The+therapeutic+target+Hsp90+and+cancer+hallmarks&doi=10.2174%2F138161213804143725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic target Hsp90 and cancer hallmarks</span></div><div class="casAuthors">Miyata, Yoshihiko; Nakamoto, Hitoshi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a major mol. chaperone that is expressed abundantly and plays a pivotal role in assisting correct folding and functionality of its client proteins in cells.  The Hsp90 client proteins include a wide variety of signal transducing mols. such as protein kinases and steroid hormone receptors.  Cancer is a complex disease, but most types of human cancer share common hallmarks, including self-sufficiency in growth signals, insensitivity to growth-inhibitory mechanism, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  A surprisingly large no. of Hsp90-client proteins play crucial roles in establishing cancer cell hallmarks.  We start the review by describing the structure and function of Hsp90 since conformational changes during the ATPase cycle of Hsp90 are closely related to its function.  Many co-chaperones, including Hop, p23, Cdc37, Aha1, and PP5, work together with Hsp90 by modulating the chaperone machinery.  Post-translational modifications of Hsp90 and its co-chaperones are vital for their function.  Many tumor-related Hsp90-client proteins, including signaling kinases, steroid hormone receptors, p53, and telomerase, are described.  Hsp90 and its co-chaperones are required for the function of these tumor-promoting client proteins; therefore, inhibition of Hsp90 by specific inhibitors such as geldanamycin and its derivs. attenuates the tumor progression.  Hsp90 inhibitors can be potential and effective cancer chemotherapeutic drugs with a unique profile and have been examd. in clin. trials.  We describe possible mechanisms why Hsp90 inhibitors show selectivity to cancer cells even though Hsp90 is essential also for normal cells.  Finally, we discuss the "Hsp90-addiction" of cancer cells, and suggest a role for Hsp90 in tumor evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCHug6Q3PILVg90H21EOLACvtfcHk0lg0dzxTOacnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D&md5=07f817fc5afc5ef0669aae0cd0dab15d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161213804143725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143725%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DNakamoto%26aufirst%3DH.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DThe%2520therapeutic%2520target%2520Hsp90%2520and%2520cancer%2520hallmarks%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D347%26epage%3D365%26doi%3D10.2174%2F138161213804143725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lihYjUykskUjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span> <span> </span><span class="NLM_article-title">Stressing the development of small molecules targeting HSP90</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1158%2F1078-0432.CCR-13-2571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=24166908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=275-277&author=L.+Neckersauthor=J.+B.+Trepel&title=Stressing+the+development+of+small+molecules+targeting+HSP90&doi=10.1158%2F1078-0432.CCR-13-2571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Stressing the Development of Small Molecules Targeting HSP90</span></div><div class="casAuthors">Neckers, Len; Trepel, Jane B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-277</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the mol. chaperone HSP90 have been in clin. development as anticancer agents since 1999.  Recent clin. studies, including the work of Saif and colleagues in this issue of Clin. Cancer Research, demonstrate that significant progress has been made in overcoming the obstacles preventing regulatory approval.  Clin Cancer Res; 20(2); 275-7. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokmt4J2prgYrVg90H21EOLACvtfcHk0lihYjUykskUjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D&md5=a81694c35395f63f394263843ba5fe3d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2571%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26atitle%3DStressing%2520the%2520development%2520of%2520small%2520molecules%2520targeting%2520HSP90%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2014%26volume%3D20%26spage%3D275%26epage%3D277%26doi%3D10.1158%2F1078-0432.CCR-13-2571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Travers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">HSP90 inhibition: two-pronged exploitation of cancer dependencies</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.drudis.2011.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22245656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=242-252&author=J.+Traversauthor=S.+Sharpauthor=P.+Workman&title=HSP90+inhibition%3A+two-pronged+exploitation+of+cancer+dependencies&doi=10.1016%2Fj.drudis.2011.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 inhibition: two-pronged exploitation of cancer dependencies</span></div><div class="casAuthors">Travers, Jon; Sharp, Swee; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">242-252</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The early clin. hypothesis for inhibiting HSP90 in cancers was based on the dependence of certain key client proteins in malignant cells - including a host of well-characterized oncoproteins - on the activity of HSP90 for their function and stability.  The addnl. concept has been established that cancer cells have heightened dependence on the efficient maintenance of intracellular proteomic homeostasis, central components of which are HSP90 and other heat shock proteins.  We evaluate the evidence that inhibiting HSP90 in cancer exploits both of these biol. vulnerabilities very effectively, we review the current status of the discovery and development of HSP90 inhibitors and we identify routes to improve their clin. efficacy, based on emerging knowledge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopukpOX3xzQrVg90H21EOLACvtfcHk0lihYjUykskUjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ggsr8%253D&md5=333666e312c67442e94d9dace72d5817</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DTravers%26aufirst%3DJ.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520inhibition%253A%2520two-pronged%2520exploitation%2520of%2520cancer%2520dependencies%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D242%26epage%3D252%26doi%3D10.1016%2Fj.drudis.2011.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummalapalli, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotella, D. P.</span></span> <span> </span><span class="NLM_article-title">Progress in the discovery and development of heat shock protein 90 (hsp90) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8718</span>– <span class="NLM_lpage">8728</span>, <span class="refDoi"> DOI: 10.1021/jm500823a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500823a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8718-8728&author=R.+Bhatauthor=S.+R.+Tummalapalliauthor=D.+P.+Rotella&title=Progress+in+the+discovery+and+development+of+heat+shock+protein+90+%28hsp90%29+inhibitors&doi=10.1021%2Fjm500823a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Tummalapalli, Sreedhar R.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8718-8728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The discovery and clin. development of heat shock protein 90 (Hsp90) inhibitors continue to progress.  A no. of Hsp90 inhibitors are in clin. trials, and preclin. discoveries of new chemotypes that bind to distinct regions in the protein as well as isoform selective compds. are active areas of research.  This review will highlight progress in the field since 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-SwLv_-B9xLVg90H21EOLACvtfcHk0lgiUK_gT3WnHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK&md5=132784687bbbcf62cfa8fe04a22577ce</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500823a%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DTummalapalli%26aufirst%3DS.%2BR.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DProgress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8718%26epage%3D8728%26doi%3D10.1021%2Fjm500823a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haystead, T. A. J.</span></span> <span> </span><span class="NLM_article-title">Hsp90, an unlikely ally in the war on cancer</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1111/febs.12147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1111%2Ffebs.12147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23356585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFWlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=1381-1396&author=J.+J.+Barrottauthor=T.+A.+J.+Haystead&title=Hsp90%2C+an+unlikely+ally+in+the+war+on+cancer&doi=10.1111%2Ffebs.12147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90, an unlikely ally in the war on cancer</span></div><div class="casAuthors">Barrott, Jared J.; Haystead, Timothy A. J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1381-1396</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  On the surface heat shock protein 90 (Hsp90) is an unlikely drug target for the treatment of any disease, let alone cancer.  Hsp90 is highly conserved and ubiquitously expressed in all cells.  There are two major isoforms α and β encoded by distinct genes and together they may constitute 1%-3% of the cellular protein.  Deletion of the protein is embryonic lethal and there are no recognized polymorphisms suggesting an assocn. or causal relationship with any human disease.  With respect to cancer, the proteins absence from two recent high profile articles, Hallmarks of cancer: the next generation' [Hanahan & Weinberg (2011) Cell144, 646-674] and Comprehensive mol. portraits of human breast tumors' [Koboldt et al. (2012) Nature] underlines the perception that it is an unlikely bona fide target to treat this disease.  Yet, to date, there are 17 distinct Hsp90 inhibitors in clin. trials for multiple indications in cancer.  The protein has been championed for over 20 years by the National Cancer Institute (Bethesda, MD,USA) as a cancer target since the discovery of the antitumor activity of the natural product geldanamycin.  This review aims to look at the conundrum of why Hsp90 can even be considered a druggable target for the treatment of cancer.  We propose that in contrast to the majority of chemotherapeutics our growing armamentarium of investigational Hsp90 drugs represents an elegant choice that offers real hope in the long-term treatment of certain cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jK5jqqavALVg90H21EOLACvtfcHk0lgiUK_gT3WnHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFWlt7g%253D&md5=d25c4efeecd07fa342bb6221f728aafa</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12147%26sid%3Dliteratum%253Aachs%26aulast%3DBarrott%26aufirst%3DJ.%2BJ.%26aulast%3DHaystead%26aufirst%3DT.%2BA.%2BJ.%26atitle%3DHsp90%252C%2520an%2520unlikely%2520ally%2520in%2520the%2520war%2520on%2520cancer%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D1381%26epage%3D1396%26doi%3D10.1111%2Ffebs.12147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jhaveri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.bbamcr.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22062686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers&doi=10.1016%2Fj.bbamcr.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span></div><div class="casAuthors">Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an ATP dependent mol. chaperone protein which integrates multiple oncogenic pathways.  As such, Hsp90 inhibition is a promising anti-cancer strategy.  Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clin. evaluation.  Robust pre-clin. data suggested anti-tumor activity in multiple cancer types.  Clin., encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma.  In breast cancer, proof-of-concept was demonstrated by first generation Hsp90 inhibitors in combination with trastuzumab mainly in human epidermal growth factor receptor 2 (HER2) + metastatic breast cancer.  There are a multitude of second generation Hsp90 inhibitors currently under investigation.  To date, however, there is no FDA approved Hsp90 inhibitor nor standardized assay to ascertain Hsp90 inhibition.  This review summarizes the current status of both first and second generation Hsp90 inhibitors based on their chem. classification and stage of clin. development.  It also discusses the pharmacodynamic assays currently implemented in clinic as well as other novel strategies aimed at enhancing the effectiveness of Hsp90 inhibitors.  Ultimately, these efforts will aid in maximizing the full potential of this class of agents.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDrDTpRQxfYrVg90H21EOLACvtfcHk0lgiUK_gT3WnHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D&md5=03cef7dc96667a4698324f635aacee7a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755%26doi%3D10.1016%2Fj.bbamcr.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Natural product inspired N-terminal Hsp90 inhibitors: from bench to bedside?</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1002/med.21351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1002%2Fmed.21351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26010985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=92-118&author=A.+Khandelwalauthor=V.+M.+Crowleyauthor=B.+S.+J.+Blagg&title=Natural+product+inspired+N-terminal+Hsp90+inhibitors%3A+from+bench+to+bedside%3F&doi=10.1002%2Fmed.21351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?</span></div><div class="casAuthors">Khandelwal, Anuj; Crowley, Vincent M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-118</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation of nascent polypeptides and the rematuration of denatured proteins.  Proteins dependent upon Hsp90 are assocd. with all six hallmarks of cancer.  Upon Hsp90 inhibition, protein substrates are degraded via the ubiquitin-proteasome pathway.  Consequentially, inhibition of Hsp90 offers a therapeutic opportunity for the treatment of cancer.  Natural product inhibitors of Hsp90 have been identified in vitro, which have served as leads for the development of more efficacious inhibitors and analogs that have entered clin. trials.  This review highlights the development of natural product analogs, as well as the development of clin. important inhibitors that arose from natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqloFmLYY5brbVg90H21EOLACvtfcHk0lgiUK_gT3WnHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK&md5=7625868e7c1e904cdd20036003ffb0d4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmed.21351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21351%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DNatural%2520product%2520inspired%2520N-terminal%2520Hsp90%2520inhibitors%253A%2520from%2520bench%2520to%2520bedside%253F%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D92%26epage%3D118%26doi%3D10.1002%2Fmed.21351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0ljbKKZ97QxDNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz-Ares, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hsp90 molecular chaperones: moving into the clinic</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e358</span>– <span class="NLM_lpage">e369</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2FS1470-2045%2813%2970169-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23896275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=e358-e369&author=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Inhibition+of+Hsp90+molecular+chaperones%3A+moving+into+the+clinic&doi=10.1016%2FS1470-2045%2813%2970169-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HSP90 molecular chaperones: moving into the clinic</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Carnero, Amancio; Paz-Ares, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e358-e369</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (HSP90) is a mol. chaperone that is crucial for the stability and function of many proteins essential for cell survival.  Many oncogenes, including tyrosine kinases, transcription factors, and cell-cycle regulatory proteins, are client proteins of HSP90.  Inhibition of HSP90 causes client protein degrdn. via the ubiquitin-proteasome pathway, and is a mechanism that might simultaneously downregulate several redundant pathways crucial for cell viability and tumor development.  HSP90 inhibitors are currently being developed as anticancer agents, and have shown early promising results in molecularly defined subgroups of solid tumors (eg, ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer) and some haematol. malignancies (eg, multiple myeloma).  Here, we review the current status of HSP90 inhibitors in clin. development, including geldanamycin derivs., resorcinol derivs., purine analogs, and other synthetic inhibitors.  We also discuss novel strategies and future perspectives on how to optimize the therapeutic potential of this exciting new class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpulM7j4PFcx7Vg90H21EOLACvtfcHk0ljbKKZ97QxDNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI&md5=4821e86073624fb17d7343105d6e82cd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970169-4%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520Hsp90%2520molecular%2520chaperones%253A%2520moving%2520into%2520the%2520clinic%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3De358%26epage%3De369%26doi%3D10.1016%2FS1470-2045%2813%2970169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/jm9004708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.+C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials&doi=10.1021%2Fjm9004708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0ljbKKZ97QxDNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17%26doi%3D10.1021%2Fjm9004708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.ctrv.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23199899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGjsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=375-387&author=D.+S.+Hongauthor=U.+Banerjiauthor=B.+Tavanaauthor=G.+C.+Georgeauthor=J.+Aaronauthor=R.+Kurzrock&title=Targeting+the+molecular+chaperone+heat+shock+protein+90+%28HSP90%29%3A+lessons+learned+and+future+directions&doi=10.1016%2Fj.ctrv.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions</span></div><div class="casAuthors">Hong, David S.; Banerji, Udai; Tavana, Bahareh; George, Goldy C.; Aaron, Joann; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Due to the crit. role of heat shock protein 90 (HSP90) in regulating the stability, activity and intracellular sorting of its client proteins involved in multiple oncogenic processes, HSP90 inhibitors are promising therapeutic agents for cancer treatment.  In cancer cells, HSP90 client proteins play a major role in oncogenic signal transduction (i.e., mutant epidermal growth factor receptor), angiogenesis (i.e., vascular endothelial growth factor), anti-apoptosis (i.e., AKT), and metastasis (i.e., matrix metalloproteinase 2 and CD91), processes central to maintaining the cancer phenotype.  Thus, HSP90 has emerged as a viable target for antitumor drug development, and several HSP90 inhibitors have transitioned to clin. trials.  HSP90 inhibitors include geldanamycin and its derivs. (i.e., tanespimycin, alvespimycin, IPI-504), synthetic and small mol. inhibitors (i.e., AUY922, AT13387, STA9090, MPC3100), other inhibitors of HSP90 and its isoforms (i.e., shepherdin and 5'-N-ethylcarboxamideadenosine).  With more than 200 "client" proteins, many of them meta-stable and oncogenic, HSP90 inhibition can affect an array of tumors.  Here we review the mol. structure of HSP90, structural features of HSP90 inhibition, pharmacodynamic effects and tumor responses in clin. trials of HSP90 inhibitors.  We also discuss lessons learned from completed clin. trials of HSP90 inhibitors, and future directions for these promising therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbTT7zy5jIsrVg90H21EOLACvtfcHk0lhTbjhM3bWmBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGjsLvM&md5=485735cfb38cb7113648b54e2ec99426</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DTavana%26aufirst%3DB.%26aulast%3DGeorge%26aufirst%3DG.%2BC.%26aulast%3DAaron%26aufirst%3DJ.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520molecular%2520chaperone%2520heat%2520shock%2520protein%252090%2520%2528HSP90%2529%253A%2520lessons%2520learned%2520and%2520future%2520directions%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2013%26volume%3D39%26spage%3D375%26epage%3D387%26doi%3D10.1016%2Fj.ctrv.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powers, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the heat shock response: biology and pharmacology</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>581</i></span>,  <span class="NLM_fpage">3758</span>– <span class="NLM_lpage">3769</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2007.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.febslet.2007.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=17559840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlaisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=3758-3769&author=M.+V.+Powersauthor=P.+Workman&title=Inhibitors+of+the+heat+shock+response%3A+biology+and+pharmacology&doi=10.1016%2Fj.febslet.2007.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the heat shock response: Biology and pharmacology</span></div><div class="casAuthors">Powers, Marissa V.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3758-3769</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A no. of human diseases can be linked to aberrations in protein folding which cause an imbalance in protein homeostasis.  Mol. chaperones, including heat shock proteins, act to assist protein folding, stability and activity in the cell.  Attention has begun to focus on modulating the expression and/or activity of this group of proteins for the treatment of a wide variety of human diseases.  This review will describe the progress made to date in developing pharmacol. modulators of the heat shock response, including both agents which affect the entire heat shock response and those that specifically target the HSP70 and HSP90 chaperone families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd1XAAhY6tPLVg90H21EOLACvtfcHk0lhTbjhM3bWmBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlaisbo%253D&md5=3be785569e7caee11e84a8cb4ca20574</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2007.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2007.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520the%2520heat%2520shock%2520response%253A%2520biology%2520and%2520pharmacology%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D3758%26epage%3D3769%26doi%3D10.1016%2Fj.febslet.2007.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskew, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vielhauer, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/mp300138n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300138n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1841-1846&author=L.+B.+Petersonauthor=J.+D.+Eskewauthor=G.+A.+Vielhauerauthor=B.+S.+J.+Blagg&title=The+hERG+channel+is+dependent+upon+the+Hsp90%CE%B1+isoform+for+maturation+and+trafficking&doi=10.1021%2Fmp300138n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking</span></div><div class="casAuthors">Peterson, Laura B.; Eskew, Jeffrey D.; Vielhauer, George A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1841-1846</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) has emerged as a promising therapeutic target for the treatment of cancer.  Several Hsp90 inhibitors have entered clin. trials.  However, some toxicol. detriments have arisen, such as cardiotoxicity resulting from hERG inhibition following the administration of Hsp90 inhibitors.  We sought to investigate this toxicity as hERG has been previously reported as a client protein that depends upon Hsp90 for its maturation and functional trafficking.  In this study we show that hERG depends upon a single Hsp90 isoform. hERG preferentially co-immunopptd. with Hsp90α, and genetic knockdown of Hsp90α, but not Hsp90β, resulted in a trafficking-defective hERG channel.  This study demonstrates the importance of delineating the isoform dependence of Hsp90 client proteins and provides rationale for the design of isoform-selective Hsp90 inhibitors that avoid detrimental effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5BFhqGrKjIbVg90H21EOLACvtfcHk0lhTbjhM3bWmBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D&md5=910dfb5e4a9150f408d5756ab881e492</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fmp300138n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300138n%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DEskew%26aufirst%3DJ.%2BD.%26aulast%3DVielhauer%26aufirst%3DG.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DThe%2520hERG%2520channel%2520is%2520dependent%2520upon%2520the%2520Hsp90%25CE%25B1%2520isoform%2520for%2520maturation%2520and%2520trafficking%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D1841%26epage%3D1846%26doi%3D10.1021%2Fmp300138n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span> <span> </span><span class="NLM_article-title">The molecular chaperone Hsp90a; deficiency causes retinal degeneration by disrupting Golgi organization and vesicle transportation in photoreceptors</span>. <i>J. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1093/jmcb/mjz048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1093%2Fjmcb%2Fmjz048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=31408169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitV2jsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=216-229&author=Y.+Wuauthor=X.+Zhengauthor=Y.+Dingauthor=M.+Zhouauthor=Z.+Weiauthor=T.+Liuauthor=K.+Liao&title=The+molecular+chaperone+Hsp90a%3B+deficiency+causes+retinal+degeneration+by+disrupting+Golgi+organization+and+vesicle+transportation+in+photoreceptors&doi=10.1093%2Fjmcb%2Fmjz048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular chaperone Hsp90U+03B1 deficiency causes retinal degeneration by disrupting Golgi organization and vesicle transportation in photoreceptors</span></div><div class="casAuthors">Wu, Yuan; Zheng, Xiudan; Ding, Yubo; Zhou, Min; Wei, Zhuang; Liu, Tao; Liao, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Cell Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-229</span>CODEN:
                <span class="NLM_cas:coden">JMCBCU</span>;
        ISSN:<span class="NLM_cas:issn">1759-4685</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an abundant mol. chaperone with two isoforms, Hsp90U+03B1 and Hsp90U+03B2.  Hsp90U+03B2 deficiency causes embryonic lethality, whereas Hsp90U+03B1 deficiency causes few abnormities except male sterility.  In this paper, we reported that Hsp90U+03B1 was exclusively expressed in the retina, testis, and brain.  Its deficiency caused retinitis pigmentosa (RP), a disease leading to blindness.  In Hsp90U+03B1-deficient mice, the retina was deteriorated and the outer segment of photoreceptor was deformed.  Immunofluorescence staining and electron microscopic anal. revealed disintegrated Golgi and aberrant intersegmental vesicle transportation in Hsp90U+03B1-deficient photoreceptors.  Proteomic anal. identified microtubule-assocd. protein 1B (MAP1B) as an Hsp90U+03B1-assocd. protein in photoreceptors.  HspU+03B1 deficiency increased degrdn. of MAP1B by inducing its ubiquitination, causing U+03B1-tubulin deacetylation and microtubule destabilization.  Furthermore, the treatment of wild-type mice with 17-DMAG, an Hsp90 inhibitor of geldanamycin deriv., induced the same retinal degeneration as Hsp90U+03B1 deficiency.  Taken together, the microtubule destabilization could be the underlying reason for Hsp90U+03B1 deficiency-induced RP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGQAxBOQ6rybVg90H21EOLACvtfcHk0lhTbjhM3bWmBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitV2jsrbM&md5=f62a02f8218b4af8484f505750dacbd3</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1093%2Fjmcb%2Fmjz048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjmcb%252Fmjz048%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DK.%26atitle%3DThe%2520molecular%2520chaperone%2520Hsp90a%253B%2520deficiency%2520causes%2520retinal%2520degeneration%2520by%2520disrupting%2520Golgi%2520organization%2520and%2520vesicle%2520transportation%2520in%2520photoreceptors%26jtitle%3DJ.%2520Mol.%2520Cell%2520Biol.%26date%3D2020%26volume%3D12%26spage%3D216%26epage%3D229%26doi%3D10.1093%2Fjmcb%2Fmjz048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagatell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paine-Murrieta, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulcini, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesell, L.</span></span> <span> </span><span class="NLM_article-title">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3312</span>– <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10955818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=3312-3318&author=R.+Bagatellauthor=G.+D.+Paine-Murrietaauthor=C.+W.+Taylorauthor=E.+J.+Pulciniauthor=S.+Akinagaauthor=I.+J.+Benjaminauthor=L.+Whitesell&title=Induction+of+a+heat+shock+factor+1-dependent+stress+response+alters+the+cytotoxic+activity+of+hsp90-binding+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of Hsp90-binding agents</span></div><div class="casAuthors">Bagatell, Rochelle; Paine-Murrieta, Gillian D.; Taylor, Charles W.; Pulcini, Elizabeth J.; Akinaga, Shiro; Benjamin, Ivor J.; Whitesell, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3312-3318</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In addn. to its classic role in the cellular stress response, heat shock protein 90 (Hsp90) plays a crit. but less well appreciated role in regulating signal transduction pathways that control cell growth and survival under basal, nonstress conditions.  Over the past 5 yr, the antitumor antibiotics geldanamycin and radicicol have become recognized as selective Hsp90-binding agents (HBA) with a novel ability to alter the activity of many of the receptors, kinases, and transcription factors involved in these cancer-assocd. pathways.  As a consequence of their interaction with Hsp90, however, these agents also induce a marked cellular heat shock response.  To study the mechanism of this response and assess its relevance to the anticancer action of the HBA, we verified that the compds. could activate a reporter construct contg. consensus binding sites for heat shock factor 1 (HSF1), the major transcriptional regulator of the vertebrate heat shock response.  The authors then used transformed fibroblasts derived from HSF1 knock-out mice to show that unlike conventional chemotherapeutics, HBA increased the synthesis and cellular levels of heat shock proteins in an HSF1-dependent manner.  Compared with transformed fibroblasts derived from wild-type mice, HSF1 knock-out cells were significantly more sensitive to the cytotoxic effects of HBA but not to doxorubicin or cisplatin.  Consistent with these in vitro data, the authors found that systemic administration of an HBA led to marked increases in the level of Hsp72 in both normal mouse tissues and human tumor xenografts.  The authors conclude that HBA are useful probes for studying mol. mechanisms regulating the heat shock response both in cells and in whole animals.  Moreover, induction of the heat shock response by HBA will be an important consideration in the clin. application of these drugs, both in terms of modulating their cytotoxic activity as well as monitoring their biol. activity in individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCXM1LsRGAfLVg90H21EOLACvtfcHk0liPEAf2aGg8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D&md5=3c6f4e392424161b38ddc010ea97afb1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DPaine-Murrieta%26aufirst%3DG.%2BD.%26aulast%3DTaylor%26aufirst%3DC.%2BW.%26aulast%3DPulcini%26aufirst%3DE.%2BJ.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DBenjamin%26aufirst%3DI.%2BJ.%26aulast%3DWhitesell%26aufirst%3DL.%26atitle%3DInduction%2520of%2520a%2520heat%2520shock%2520factor%25201-dependent%2520stress%2520response%2520alters%2520the%2520cytotoxic%2520activity%2520of%2520hsp90-binding%2520agents%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2000%26volume%3D6%26spage%3D3312%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, R. I.</span></span> <span> </span><span class="NLM_article-title">Role of the heat shock response and molecular chaperones in oncogenesis and cell death</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">1564</span>– <span class="NLM_lpage">1572</span>, <span class="refDoi"> DOI: 10.1093/jnci/92.19.1564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1093%2Fjnci%2F92.19.1564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=11018092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVKitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1564-1572&author=C.+Jollyauthor=R.+I.+Morimoto&title=Role+of+the+heat+shock+response+and+molecular+chaperones+in+oncogenesis+and+cell+death&doi=10.1093%2Fjnci%2F92.19.1564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the heat shock response and molecular chaperones in oncogenesis and cell death</span></div><div class="casAuthors">Jolly, Caroline; Morimoto, Richard I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1564-1572</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 127 refs.  Exposure of cells to conditions of environmental stress - including heat shock, oxidative stress, heavy metals, or pathol. conditions, such as ischemia and reperfusion, inflammation, tissue damage, infection, and mutant proteins assocd. with genetic diseases - results in the inducible expression of heat shock proteins that function as mol. chaperones or proteases.  Mol. chaperones are a class of proteins that interact with diverse protein substrates to assist in their folding, with a crit. role during cell stress to prevent the appearance of folding intermediates that lead to misfolded or otherwise damaged mols.  Consequently, heat shock proteins assist in the recovery from stress either by repairing damaged proteins (protein refolding) or by degrading them, thus restoring protein homeostasis and promoting cell survival.  The events of cell stress and cell death are linked, such that mol. chaperones induced in response to stress appear to function at key regulatory points in the control of apoptosis.  On the basis of these observations - and on the role of mol. chaperones in the regulation of steroid aporeceptors, kinases, caspases, and other protein remodeling events involved in chromosome replication and changes in cell structure - it is not surprising that the heat shock response and mol. chaperones were implicated in the control of cell growth.  In this review, the authors address some of the mol. and cellular events initiated by cell stress - the interrelationships between stress signaling, cell death, and oncogenesis - and chaperones as potential targets for cancer diagnosis and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrht7F_WJ5_Q7Vg90H21EOLACvtfcHk0liPEAf2aGg8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVKitr4%253D&md5=353f48d5f8135334dd45e541445a0744</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.19.1564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.19.1564%26sid%3Dliteratum%253Aachs%26aulast%3DJolly%26aufirst%3DC.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DRole%2520of%2520the%2520heat%2520shock%2520response%2520and%2520molecular%2520chaperones%2520in%2520oncogenesis%2520and%2520cell%2520death%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D1564%26epage%3D1572%26doi%3D10.1093%2Fjnci%2F92.19.1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraldeschi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centenera, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Maximizing the therapeutic potential of HSP90 inhibitors</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1445</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-15-0234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1158%2F1541-7786.MCR-15-0234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26219697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=1445-1451&author=L.+M.+Butlerauthor=R.+Ferraldeschiauthor=H.+K.+Armstrongauthor=M.+M.+Centeneraauthor=P.+Workman&title=Maximizing+the+therapeutic+potential+of+HSP90+inhibitors&doi=10.1158%2F1541-7786.MCR-15-0234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Maximizing the Therapeutic Potential of HSP90 Inhibitors</span></div><div class="casAuthors">Butler, Lisa M.; Ferraldeschi, Roberta; Armstrong, Heather K.; Centenera, Margaret M.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1445-1451</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HSP90 is required for maintaining the stability and activity of a diverse group of client proteins, including protein kinases, transcription factors, and steroid hormone receptors involved in cell signaling, proliferation, survival, oncogenesis, and cancer progression.  Inhibition of HSP90 alters the HSP90-client protein complex, leading to reduced activity, misfolding, ubiquitination, and, ultimately, proteasomal degrdn. of client proteins.  HSP90 inhibitors have demonstrated significant antitumor activity in a wide variety of preclin. models, with evidence of selectivity for cancer vs. normal cells.  In the clinic, however, the efficacy of this class of therapeutic agents has been relatively limited to date, with promising responses mainly obsd. in breast and lung cancer, but no major activity seen in other tumor types.  In addn., adverse events and some significant toxicities have been documented.  Key to improving these clin. outcomes is a better understanding of the cellular consequences of inhibiting HSP90 that may underlie treatment response or resistance.  This review considers the recent progress that has been made in the study of HSP90 and its inhibitors and highlights new opportunities to maximize their therapeutic potential.  Mol Cancer Res; 13(11); 1445-51. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWZoeQQ9MOV7Vg90H21EOLACvtfcHk0liPEAf2aGg8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbbP&md5=da00f7d2b830fed75f4e4141ff04d128</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-15-0234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-15-0234%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DL.%2BM.%26aulast%3DFerraldeschi%26aufirst%3DR.%26aulast%3DArmstrong%26aufirst%3DH.%2BK.%26aulast%3DCentenera%26aufirst%3DM.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DMaximizing%2520the%2520therapeutic%2520potential%2520of%2520HSP90%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2015%26volume%3D13%26spage%3D1445%26epage%3D1451%26doi%3D10.1158%2F1541-7786.MCR-15-0234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panaretou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4829</span>– <span class="NLM_lpage">4836</span>, <span class="refDoi"> DOI: 10.1093/emboj/17.16.4829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1093%2Femboj%2F17.16.4829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=9707442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADyaK1cXlslyjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4829-4836&author=B.+Panaretouauthor=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=ATP+binding+and+hydrolysis+are+essential+to+the+function+of+the+Hsp90+molecular+chaperone+in+vivo&doi=10.1093%2Femboj%2F17.16.4829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span></div><div class="casAuthors">Panaretou, Barry; Prodromou, Chrisostomos; Roe, S. Mark; O'Brien, Ronan; Ladbury, John E.; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4829-4836</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hsp90 is an abundant mol. chaperone essential to the establishment of many cellular regulation and signal transduction systems, but remains one of the least well described chaperones.  The biochem. mechanism of protein folding by Hsp90 is poorly understood, and the direct involvement of ATP has been particularly contentious.  Here we demonstrate in vitro an inherent ATPase activity in both yeast Hsp90 and the Escherichia coli homolog HtpG, which is sensitive to inhibition by the Hsp90-specific antibiotic geldanamycin.  Mutations of residues implicated in ATP binding and hydrolysis by structural studies abolish this ATPase activity in vitro and disrupt Hsp90 function in vivo.  These results show that Hsp90 is directly ATP dependent in vivo, and suggest an ATP-coupled chaperone cycle for Hsp90-mediated protein folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA12RZ3cNnYbVg90H21EOLACvtfcHk0ljVTdyGzUPfkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslyjsLo%253D&md5=c61fa708d60f9ef44a94aab7e4e1d1ce</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.16.4829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.16.4829%26sid%3Dliteratum%253Aachs%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP%2520binding%2520and%2520hydrolysis%2520are%2520essential%2520to%2520the%2520function%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4829%26epage%3D4836%26doi%3D10.1093%2Femboj%2F17.16.4829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kijima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatokoro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamit-Kush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0141786</span>– <span class="NLM_lpage">e0141786</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0141786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1371%2Fjournal.pone.0141786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=26517842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0141786-e0141786&author=T.+L.+Princeauthor=T.+Kijimaauthor=M.+Tatokoroauthor=S.+Leeauthor=S.+Tsutsumiauthor=K.+Yimauthor=C.+Rivasauthor=S.+Alarconauthor=H.+Schwartzauthor=K.+Khamit-Kushauthor=B.+T.+Scrogginsauthor=K.+Beebeauthor=J.+B.+Trepelauthor=L.+Neckers&title=Client+proteins+and+small+molecule+inhibitors+display+distinct+binding+preferences+for+constitutive+and+stress-induced+HSP90+isoforms+and+their+conformationally+restricted+mutants&doi=10.1371%2Fjournal.pone.0141786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants</span></div><div class="casAuthors">Prince, Thomas L.; Kijima, Toshiki; Tatokoro, Manabu; Lee, Sunmin; Tsutsumi, Shinji; Yim, Kendrick; Rivas, Candy; Alarcon, Sylvia; Schwartz, Harvey; Khamit-Kush, Kofi; Scroggins, Bradley T.; Beebe, Kristin; Trepel, Jane B.; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0141786/1-e0141786/15</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The two cytosolic/nuclear isoforms of the mol. chaperone HSP90, stress-inducible HSP90α and constitutively expressed HSP90β, fold, assemble and maintain the threedimensional structure of numerous client proteins.  Because many HSP90 clients are important in cancer, several HSP90 inhibitors have been evaluated in the clinic.  However, little is known concerning possible unique isoform or conformational preferences of either individual HSP90 clients or inhibitors.  In this report, we compare the relative interaction strength of both HSP90α and HSP90β with the transcription factors HSF1 and HIF1α, the kinases ERBB2 and MET, the E3-ubiquitin ligases KEAP1 and RHOBTB2, and the HSP90 inhibitors geldanamycin and ganetespib.  We obsd. unexpected differences in relative client and drug preferences for the two HSP90 isoforms, with HSP90α binding each client protein with greater apparent affinity compared to HSP90β, while HSP90β bound each inhibitor with greater relative interaction strength compared to HSP90α.  Stable HSP90 interaction was assocd. with reduced client activity.  Using a defined set of HSP90 conformational mutants, we found that some clients interact strongly with a single, ATP-stabilized HSP90 conformation, only transiently populated during the dynamic HSP90 chaperone cycle, while other clients interact equally with multiple HSP90 conformations.  These data suggest different functional requirements among HSP90 clientele that, for some clients, are likely to be ATP-independent.  Lastly, the two inhibitors examd., although sharing the same binding site, were differentially able to access distinct HSP90 conformational states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqmyydx9DNLVg90H21EOLACvtfcHk0ljVTdyGzUPfkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjsr7N&md5=993b552322f7e9ebe20f26f9aa6d198a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0141786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0141786%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DT.%2BL.%26aulast%3DKijima%26aufirst%3DT.%26aulast%3DTatokoro%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DYim%26aufirst%3DK.%26aulast%3DRivas%26aufirst%3DC.%26aulast%3DAlarcon%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DH.%26aulast%3DKhamit-Kush%26aufirst%3DK.%26aulast%3DScroggins%26aufirst%3DB.%2BT.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DClient%2520proteins%2520and%2520small%2520molecule%2520inhibitors%2520display%2520distinct%2520binding%2520preferences%2520for%2520constitutive%2520and%2520stress-induced%2520HSP90%2520isoforms%2520and%2520their%2520conformationally%2520restricted%2520mutants%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0141786%26epage%3De0141786%26doi%3D10.1371%2Fjournal.pone.0141786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zubrienė, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutkowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulienė, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaleckis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailovienė, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voroncova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venclovas, Č.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zylicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zylicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, D.</span></span> <span> </span><span class="NLM_article-title">Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms</span>. <i>Biophys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.bpc.2010.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.bpc.2010.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=20943306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2isrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2010&pages=153-163&author=A.+Zubrien%C4%97author=M.+Gutkowskaauthor=J.+Matulien%C4%97author=R.+Chaleckisauthor=V.+Michailovien%C4%97author=A.+Voroncovaauthor=%C4%8C.+Venclovasauthor=A.+Zyliczauthor=M.+Zyliczauthor=D.+Matulis&title=Thermodynamics+of+radicicol+binding+to+human+Hsp90+alpha+and+beta+isoforms&doi=10.1016%2Fj.bpc.2010.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms</span></div><div class="casAuthors">Zubriene, Asta; Gutkowska, Malgorzata; Matuliene, Jurgita; Chaleckis, Romanas; Michailoviene, Vilma; Voroncova, Aliona; Venclovas, Ceslovas; Zylicz, Alicja; Zylicz, Maciej; Matulis, Daumantas</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">BICIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0301-4622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Radicicol (RD) is a natural antibiotic that specifically inhibits chaperone Hsp90 activity and binds to its active site with nanomolar affinity.  Radicicol has been widely used as a lead compd. to generate synthetic analogs with reduced toxicity and increased stability that could be employed clin.  Here we present a detailed thermodn. description of radicicol binding to human Hsp90 and yeast Hsc82 studied by isothermal titrn. calorimetry (ITC) and thermal shift assay (TSA).  Titrns. as a function of pH showed a linked protonation event upon radicicol binding.  The intrinsic binding const. and the thermodn. parameters (including the enthalpy, entropy, and heat capacity) were detd. for yeast Hsc82, and human alpha and beta Hsp90.  Recent exptl. evidence in literature shows that yeast Hsc82 has significant differences from human Hsp90 isoenzymes.  Here we support this by demonstrating differences in radicicol binding thermodn. to these proteins.  The intrinsic enthalpy of radicicol binding to Hsc82 was -46.7 kJ/mol, to Hsp90alpha -70.7 kJ/mol, and to Hsp90beta was -66.8 kJ/mol.  The enthalpies of binding were significantly different, while the intrinsic dissocn. consts. were quite similar, equal to 0.25, 0.04, and 0.15 nM, resp.  The structural features responsible for such large difference in binding enthalpy but small difference in the intrinsic binding Gibbs free energy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquG-QjiRgoArVg90H21EOLACvtfcHk0ljVTdyGzUPfkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2isrrO&md5=5d709500f52952cca335323cb497475d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bpc.2010.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpc.2010.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DZubrien%25C4%2597%26aufirst%3DA.%26aulast%3DGutkowska%26aufirst%3DM.%26aulast%3DMatulien%25C4%2597%26aufirst%3DJ.%26aulast%3DChaleckis%26aufirst%3DR.%26aulast%3DMichailovien%25C4%2597%26aufirst%3DV.%26aulast%3DVoroncova%26aufirst%3DA.%26aulast%3DVenclovas%26aufirst%3D%25C4%258C.%26aulast%3DZylicz%26aufirst%3DA.%26aulast%3DZylicz%26aufirst%3DM.%26aulast%3DMatulis%26aufirst%3DD.%26atitle%3DThermodynamics%2520of%2520radicicol%2520binding%2520to%2520human%2520Hsp90%2520alpha%2520and%2520beta%2520isoforms%26jtitle%3DBiophys.%2520Chem.%26date%3D2010%26volume%3D152%26spage%3D153%26epage%3D163%26doi%3D10.1016%2Fj.bpc.2010.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Paralog specific Hsp90 inhibitors - a brief history and a bright future</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.2174%2F1568026616666160413141154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=27072700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2779-2791&author=D.+T.+Gewirth&title=Paralog+specific+Hsp90+inhibitors+-+a+brief+history+and+a+bright+future&doi=10.2174%2F1568026616666160413141154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future</span></div><div class="casAuthors">Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2779-2791</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background. The high sequence and structural homol. among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition.  Objective. This review surveys the state of developments in structural anal., compd. screening, and structure-based design that have been brought to bear on this problem.  Results. First generation compds. that selectively bind to Hsp90, Grp94, or Trap-1 have been identified.  Conclusion. With the proof of principle firmly established, the prospects for further progress are bright.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdyZyrXOyou7Vg90H21EOLACvtfcHk0lg65Fm8miAolQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN&md5=208025ff36aa6e2d92d3ee107b20ab5f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141154%26sid%3Dliteratum%253Aachs%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DParalog%2520specific%2520Hsp90%2520inhibitors%2520-%2520a%2520brief%2520history%2520and%2520a%2520bright%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2779%26epage%3D2791%26doi%3D10.2174%2F1568026616666160413141154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheon, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span> <span> </span><span class="NLM_article-title">Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">4358</span>– <span class="NLM_lpage">4367</span>, <span class="refDoi"> DOI: 10.1021/ja511893n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja511893n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=4358-4367&author=C.+Leeauthor=H.+K.+Parkauthor=H.+Jeongauthor=J.+Limauthor=A.+J.+Leeauthor=K.+Y.+Cheonauthor=C.+S.+Kimauthor=A.+P.+Thomasauthor=B.+Baeauthor=N.+D.+Kimauthor=S.+H.+Kimauthor=P.+G.+Suhauthor=J.+H.+Ryuauthor=B.+H.+Kang&title=Development+of+a+mitochondria-targeted+Hsp90+inhibitor+based+on+the+crystal+structures+of+human+TRAP1&doi=10.1021%2Fja511893n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1</span></div><div class="casAuthors">Lee, Changwook; Park, Hye-Kyung; Jeong, Hanbin; Lim, Jaehwa; Lee, An-Jung; Cheon, Keun Young; Kim, Chul-Su; Thomas, Ajesh P.; Bae, Boram; Kim, Nam Doo; Kim, Seong Heon; Suh, Pann-Ghill; Ryu, Ja-Hyoung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4358-4367</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mitochondrial pool of Hsp90 and its mitochondrial paralog, TRAP1, suppresses cell death and reprograms energy metab. in cancer cells; therefore, Hsp90 and TRAP1 have been suggested as target proteins for anticancer drug development.  Here, the authors report that the actual target protein in cancer cell mitochondria is TRAP1, and current Hsp90 inhibitors cannot effectively inactivate TRAP1 because of their insufficient accumulation in the mitochondria.  To develop mitochondrial TRAP1 inhibitors, the authors detd. the crystal structures of human TRAP1 complexed with Hsp90 inhibitors.  The iso-Pr amine of the Hsp90 inhibitor PU-H71 was replaced with the mitochondria-targeting moiety triphenylphosphonium to produce SMTIN-P01.  SMTIN-P01 showed a different mode of action from the nontargeted PU-H71, as well as much improved cytotoxicity to cancer cells.  In addn., the authors detd. the structure of a TRAP1-adenylyl-imidodiphosphate (AMP-PNP) complex.  On the basis of comparative anal. of TRAP1 structures, the authors propose a mol. mechanism of ATP hydrolysis that is crucial for chaperone function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-VB5CkPi2LVg90H21EOLACvtfcHk0lg65Fm8miAolQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D&md5=c1142149eaa5f4157377ce64662fcfc1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja511893n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja511893n%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DCheon%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DC.%2BS.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DBae%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSuh%26aufirst%3DP.%2BG.%26aulast%3DRyu%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DB.%2BH.%26atitle%3DDevelopment%2520of%2520a%2520mitochondria-targeted%2520Hsp90%2520inhibitor%2520based%2520on%2520the%2520crystal%2520structures%2520of%2520human%2520TRAP1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D4358%26epage%3D4367%26doi%3D10.1021%2Fja511893n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lhyjB2JU_omLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+J.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhyjB2JU_omLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizziah, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of glucose regulated protein 94-selective inhibitors based on the BnIm and Radamide scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3488</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3471-3488&author=V.+M.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=A.+R.+Stothertauthor=D.+J.+E.+Huardauthor=J.+Zhaoauthor=A.+Muthauthor=A.+S.+Duerfeldtauthor=J.+L.+Kizziahauthor=R.+L.+Liebermanauthor=C.+A.+Dickeyauthor=B.+S.+J.+Blagg&title=Development+of+glucose+regulated+protein+94-selective+inhibitors+based+on+the+BnIm+and+Radamide+scaffold&doi=10.1021%2Facs.jmedchem.6b00085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold</span></div><div class="casAuthors">Crowley, Vincent M.; Khandelwal, Anuj; Mishra, Sanket; Stothert, Andrew R.; Huard, Dustin J. E.; Zhao, Jinbo; Muth, Aaron; Duerfeldt, Adam S.; Kizziah, James L.; Lieberman, Raquel L.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3471-3488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Arylmethyl)imidazolylethyl chlorodihydroxybenzoates I (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) were prepd. as selective inhibitors of glucose regulated protein 94 (Grp94), the endoplasmic reticulum-resident isoform of the heat shock protein 90 (Hsp90), for potential use in the treatment of glaucoma and cancer; the effect of the aryl substituents on Grp94 binding and selectivity was detd.  I were prepd. by the cyclocondensation of a bissilylated chloro(oxopropyl)dihydroxybenzoate with glyoxal and arylmethylamines RCH2NH2 (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) followed by desilylation.  I (R = 2-MeO-4-MeC6H3CH2, 5-chloro-2-furanylmethyl) were tested as inhibitors of cell migration in a cancer metastasis model and for their enhancement of the degrdn. of mutants of the protein myocilin in a glaucoma model.  The structures of the lead compd. radamide bound to Hsp82 and Grp94 and of I (R = 5-chloro-2-furanyl) bound to the N-terminal domain of Hsp94 lacking its acidic linker were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3v_0NEYj1Z7Vg90H21EOLACvtfcHk0liT4zF3PCabcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D&md5=c73bbf30c243e281aae197689162c9e1</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00085%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%2BE.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DKizziah%26aufirst%3DJ.%2BL.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520glucose%2520regulated%2520protein%252094-selective%2520inhibitors%2520based%2520on%2520the%2520BnIm%2520and%2520Radamide%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3471%26epage%3D3488%26doi%3D10.1021%2Facs.jmedchem.6b00085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Transformation of the non-selective aminocyclohexanol-based Hsp90 inhibitor into a Grp94-seletive scaffold</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=244-253&author=S.+J.+Mishraauthor=S.+Ghoshauthor=A.+R.+Stothertauthor=C.+A.+Dickeyauthor=B.+S.+J.+Blagg&title=Transformation+of+the+non-selective+aminocyclohexanol-based+Hsp90+inhibitor+into+a+Grp94-seletive+scaffold&doi=10.1021%2Facschembio.6b00747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DTransformation%2520of%2520the%2520non-selective%2520aminocyclohexanol-based%2520Hsp90%2520inhibitor%2520into%2520a%2520Grp94-seletive%2520scaffold%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D244%26epage%3D253%26doi%3D10.1021%2Facschembio.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzbeierlein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">425</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fs41467-017-02013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=29382832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=425&author=A.+Khandelwalauthor=C.+N.+Kentauthor=M.+Balchauthor=S.+Pengauthor=S.+J.+Mishraauthor=J.+Dengauthor=V.+W.+Dayauthor=W.+Liuauthor=C.+Subramanianauthor=M.+Cohenauthor=J.+M.+Holzbeierleinauthor=R.+Mattsauthor=B.+S.+J.+Blagg&title=Structure-guided+design+of+an+Hsp90%CE%B2+N-terminal+isoform-selective+inhibitor&doi=10.1038%2Fs41467-017-02013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span></div><div class="casAuthors">Khandelwal Anuj; Mishra Sanket J; Kent Caitlin N; Blagg Brian S J; Balch Maurie; Peng Shuxia; Deng Junpeng; Matts Robert; Day Victor W; Liu Weiya; Holzbeierlein Jeffery M; Subramanian Chitra; Cohen Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">425</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression.  Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways.  Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response.  The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments.  Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels.  Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmyRre9-yoQBpyrDyM_m9cfW6udTcc2eZsJCJ3PfTpWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D&md5=cfa47e314c9bdbc1c38802108330cba7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBalch%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DV.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DHolzbeierlein%26aufirst%3DJ.%2BM.%26aulast%3DMatts%26aufirst%3DR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520an%2520Hsp90%25CE%25B2%2520N-terminal%2520isoform-selective%2520inhibitor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D425%26doi%3D10.1038%2Fs41467-017-02013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vought, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1016%2Fj.bmcl.2013.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=24332488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=204-208&author=J.+T.+Ernstauthor=M.+Liuauthor=H.+Zuccolaauthor=T.+Neubertauthor=K.+Beaumontauthor=A.+Turnbullauthor=A.+Kallelauthor=B.+Voughtauthor=D.+Stamos&title=Correlation+between+chemotype-dependent+binding+conformations+of+HSP90%CE%B1%2F%CE%B2+and+isoform+selectivity-Implications+for+the+structure-based+design+of+HSP90%CE%B1%2F%CE%B2+selective+inhibitors+for+treating+neurodegenerative+diseases&doi=10.1016%2Fj.bmcl.2013.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span></div><div class="casAuthors">Ernst, Justin T.; Liu, Michael; Zuccola, Harmon; Neubert, Timothy; Beaumont, Kevin; Turnbull, Amy; Kallel, Adam; Vought, Bryan; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-208</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HSP90 continues to be a target of interest for neurodegeneration indications.  Selective knockdown of the HSP90 cytosolic isoforms α and β is sufficient to reduce mutant huntingtin protein levels in vitro.  Chemotype-dependent binding conformations of HSP90α/β appear to strongly influence isoform selectivity.  The rational design of HSP90α/β inhibitors selective vs. the mitochondrial (TRAP1) and endoplasmic reticulum (GRP94) isoforms offers a potential mitigating strategy for mechanism-based toxicities.  Better tolerated HSP90 inhibitors would be attractive for targeting chronic neurodegenerative diseases such as Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64ZOr5JsRerVg90H21EOLACvtfcHk0li3RIYLBx-3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO&md5=6799a46090ee297d70700f7c42b79f80</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DKallel%26aufirst%3DA.%26aulast%3DVought%26aufirst%3DB.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DCorrelation%2520between%2520chemotype-dependent%2520binding%2520conformations%2520of%2520HSP90%25CE%25B1%252F%25CE%25B2%2520and%2520isoform%2520selectivity-Implications%2520for%2520the%2520structure-based%2520design%2520of%2520HSP90%25CE%25B1%252F%25CE%25B2%2520selective%2520inhibitors%2520for%2520treating%2520neurodegenerative%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D204%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2013.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llauger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huezo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span>. <i>J. Biomol. Screen.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1177/1087057104265995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=L.+Llaugerauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+Hsp90&doi=10.1177%2F1087057104265995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0li3RIYLBx-3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381%26doi%3D10.1177%2F1087057104265995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woody, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcacio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3400</span>, <span class="refDoi"> DOI: 10.1021/jm500042s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500042s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=3382-3400&author=J.+T.+Ernstauthor=T.+Neubertauthor=M.+Liuauthor=S.+Sperryauthor=H.+Zuccolaauthor=A.+Turnbullauthor=B.+Fleckauthor=W.+Kargoauthor=L.+Woodyauthor=P.+Chiangauthor=D.+Tranauthor=W.+Chenauthor=P.+Snyderauthor=T.+Alcacioauthor=A.+Nezamiauthor=J.+Reynoldsauthor=K.+Alviauthor=L.+Gouletauthor=D.+Stamos&title=Identification+of+novel+HSP90%CE%B1%2F%CE%B2+isoform+selective+inhibitors+using+structure-based+drug+design.+demonstration+of+potential+utility+in+treating+CNS+disorders+such+as+Huntington%E2%80%99s+disease&doi=10.1021%2Fjm500042s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease</span></div><div class="casAuthors">Ernst, Justin T.; Neubert, Timothy; Liu, Michael; Sperry, Samuel; Zuccola, Harmon; Turnbull, Amy; Fleck, Beth; Kargo, William; Woody, Lisa; Chiang, Peggy; Tran, Dao; Chen, Weichao; Snyder, Phillip; Alcacio, Timothy; Nezami, Azin; Reynolds, James; Alvi, Khisal; Goulet, Lance; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-based drug design strategy was used to optimize a novel benzolactam series of HSP90α/β inhibitors to achieve >1000-fold selectivity vs. the HSP90 endoplasmic reticulum and mitochondrial isoforms (GRP94 and TRAP1, resp.).  Selective HSP90α/β inhibitors were found to be equipotent to pan-HSP90 inhibitors in promoting the clearance of mutant huntington protein (mHtt) in vitro, however with less cellular toxicity.  Improved tolerability profiles may enable the use of HSP90α/β selective inhibitors in treating chronic neurodegenerative indications such as Huntington's disease (HD).  A potent, selective, orally available HSP90α/β inhibitor, 8-Cyclopentyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one, was identified that crosses the blood-brain barrier and demonstrated proof of concept by successfully reducing brain Htt levels following oral dosing in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKpHcuphxPXbVg90H21EOLACvtfcHk0li3RIYLBx-3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D&md5=0d55fb738fc0f0615b5336b8dc17056a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500042s%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DFleck%26aufirst%3DB.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DWoody%26aufirst%3DL.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSnyder%26aufirst%3DP.%26aulast%3DAlcacio%26aufirst%3DT.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DAlvi%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520novel%2520HSP90%25CE%25B1%252F%25CE%25B2%2520isoform%2520selective%2520inhibitors%2520using%2520structure-based%2520drug%2520design.%2520demonstration%2520of%2520potential%2520utility%2520in%2520treating%2520CNS%2520disorders%2520such%2520as%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26spage%3D3382%26epage%3D3400%26doi%3D10.1021%2Fjm500042s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slamon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, W. L.</span></span> <span> </span><span class="NLM_article-title">Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1126/science.3798106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1126%2Fscience.3798106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=3798106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADyaL2sXhtVSht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=177-182&author=D.+J.+Slamonauthor=G.+M.+Clarkauthor=S.+G.+Wongauthor=W.+J.+Levinauthor=A.+Ullrichauthor=W.+L.+McGuire&title=Human+breast+cancer%3A+correlation+of+relapse+and+survival+with+amplification+of+the+HER-2%2Fneu+oncogene&doi=10.1126%2Fscience.3798106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Human breast cancer:  correlation of relapse and survival with amplification of the HER-2/neu oncogene</span></div><div class="casAuthors">Slamon, Dennis J.; Clark, Gary M.; Wong, Steven G.; Levin, Wendy J.; Ullrich, Axel; McGuire, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">4785</span>),
    <span class="NLM_cas:pages">177-82</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The HER-2/neu oncogene is a member of the erbB-like oncogene family, and is related to, but distinct from, the epidermal growth factor receptor.  This gene has been shown to be amplified in human breast cancer cell lines.  In the current study, alterations of the gene in 189 primary human breast cancers were investigated.  HER-2/neu was found to be amplified from 2- to >20-fold in 30% of the tumors.  Correlation of gene amplification with several disease parameters was evaluated.  Amplification of the HER-2neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer.  It retained its significance even when adjustments were made for other known prognostic factors.  Moreover, HER-2/neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal-receptor status, in lymph node-pos. disease.  These data indicate that this gene may play a role in the biol. behavior and(or) pathogenesis of human breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWPpNbN8S_QrVg90H21EOLACvtfcHk0lgq2T0K6LRn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtVSht7s%253D&md5=0889410d6e47651de4d8085e9bbd70d9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscience.3798106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3798106%26sid%3Dliteratum%253Aachs%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DClark%26aufirst%3DG.%2BM.%26aulast%3DWong%26aufirst%3DS.%2BG.%26aulast%3DLevin%26aufirst%3DW.%2BJ.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DMcGuire%26aufirst%3DW.%2BL.%26atitle%3DHuman%2520breast%2520cancer%253A%2520correlation%2520of%2520relapse%2520and%2520survival%2520with%2520amplification%2520of%2520the%2520HER-2%252Fneu%2520oncogene%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D177%26epage%3D182%26doi%3D10.1126%2Fscience.3798106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffernan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1729</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1128/MCB.6.5.1729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1128%2FMCB.6.5.1729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=2878363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADyaL28XktlKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1986&pages=1729-1740&author=D.+F.+Sternauthor=P.+A.+Heffernanauthor=R.+A.+Weinberg&title=p185%2C+a+product+of+the+neu+proto-oncogene%2C+is+a+receptorlike+protein+associated+with+tyrosine+kinase+activity&doi=10.1128%2FMCB.6.5.1729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">p185, A product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity</span></div><div class="casAuthors">Stern, David F.; Heffernan, Patricia A.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1729-40</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The neu oncogene was originally identified in cell lines derived from rat neuroectodermal tumors; neu is related to but distinct from the c-erbB gene, which encodes the epidermal growth factor (EGF) receptor.  Instead, neu encodes a protein, designated p185, that is serol. related to the EGF receptor.  Identification of the normal homolog of p185 encoded by the neu proto-oncogene permitted comparison of the product of the neu proto-oncogene with the mutated version specified by the neu oncogene and with the EGF receptor.  The normal form of p185 was structurally similar to its transforming counterpart, indicating that activation of the neu oncogene did not cause major structural alterations in the gene product.  Both normal and transforming forms of p185 were assocd. with tyrosine kinase  [80449-02-1] activity, supporting the idea that normal p185 functions as a growth factor receptor.  The p185 differed both structurally and functionally from the EGF receptor; the 2 proteins had distinct electrophoretic mobilities when synthesized under normal culture conditions or in the presence of tunicamycin.  EGF did not stimulate increased turnover of p185 and did not bind quant. to p185.  A no. of other growth factors failed to stimulate either degrdn. of p185 or tyrosine phosphorylation of p185 and are therefore unlikely to be ligands for p185.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJA1YsOnmi0LVg90H21EOLACvtfcHk0lgq2T0K6LRn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktlKlsr0%253D&md5=3d97172b5179592e7651d5e8dc1c1177</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FMCB.6.5.1729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.6.5.1729%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DD.%2BF.%26aulast%3DHeffernan%26aufirst%3DP.%2BA.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3Dp185%252C%2520a%2520product%2520of%2520the%2520neu%2520proto-oncogene%252C%2520is%2520a%2520receptorlike%2520protein%2520associated%2520with%2520tyrosine%2520kinase%2520activity%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1986%26volume%3D6%26spage%3D1729%26epage%3D1740%26doi%3D10.1128%2FMCB.6.5.1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moasser, M. M.</span></span> <span> </span><span class="NLM_article-title">The oncogene HER2; Its signaling and transforming functions and its role in human cancer pathogenesis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">6469</span>– <span class="NLM_lpage">6487</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=10.1038%2Fsj.onc.1210477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=17471238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=6469-6487&author=M.+M.+Moasser&title=The+oncogene+HER2%3B+Its+signaling+and+transforming+functions+and+its+role+in+human+cancer+pathogenesis&doi=10.1038%2Fsj.onc.1210477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis</span></div><div class="casAuthors">Moasser, M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">6469-6487</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The year 2007 marks exactly two decades since Human Epidermal Growth Factor Receptor-2 (HER2) was functionally implicated in the pathogenesis of human breast cancer.  This finding established the HER2 oncogene hypothesis for the development of some human cancers.  The subsequent two decades have brought about an explosion of information about the biol. of HER2 and the HER family.  An abundance of exptl. evidence now solidly supports the HER2 oncogene hypothesis and etiol. links amplification of the HER2 gene locus with human cancer pathogenesis.  The mol. mechanisms underlying HER2 tumorigenesis appear to be complex and a unified mechanistic model of HER2-induced transformation has not emerged.  Numerous hypotheses implicating diverse transforming pathways have been proposed and are individually supported by exptl. models and HER2 may indeed induce cell transformation through multiple mechanisms.  Here I review the evidence supporting the oncogenic function of HER2, the mechanisms that are felt to mediate its oncogenic functions, and the evidence that links the exptl. evidence with human cancer pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3J_STszvOrVg90H21EOLACvtfcHk0lgq2T0K6LRn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagsbnN&md5=1ca26e99dc27692105e2751c90ccdb45</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210477%26sid%3Dliteratum%253Aachs%26aulast%3DMoasser%26aufirst%3DM.%2BM.%26atitle%3DThe%2520oncogene%2520HER2%253B%2520Its%2520signaling%2520and%2520transforming%2520functions%2520and%2520its%2520role%2520in%2520human%2520cancer%2520pathogenesis%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D6469%26epage%3D6487%26doi%3D10.1038%2Fsj.onc.1210477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYM','PDB','1UYM'); return false;">PDB: 1UYM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XAB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XAB','PDB','2XAB'); return false;">PDB: 2XAB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UCJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UCJ','PDB','5UCJ'); return false;">PDB: 5UCJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O0B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O0B','PDB','4O0B'); return false;">PDB: 4O0B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH7','PDB','4NH7'); return false;">PDB: 4NH7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01700">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47663"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01700?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01700</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Effect of Hsp90β inhibition on proliferation of Hsp90α KO cells, HPLC analysis of select compound, and NCI-60 cell line screening results of <b>4d</b> and <b>6a</b>; Grp94 and Trap1 inhibition data, GI50 values of <b>4a</b>, <b>5b</b>, and <b>6a</b> against Hek293 cells, molecular formula strings file with IC50 value against cancer cell lines and computational models (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_002.csv">CSV</a>)</p></li><li><p class="inline"><b>4d</b> (beta) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_003.pdb">PDB</a>)</p></li><li><p class="inline"><b>4d</b> (alpha) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_004.pdb">PDB</a>)</p></li><li><p class="inline"><b>6a</b> (beta) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_005.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_001.pdf">jm0c01700_si_001.pdf (1.37 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_002.csv">jm0c01700_si_002.csv (0.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_003.pdb">jm0c01700_si_003.pdb (149.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_004.pdb">jm0c01700_si_004.pdb (151.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01700/suppl_file/jm0c01700_si_005.pdb">jm0c01700_si_005.pdb (149.22 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01700&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01700" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01700" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991bef2dacd94e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
